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Abstract 
Matrix-induced autologous chondrocyte implantation offers a potential cure for joint 
disease and is currently challenged by loss of differentiated phenotype upon culture. To 
investigate the mechanism of dedifferentiation, chondrocytes were cultured at low 
density (1x104cell/cm2) and subcultured on days 9 (P1), 14 (P2) and 21 (P3). A loss of a 
differentiated phenotype was observed in P1 with a reduction in sphericity from 
0.72±0.02 to 0.52±0.03. Changes in cellular dimensions in response to 2D culture were 
additionally recorded with an increase and decrease in cell length and depth, 
respectively, yielding an increase in cell volume from 474.72±32.08 to 
725.20±35.55µm3. Furthermore, the effect of 2D culture-induced dedifferentiation on 
mechanotransduction was investigated in response to a hyperosmotic challenge 
whereby regulatory volume increase (RVI) was only observed in 2D cultured 
chondrocytes with linear volume recovery rates in P1 and biphasic RVI in P2 and P3. 
Similarly, a REV5901-induced intracellular calcium rise via PLCβ  and PKC was shown 
to be sensitive to extracellular sodium ([Na+]e) in freshly isolated and Gd3+ in 2D 
cultured chondrocytes. A 2.70±0.63-fold increase in type I collagen (col1) expression 
was observed in P1 chondrocytes, whereas a 1.58±0.43-fold increase in type II 
collagen (col2) was followed by a decline to baseline levels upon further culture. A 
transient rise in the chondrocytic transcription factor Sox9 and Developmental 
Endothelial Locus 1 (DEL1) was observed in P1 chondrocytes, suggesting the 
existence of a third phenotype termed ‘mesodifferentiated*’ and a potential role for 
DEL1 in chondrocyte dedifferentiation. DEL1 knockdown by RNA interference (RNAi) 
promoted a differentiated phenotype as characterised by a decrease in cell volume, 
reduced col1 expression, inhibition of RVI and elevated sensitivity to [Na+]e. DEL1 
knockdown was shown to inhibit P1-associated Akt phosphorylation and the expression 
of the dedifferentiation transcription factor Twist, additionally reduced in the presence of 
R-Etodolac. The induction of Sox9 expression using Bone Morphogenetic Protein 2 and 
Twist knockdown using RNAi enhanced the expression of DEL1, suggesting DEL1 
regulation of dedifferentiation by a feedback signal previously unreported.  
                                                 
* Greek, from mesos, middle 
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1 Introduction 
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Osteoarthritis (OA) is a common joint disease that leads to disability with six 
million working days lost in the UK and a total estimated cost totalling £5.5 billion 
(Peach et al., 2005). An emerging treatment for OA is cartilage replacement 
where cartilage explants are removed from patients, the chondrocytes isolated 
and then subsequently grown in 2D (expansion) monolayer culture medium in 
vitro (Giannoni et al., 2005; Sgaglione, 2005; Tallheden et al., 2005). An 
important factor when working with articular cartilage is the regulation of the cell 
phenotype whereby as a result of monolayer culture, chondrocytes undergo 
dedifferentiation and acquire a fibroblast-like phenotype (Benya & Shaffer, 
1982b). Changes in cell shape, actin reorganisation, regulatory volume increase 
(RVI), calcium homeostasis, and key genes expression was investigated in 
response to 2d culture to further our understanding of dedifferentiation. 
 
1.1 Cartilage and Chondrocytes 
 
1.1.1 Structure of Cartilage 
Articular Cartilage is a dense connective tissue which provides a scaffold for 
bone deposition and smooth surfaces for the movement of articulating bones 
(Stockwell, 1978; Buckwalter & Mankin, 1998; Gray, 2000). Cartilage, in 
conjunction with synovial fluid, provides protection against both compressive 
and dynamic loading as a consequence of joint use by dissipating the weight 
over a larger surface area (Stockwell, 1971b, c; Gray, 2000). Cartilage has a 
glassy appearance with a white colour (Stockwell, 1979; Hall, 1998b). Cartilage 
is comprised of an extracellular matrix (ECM) synthesised by the only resident 
cell type chondrocytes, which account for ~10% of the tissue volume as 
measured in adult human hip cartilage (Stockwell, 1971a; Byers et al., 1977). In 
response to physio-chemical environment, chondrocytes maintain a balance of 
anabolism and catabolism of a limited number of ECM macromolecules thus 
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maintaining and adapting the ECM to the forces against it (Holmes et al., 1988; 
Urban, 1994; Archer & Francis-West, 2003; Lin et al., 2006). 
 
The ECM of articular cartilage is comprised principally of collagen type II, which 
is the most abundant form of collagen in healthy adult cartilage (Matyas et al., 
1995; Nalin et al., 1995), and proteoglycan (PG). PGs contribute to the ability of 
cartilage to resist compression (Urban, 1994) and are composed of chains of 
Glucosaminoglycans (GAG; mainly chondroitin sulphate and keratan sulphate) 
attached to aggrecan core protein (Hughes, 1997). PGs are further interlinked 
by a backbone of hyaluronic acid, which is in turn bound to cluster of 
differentiation 44 (CD44) on the chondrocyte cell membrane, forming clusters in 
the order of 5x104 to 5x105 kDa (Figure 1.1). Due to the negative charge on their 
carboxyl and sulphonic groups, PGs have a high affinity to cations (mainly, 
sodium and to a less extent potassium and calcium) and therefore contribute to 
a relatively higher ionic strength of cartilage (310-370 mOsm) compared to that 
of other body fluids (Stockwell, 1991b; Urban, 1994; Wilkins et al., 2000). 
 
 
Type II Collagen is a homotrimeric protein with a characteristic Gly-X-Y repeat 
forming right handed helical fibres fibres, 30-200nm in diameter. Collagen type I 
is expressed in smaller quantities throughout cartilage and more abundantly in 
bone-cartilage surface (Roberts, 1985) forming a heterotrimeric helix. 
Conversely, Type IX collagen is a highly glycosylated non fibular protein that 
interlinks type II collagen fibres, thereby forming a complex mesh that ‘traps’ 
chondrocytes and prevents maximal hydration of PGs (Stockwell, 1991a; Eyre et 
al., 2002). This mesh is able to tolerate high pressures that arise during load 
bearing, sometimes as high as 0.2MPa in the adult human hip (Hodge, 1986). 
 
As well as structural proteins, cartilage comprises of other proteins involved in 
the regulation of the ECM. Fibronectin, Anchorin and Cartilage Oligomeric 
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Proteins (COMP) are involved in linking extracellular fibres to the chondrocyte 
cell surface and are thus implicated in the maintenance and repair of ECM 
(Roberts, 1985). COMP interacts with type II collagen by its third epithelial 
growth factor (EGF) repeat (Tan et al., 2009) where mutations can cause 
osteochondrodysplasias pseudoachondroplasia (Song et al., 2003; Tufan et al., 
2007), thereby suggesting a role for COMP in cartilage development. 
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Figure 1.1: Schematic diagram of the structure of the extracellular matrix (ECM). 
The extracellular matrix (ECM) of cartilage is mainly composed of proteoglycans (PGs) and 
collagen fibrils. PGs branch from hyaluronan molecules that extend from the chondrocyte cell 
surface. Negatively charged glycosaminoglucan chains of PGs attract cations and cause water 
retention in the tissue. Collagen Type II fibrils are interlinked by collagen Type IX fibrils and 
together they form a mesh that traps PGs. Adapted from Urban, 1994.  
Collagen Type 
II fibrils 
Fixed Cations 
Proteoglycan 
Hyaluronan 
Mobile Anions 
Chondrocyte 
Nucleus 
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1.1.2 Chondrocytes and chondrocytic phenotype 
Chondrocytes are the only resident cells found in cartilage at a density of up to 
10,000 chondrocytes/mm3 in human adult femoral head cartilage and are 
responsible for the maintenance of the cartilage ECM (Stockwell, 1971). During 
embryogenesis, chondrocyte are extensively distributed within the foetus and 
are responsible for the longitudinal bone growth within the epiphyseal growth 
plate (Hall & Miyake, 1992; Archer & Francis-West, 2003). Chondrocytes 
differentiate from colony-forming unit-fibroblast, and later mesenchymal stem 
cells (MSC) which appear as condensations between 10-12 days postcoitum 
and initially express collagen type I prior to differentiation into foetal 
chondrocytes (Lui et al., 1995). 
 
In vivo, three distinct chondrocytic phenotypes have been observed in healthy 
tissue; foetal in embryonic tissue, hypertrophic in immature, and differentiated in 
mature cartilage. During embryogenesis, mesenchymal stem cells differentiate 
into foetal chondrocytes, which are arranged in two distinct zones termed 
reserve and proliferative zones (Ryan & Sandell, 1990). Chondrocytes in the 
reserve zone possess a volume of 1500±240µm3, are uniform yet compactly 
arranged, and occur singly or in pairs (Melrose et al., 2008). Conversely, 
chondrocytes in the proliferative zone are flat and well divided into longitudinal 
columns with exclusive mitotic activity (Ballock & O'Keefe, 2003). Foetal 
chondrocytes switch to the expression of chondrocyte specific type II collagen 
(Ryan & Sandell, 1990; Sandell et al., 1991) in addition to type IX and XI 
collagens, while levels of type I collagen expression are significantly inhibited 
(Luo et al., 1995).  
 
During postnatal bone growth, foetal chondrocytes in growth plates proceed 
through a differentiation pathway characterised by cellular enlargement 
(chondrocyte hypertrophy) and resulting in terminal differentiation (Drissi et al., 
2005). Hypertrophic chondrocytes increase in volume by a factor ~10x 
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compared to foetal chondrocytes reaching a volume of 17,500±425µm3 (Bohme 
et al., 1995; Ng et al., 1997; DeLise et al., 2000), primarily as a result of water 
imbibition (Buckwalter et al., 1986), and express high levels of collagen X, the 
role of which is to facilitate calcium deposition within the matrix (Alvarez et al., 
2001). 
 
Differentiated (mature) chondrocytes synthesise and maintain the ECM, and are 
therefore ‘maturationally arrested’ and do not exhibit proliferation potential 
(Sailor et al., 1996; Buckwalter & Mankin, 1998; Drissi et al., 2005). As cartilage 
is avascular in nature, chondrocytes operate and maintain low oxygen tension to 
outgrow fibroblasts, and rely on nutrients obtained from the articular surface by 
diffusion (Rajpurohit et al., 1996) as well as signals obtained by the extracellular 
ionic environment and ECM interactions (Stockwell, 1991a). Chondrocytes 
produce PGs and types II, III, IX and XI collagens, degrading the ECM by the 
secretion of collagenases and gelatinases and inhibit blood vessel invasion by 
synthesis of tissue inhibitor metalloproteinases (Stockwell, 1991a).  
 
A cross section of mature cartilage (Figure 1.2) highlights the presence of four 
zones; superficial zone (SZ), middle zone (MZ), deep zone (DZ) and calcified 
zone (Stockwell, 1991a). In the SZ, collagen fibres are densely packed around 
flattened chondrocytes, ellipsoid in shape and are approximately 2-3µm in 
diameter with a volume of 454±18µm3, whereas In the MZ, chondrocytes are 
spherical (sometimes found in pairs) with a lightly larger volume of 553±15µm3 
and are embedded in randomly arranged collagen fibres forming a ‘Basket 
Weave’ structure (Table 1.1). The DZ is characterised by columns of ellipsoid 
cells possessing a volume of 805±79µm3 distributed between radially oriented 
collagen fibres that extend into the calcified zone (Stockwell, 1991a; Hall, 
1998b).  
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The transcription factor SOX9 is a key regulator of chondrocyte differentiation in 
both mesenchymal stem cells and foetal chondrocytes (Ng et al., 1997; DeLise 
et al., 2000) and the expression level remains elevated in differentiated 
chondrocytes accounting to 20% of the expression of Glyceraldehyde 3-
phosphate dehydrogenase (GAPD) (Haag et al., 2008). The expression of 
various chondrocyte-specific genes including type II collagen is tightly regulated 
by chondrocyte-specific SOX9 transcription factor (de Crombrugghe et al., 2000) 
and mutations in SOX9 lead to skeletal malformation syndromes including 
campomelic dysplasia (Sock et al., 2003). 
 
Chondrocytes are able to ‘sense’ and respond to external factors and regulate 
matrix synthesis to the forces and stimuli perceived, some of which will be 
introduced in following sections (Table 1.2). 
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Figure 1.2: Representative image of bovine articular cartilage. 
Cartilage explant from bovine metacarpal and metatarsal pharyngeal joints were isolated 
asceptically and loaded with 5µM calcein-AM (green) and propidium iodide (red) and  
subsequently imaged using confocal laser scanning microscopy. Chondrocytes in Superficial 
Zone are aligned parallel to the cartilage surface, whereas in the Mid Zone and Deep Zone, 
chondrocytes are found in pairs or in columnar stacks of 4 perpendicular to the articular surface, 
respectively. Image acquired by Dr Mark J. P. Kerrigan, adapted with permission.  
Calcified Zone 
 
Deep Zone (DZ) 
 
Mid Zone (MZ) 
 
Superficial Zone (SZ) 
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Table 1.1: Summary of the properties of the zones of mature articular cartilage.  
Chondrocytes in the three zones of cartilage appear to possess distinctly different 
characteristics. Chondrocytes in the Superficial Zone (SZ) are embedded in tangentially 
arranged collagen fibres whereas in the Mid Zone (MZ), chondrocytes are larger in diameter and 
thus volume, found in pairs and embedded in a ‘basketweave’ structure of collagens. In the 
Deep Zone (DZ), however, chondrocytes are still larger than in the MZ and arranged in collagen 
fibres with an orientation perpendicular to the articular surface {Hall, 1998; Urban, 1994; 
Maroudas, 1980; Bush and Hall, 2001). 
 
 
Zone Chondrocyte 
morphology 
Volume 
(µm3) 
Cellular 
Density 
(%) 
Collagen 
orientiation 
Osmolarity 
(mOsm) 
 
SZ 
 
Single, 
ellipsoid 
 
454±18 
 
17% 
Tangential, tight 
fibrils mainly 
aligned with 
tangential stress 
 
310 – 370 
 
MZ 
 
 
Single or in 
pairs, ovoid 
 
553±15 
 
53% 
 
Radial random 
‘basketweave’ 
 
- 
 
DZ 
 
Small groups, 
short columns 
of 2-6 cells 
 
805±79 
 
30% 
 
Perpindicular to 
articular surface 
 
370 - 480 
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Table 1.2: The effect of various stimuli on the regulation of ECM in chondrocytes. 
Chondrocytes are able to respond to chemical and mechanical stimuli by the regulation of the 
Extracelullar Matrix. In response to Vitamin D3, ascorbic acid or mechanical loading there was 
an upregulation of aggrecan synthesis, whereas incubation with Interleukin 1β or in hypo-
osmotic condtions suppressed the expression of collagen and proteoglycans.  
 
 
Regulator Effect References 
Vitamin D3 Stimulation of proteoglycan 
synthesis 
Harmand et al., 1984; 
Horton et al., 1991 
Ascorbic Acid Expression of type X 
collagen 
Hering et al., 1994 
Thyroid hormone Increase in alkaline 
phophatase synthesis 
Williams et al., 1998 
Mechanical loading Stimulation of aggrecan 
synthesis 
Buschmann et al., 1996; 
Valhmu et al., 1998 
Interleukin 1β Suppression of collagen and 
proteoglycan synthesis 
Ikebe et al., 1988; Tyler & 
Benton, 1988; Yaron et 
al., 1989 
Hypo-osmotic 
conditions 
Suppression of matrix 
synthesis 
Hopewell & Urban, 2003 
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1.2 Osteoarthritis 
 
Osteoarthritis (OA; or more accurately yet less commonly referred to as 
Osteoarthrosis) is a common joint disease that leads to disability. In the UK, 7 
million people are diagnosed with OA (Arthritis Research Campaign website), 
and 206 million working days were lost in 1999-2000 with a total estimated cost 
of £5.5 billion (Peach et al., 2005). Symptoms of OA include pain, stiffness and 
in severe cases loss of joint function (Bulstrode, 2002).  
 
Cartilage can be damaged by bone remodelling or trauma (Roos et al., 1998), 
metabolic diseases (haemochromatosis and Ochnronosis), accumulation of 
toxins in the synonvium, alteration in load bearing in people suffering from 
obesity (Anderson & Felson, 1988) or anatomical abnormalities (Roos et al., 
1998; Mototani et al., 2005). This is followed by attempted cartilage repair which 
leads to cartilage “fibrillation” (Stockwell, 1991a), subchondral cyst formation, 
bone outgrowth, hyperplasia of the synovium and sclerosis of subchondral bone 
(Stevens & Lowe, 2000).  
 
In OA, there is an increase in cartilage hydration attributed to the degradation of 
collagen structures and thus the increased swelling capacity of PGs (Stockwell, 
1991b). Tissue hydration causes an increase in the bioavailability of diffusible 
factors, including cytokines and nutrients, and subsequent changes in ionic 
environment. An increase in OA chondrocyte cell volume was also observed and 
an article reported that it was due to passive swelling in the over-hydrated tissue 
(Bush & Hall, 2005).  
 
On the cellular level, OA chondrocytes escape the maturation arrest (tightly 
regulated by Transforming Growth Factor Beta; TGF-β) and undergo a 
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hypertrophic-like Bone Morphogenetic Protein (BMP) dependent maturation 
(Ballock et al., 1993; Serra et al., 1999; Grimsrud et al., 2001; Li et al., 2006) 
whilst expressing high levels of types X, III, IIA and VI collagen (Schmid et al., 
1991; Aigner et al., 1995; Soder et al., 2002; Gebhard et al., 2003) and 
abnormal levels of versican, a chondroitin sulphate proteoglycan (Martin et al., 
2001). Moreover, there is also an upregulation of inflammatory mediators 
including IL-1β, IL-4, TNFα, Nitric Oxide (LeGrand et al., 2001), and matrix 
metalloproteinases (Tetlow et al., 2001; Fernandes et al., 2002). 
 
Osteoarthritis is managed using painkillers (Paracetamol), non-steroidal anti-
inflammatory drugs (NSAIDs; aspirin, Ibuprofen and, to a less degree, selective 
COX-2 inhibitors including Celecoxib) and/or corticosteroid treatment 
(Prednisone; on the website of the National Health Service). More recent 
developments in OA therapy include MabThera, a chimeric human monoclonal 
antibody against CD20 (Tsiakalos et al., 2008; Nakou et al., 2009), and other 
similar biotechnological drugs against TNFα and IL-1 (Koumakis et al., 2009; 
Mertens & Singh, 2009). Nevertheless, the aetiology and mechanism of disease 
progression is still largely unknown and the only treatment to OA is joint 
arthroplasty. 
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1.3 In vitro Expansion of chondrocytes 
 
An emerging treatment for OA is cartilage replacement (Giannoni et al., 2005; 
Sgaglione, 2005; Tallheden et al., 2005) whereby cartilage explants are 
removed from patients and chondrocytes isolated, and subsequently grown 
(‘expanded’) in 2D monolayer culture medium in vitro until a suitable density is 
reached. Chondrocytes can then be re-introduced into the patient via a 3D 
support (Chen et al., 2003; Kino-oka et al., 2005). The focus of this technology is 
to provide a viable cartilage replacement, specific to an individual patient, and 
thus improve the treatment of OA although there are technological limitations to 
this therapy. 
 
Regulation of the chondrocyte phenotype is an important factor when working 
with articular cartilage (Drissi et al., 2005). As previously discussed, 
chondrocytes in situ exhibit a ‘differentiated’ phenotype whereby chondrocytes 
appear rounded (Figure 1.3A) and express aggrecan and elevated levels of 
ratios of collagen type II to collagen type I expression (Benya et al., 1981; Benya 
& Shaffer, 1982a). Conversely, as a result of monolayer culture, chondrocytes 
exhibit what is termed ‘dedifferentiated phenotype’ acquring fibroblast-like 
morphology (Figure 1.3B) and low ratio of expression of type II collagen to type I 
collagen (Benya & Shaffer, 1982b; Stokes et al., 2001; Table 1.3).  
 
Dedifferentiated phenotype is also characterised by the expression of Cathepsin 
B (Benya et al., 1981; Benya & Shaffer, 1982a; Baici et al., 1988b) and Twist 
(Stokes et al., 2002), a transcription factor that forms complexes with a wide 
range of transcription factors (Reinhold et al., 2006). In chondrocytes, the 
expression of Twist via β-catenin-dependent pathway strongly inhibited SOX9-
mediated differentiated phenotype (Reinhold et al., 2006). Moreover, Twist 
interacts with transcription factor 3 leading to expression of CD44 (Nusse, 
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2005), a collagen receptor upregulated in 2D-cultured chondrocytes (Stokes et 
al., 2002). 
 
 
Trying to ‘recapture’ the chondrocytic differentiated phenotype following 
expansion has been under intensive research. It has been shown that it was 
possible to maintain the chondrocyte phenotype by growing chondrocytes in 3D 
supports composed of type II collagen, agarose or alginate (Nehrer et al., 1997; 
Beekman et al., 1997; Benz et al., 2002b; Miot et al., 2005a). Supplementation 
with TGFβ1 or BMP6 induced the upregulation of chondrocyte-specific genes 
including type II collagen, SOX9 and aggrecan (Zhou et al., 2008; Sung et al., 
2009; van der Windt et al., 2009). Similarly, the application of cyclic hydrostatic 
pressure has been shown to induce the expression of GAG and type II collagen 
whilst downregulating type I collagen (Heyland et al., 2006; Kawanishi et al., 
2007). Finally, treatment with actin depolymerising drugs including cytochalasin 
D have been shown to induce the re-expression of type II collagen and 
upregulation of PGs synthesis (Newman & Watt, 1988; Benz et al., 2002a; Miot 
et al., 2005b).  
 
The success of the recapture methodologies was found to be influenced by the 
passage number where introduction of chondrocytes cultured for 3-12 days into 
3D high-density culture induced a recovery of phenotype (Shakibaei, 1998, 
Schulze-Tanzil et al., 2002). Upon further culture, however, chondrocyte 
phenotype recovery was abolished, suggesting the existence of irreverisibly 
dedifferentiated chondrocytes in later passages (Haisch et al., 2006). 
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Table 1.3: Summary of chondrocytic phenotypes in relation to the types of collagen 
synthesised. 
The types of collagen synthesised in the extracellular matrix is highly dependent on the 
chondrocytic phenotype. In vivo, foetal chondrocytes express elevated levels of type III collagen, 
hypertrophic chondrocytes are characterised by the expression of type X collagen and 
differentiated adult chondrocytes by the expression of predominantly type II collagen. In 
Osteoarthritic tissue however, chondrocytes express elevated levels of type X and VI collagen 
and upon 2D culture chondrocytes upregulated the expression of type I collagen. 
 
 
Phenotype Collagen References 
Foetal Type III Hayes et al., 2001 
Differentiated Type II, III, IX, XI Benya & Shaffer, 1982b; Benya et al., 1988; 
Hauselmann et al., 1994; Hauselmann et al., 
1996 
Dedifferentiated 
(Fibroblastic) 
 
Type I, III Benya & Shaffer, 1982b; Baici et al., 1988a; 
Liu et al., 1998; Zwicky & Baici, 2000 
Hypertrophic Type X (Aigner & McKenna, 2002) 
Osteoarthritic Type II, III, X, VI Aigner et al., 1995; Soder et al., 2002; 
Gebhard et al., 2003 
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Figure 1.3: Morphology of freshly isolated and 2D-cultured chondrocytes 
Freshly isolated and 2D-cultured chondrocytes were incubated with 5µM calcein-AM for 30 
minutes and imaged using confocal microscopy (Panels A and B, respectively). Freshly isolated 
chondrocytes (Panels A) possessed a round shape, whereas following 21 days in monolayer 
culture, 2D-cultured chondrocytes (Panels B) appeared ‘fibroblastic’ with an irregular ‘flat’ 
morphology. 
B A 
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1.4 Mechanotransduction and Calcium Homeostasis 
 
As previously mentioned, chondrocytes residing in articular cartilage are 
subjected to various mechanical stimuli and possess the capacity to ‘sense’ and 
convert these stimuli into chemical and physiological responses using a group of 
mechanisms termed mechanotransduction. Mechanotransduction of these 
stimuli enables chondro-cytes to adapt to the changes in the extracellular 
environment and respond appropriately to maintain optimal intracellular 
environment and/or to modify extracellular matrix components. Calcium 
signalling is a crucial factor in regulation of chondrocytic phenotype and changes 
in intracellular calcium ([Ca2+i]) have been closely linked to different mechanical 
signals including fluid flow (Yellowley et al., 1997; Yellowley et al., 1999), 
osmotic challenge (Urban et al., 1993; Hopewell & Urban, 2003; Kerrigan & Hall, 
2005; Kerrigan et al., 2006), pressure (Guilak et al., 1999a) and membrane 
deformation (Guilak et al., 1999b).  
 
During walking, the pressure on articulating cartilage oscillates between 0.2MPa 
and 0.3-0.5MPa and results in the deformation of cartilage and chondrocytes 
embedded within (Broom & Myers, 1980). Above 0.5MPa static compression 
causes irreversible damage to cartilage and chondrocyte metabolic activities are 
impaired (Burton-Wurster et al., 1993; Guilak et al., 1994). Pressure also 
induces the loss of interstitial fluid, concentration of PG’s and thus an increase in 
extracellular osmolarity, an effect which is reversible in healthy cartilage upon 
removal of the load, with the tissue rehydrating until equilibrium is reached 
(Maroudas & Bannon, 1981; Urban, 1994). Pressure induces a set of cellular 
responses including integrin α5β1 activation (Wright et al., 1997), PLB3K-
dependent calcium rise (Valhmu et al., 1998) and the up-regulation of aggrecan, 
collagen type II, β-actin and Matrix metalloproteinase (MMP) -3 (Lee et al., 2000; 
Millward-Sadler et al., 2000).  
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Chondrocytes are embedded in an overall negatively charged matrix attracting 
cations, which in turn increase the water content of cartilage. The mobile fluid 
phase flows surrounding chondrocytes during joint articulation, and therefore, 
fluid flow has been employed in vitro to mimic shear-induced stress (Yellowley et 
al., 1997). It has been observed that fluid flow induced both a G-protein-
mediated Ca2+ release from intracellular stores and stretch-activated cation 
channels (SACC) activation (Yellowley et al., 1997; Yellowley et al., 1999). 
Conversely, membrane deformation, as a result of fluid flow in vivo or 
mechanical stimulation in vitro, has been shown to induce an intracellular store-
independent [Ca2+]i  rise which was inhibited by pharmacological inhibitors of 
Sodium Calcium Exchanger (NCX) and SACC (Guilak, 1999). 
 
NCX (also known as Solute carrier family 8 (sodium/calcium exchanger), 
member 3) is involved in maintaining [Ca2+]i  homeostasis in a wide variety of 
cell types with NCX3 being restricted to neurons (Thruneysen et al., 2002). NCX 
can transport Ca2+ at high speed of 5,000 ions/s (Carafoli et al., 2001), is 
regulated by [Ca2+]i  and is found on both the plasma membrane and intracellular 
organellar membranes (Gabellini, 2004). SACC, conversely, is a group of Gd3+-
sensitive channels that respond to mechanical ‘stress’ by allowing the exchange 
of cations. 
 
It has been shown that freshly isolated chondrocytes, but not 2D-cultured 
chondrocytes, exhibited a transient increase in intracellular calcium in a 
gadolinium-sensitive manner in response to a hypo-osmotic challenge (Kerrigan 
& Hall, 2007) mediated by PLC/IP3-depandant calcium release from intracellular 
stores (Sanchez et al., 2003), whereas only NCX was involved in hyperosmotic 
challenge-induce [Ca2+]i  rise (Sanchez & Wilkins, 2004). Moreover, treatment of 
2D cultured chondrocytes with Gadolinium, a SACC inhibitor, induced the loss of 
a differentiated phenotype (Perkins et al., 2005) potentially via a calcium-
dependent pathway (Wright et al., 1996). Therefore, investigating changes in 
calcium signalling pathways is an area of continued research.  
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1.5 Volume Regulation and 2D Expansion 
 
In non-impacted cartilage tissue, the extracellular environment possesses an 
ionic concentration ranging between 355±5mOsm in the SZ and 410±30mOsm 
in the DZ (Urban, 1994). As previously described, joint loading induces an 
changes in extracellular ionic environment (Urban et al., 1993; Kerrigan & Hall, 
2005; Kerrigan et al., 2006) and the activation of volume regulatory mechanism 
including Regulatory Volume Decrease (RVD) and post-RVD Regulatory 
Volume Increase (post-RVD RVI; Kerrigan et al., 2006).  
 
RVI and RVD are two mechanisms by which some cell types maintain constant 
(in dynamic equilibrium) volume and intracellular ionic strength necessary to 
support physiological processes and optimal metabolism during a hyperosmotic 
and hypo-osmotic challenges, respectively (O'Neill, 1999). These mechanisms 
result in an opposing water motion and gradual restoration of cell volume 
(Hoffmann et al., 2007). RVI is mediated by several different types of membrane 
transporters (Figure 1.4) including sodium/potassium/chloride transporter 
(Trujillo et al., 1999; Kerrigan et al., 2006), Na+/H+ antiporter (Trujillo et al., 
1999), anion exchanger (Shrode et al., 1997; Trujillo et al., 1999; Yamazaki et 
al., 2000; Tattersall et al., 2003), Na+/HCO3- coupled cotransporter and Na+/K+ 
pump (O'Neill, 1999).  
 
It has been shown that deviations from range of osmolarity values found 
naturally in vivo resulted in a reduction in ECM production (Urban et al., 1993; 
Hopewell & Urban, 2003). In OA hydrated cartilage, for example, there is a 
decrease in extracellular osmolarity and an increase in fluid flow (Maroudas & 
Venn, 1977; Mizrahi et al., 1986; Bush & Hall, 2005), possibly contributing to 
changes in chondrocyte phenotype in OA.  
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Previous studies have shown variations in response to extracellular omsolarity 
between differentiated and 2D-cultured chondrocytes, and therefore the ability of 
chondrocytes to exhibit volume regulatory mechanisms appears to be closely 
linked to the phenotypic state. 2D-cultured chondrocytes exhibited RVI whereas 
freshly isolated and in situ chondrocytes did not (Kerrigan et al., 2006), thereby 
confirming that 2D-cultured chondrocytes respond differently to mechanical 
stimuli. Nevertheless, treatment of freshly isolated chondrocytes with latrunculin 
B induced a bumetanide-sensitive RVI response suggesting the involvement of 
NKCC1 in RVI in chondrocytes. Furthermore, molecular inhibition of NKCC1 
using RNA intereference (RNAi) in chondrocytic cell line C-20/A4 induced the 
loss of RVI mechanisms, thus confirming the role of NKCC in chondrocytes 
(Qusous et al., in press). 
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Figure 1.4: Representative Diagram of transporters involved in RVI. 
NKCC1 (sky blue), Na+/H+ antiporter (NHE; yellow), anion exchanger (blue), Na+/HCO3
- coupled 
cotransporter (red), Na+/K+ pump (green). Membrane transporters pump ions into the cell 
cytoplasm upon cell shrinkage. This is followed by a passive water influx that restores the 
volume of the cell. Adapted from O'Neill, 1999. 
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1.6 Actin Cytoskeletal Organisation 
 
The actin cytoskeleton is a dynamic intracellular structure, which gives 
mechanical support to cells and is involved in a wide range of cellular functions. 
Actin, reported to be the most abundant protein in eukaryotic cells with a cellular 
concentration of over 100µM, is a 43kDa globular protein (and thus termed G-
actin) that forms a unipolymer termed F-actin. Actin polymerisation is ATP and 
Mg2+/Ca2+-dependent and is regulated by a variety of actin binding proteins 
including nucleation promoting proteins Arp2/3 and Profilin (Goley & Welch, 
2006), depolymerising proteins ADF and Cofillin (Ono, 2007), G-actin 
sequestering protein Thymosin β4 (Yarmola & Bubb, 2004) and capping protein 
Gelsolin (Yarmola & Bubb, 2004). Other factors that influence actin organisation 
include hyperosmotic and hypo-osmotic conditions leading to an increase and a 
decrease in F-actin, respectively (Guilak et al., 2002).  
 
Several reports have demonstrated that actin organisation follows a cortical 
disribution with predominant localisation to the cell periphery in situ (Durrant et 
al., 1999; Langelier et al., 2000), in agarose 3D cultured (Idowu et al., 2000; 
Knight et al., 2001) and in high-density monolayer chondrocytes (Blain et al., 
2006). Conversely, in 2D cultured chondrocytes the cortical arrangement is lost 
and actin filaments span the whole cell (Idowu et al., 2000; Loty et al., 2000; 
Figure 1.5). Interestingly, in OA chondrocytes F-actin is less defined than in 
differentiated chondrocytes and localised diffusely in the cytoplasm (Fioravanti 
et al., 2003).  
 
The actin cytoskeleton provides chondrocytes with the mechanical integrity 
required to withstand compressive loads (Guilak, 1995) as seen by the reduction 
of chondrocyte stiffness by 90% and the increase in apparent viscosity by 80% 
in response to treatment with cytochalasin D (Trickey et al., 2004) a fungal 
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metabolite that inhibits actin polymerisation (Schliwa, 1982). Furthermore, 
cytochalasin D treatment has been shown to reduce both the rate of matrix 
synthesis as well as chondrocyte anchorage to extracellular PGs, thus 
suggesting a role for actin in signal transduction and phenotype modulation 
(Nofal & Knudson, 2002). The effects of actin organisation on chondrocyte 
morphology and phenotype has been well documented with dedifferentiated 
chondrocytes re-expressing type II collagen and upregulating PGs expression in 
response to cytochalasin D treatment (Newman & Watt, 1988; Benz et al., 
2002a; Miot et al., 2005b), an effect found to be independent of morphology 
(Brown & Benya, 1988).  
 
As previously mentioned, freshly isolated chondrocytes do not exhibit RVI but it 
has been reported that chondrocytes treated with Latrunculin B, an actin 
capping agent, exhibited bumetanide-sensitive RVI in freshly isolated 
chondrocytes (Kerrigan et al., 2006). Moreover, Latrunculin B treatment induced 
a significant increase in the number of cells expressing ‘fast’ RVD (Kerrigan & 
Hall, 2005), thereby implying that the actin cytoskeleton plays a role in the 
regulation of membrane transporters, possibly the NKCC, and thus the RVI 
mechanisms. The above findings suggest a wide role for actin in the regulation 
of chondrocytic phenotype and mechanotransduction. 
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Figure 1.5: Actin organisation of freshly isolated and 2D-cultured chondrocytes 
Freshly isolated and 2D-cultured chondrocytes were fixed using 3% formaldehyde, 
permeabilised using Triton X100 and subsequently labelled using Alexa 488-Phalloidin to label 
the actin cytoskeleton (Panels A and B, respectively). Freshly isolated chondrocytes (Panel A) 
had thick cortical actin structures whereas following 21 days in monolayer culture, 2D-cultured 
chondrocytes (Panel B) possessed a dense network of filamentous actin. 
B A 
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1.7 DEL1 and Integrin Signalling 
 
Integrins are transmembrane homo or heterodimers composed of α and/or β 
chains covalently bound with a ligand affinity dependent on the combination of 
chains (Hemler, 1990; Hynes, 1992). Integrins are involved in a wide range of 
cellular functions including cellular attachment (Enomoto-Iwamoto et al., 1997), 
maintaining shape, proliferation and actin organisation, (Hirsch et al., 1997; 
Shakibaei et al., 1997) and relaying pressure-induced mechanotransduction 
signals (Wright et al., 1997). Changes in the expression of integrin dimers in 
response to 2D culture have been reported including an upregulation of α2-6 
chains and α5β1 (Fibronectin receptors; FnR) heterodrimers (Enomoto-Iwamoto 
et al., 1997; Diaz-Romero et al., 2005), indicating a role for Integrin signalling in 
the regulation of phenotype upon 2D expansion. The role of integrin signalling in 
differentiation and gene expression has been investigated in mammary gland 
epithelium (Schmidhauser et al., 1992), myogenesis (Enomoto et al., 1993), 
keratinocytes (Adams & Watt, 1991) and kidney tubule epithelium (Sorokin et 
al., 1990). 
 
In chondrocytes, gene mutations in integrin-mediated adhesion signalling lead to 
various chondroskeletal complications. α1 integrin knock-out models developed 
growth plate abnormalities and osteoarthritis (Zemmyo et al., 2003), whereas 
α10 integrin knock-outs developed growth retardation, increased apoptosis and 
abnormal cell shape (Bengtsson et al., 2005). Moreover, tissue specific knock-
out of β1 integrin disorganised the growth plate and proliferative columns, 
reduced proliferation, caused abnormal cell shape and decreased cellular 
adhesion (Aszodi et al., 2003). 
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1.7.1 Integrin Signalling 
Binding of ECM ligands to integrins can induce a set of cellular responses 
including the expression of matrix genes (Clancy et al., 1997), the degradation 
of the matrix by inducing the synthesis of matrix proteinases (Werb et al., 1989) 
and organisation of the actin cytoskeleton (Turner & Burridge, 1991; Wang & 
Kandel, 2004). Integrins do not possess tyrosine kinase domains but are 
associated with a group of proteins which induce a cascade of phosphorylation. 
Following ligand binding and subsequent integrin activation and aggregation 
(Schaller et al., 1994), FAK trans-autophophorylation is induced which in turn 
results in the activation of PI3K (Chen et al., 1996) and Rho (Hotchin & Hall, 
1995). PI3K activation leads to the phophorylation of Akt, whereas Rho signals 
induce Erk and cofilin activation which regulate the cell cycle and actin 
polymerisation, respectively (Renshaw et al., 1996). 
 
Akt is also involved in a number of cell signalling pathways including cell survival 
and motility and has been shown to regulate the expression of Basic helix-loop-
helix transcription factors (Vojtek et al., 2003) including Twist. There has also 
been evidence that the signalling strategies used by integrins include additional 
pathway to those employed by growth factor cell receptors. It has been found 
that focal contact sites do not only contain cytoskeletal-regulatory tyrosine 
kinases (Schaller et al., 1992), but also low amounts of a number of non-
enzymatic proteins that are activated by tyrosine kinases and mediate protein-
protein interactions in the focal contact (Turner & Burridge, 1991).  
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1.7.2 Developmental Endothelial Locus 1 (DEL1) 
DEL1 (also known as EGF-like repeats and discoidin I-like domains 3; Edil3) is a 
52kDa matrix adhesion protein composed of two Endothelial Growth Factor-like 
(EGF-like) domains, the second of which containing an integrin-binding Arginine-
Glycine-Aspartic acid (RGD) motif (Hidai et al., 1998). Similarly to Edil1 
(lactadherin; Silvestre et al., 2005), DEL1 interacts with αvβ3 phosphorylating 
proteins in the focal contact including FAK, MAPK, Shc and Akt and providing an 
autocrine angiogenic pathway as evident by inhibition of productive activation of 
its receptor by matrix substrates (Penata et al., 1998). 
 
It has been shown that DEL1 influenced endothelial cell behaviour and played 
an important role in mediating angiogenesis, vessel wall remodelling and 
development (Aoka et al., 2002; Ho et al., 2004). In vascular smooth muscle 
cells, DEL1 is involved in adhesion, migration and proliferation through 
interaction with integrin αvβ3 and actin filaments re-organisation (Rezaee et al., 
2002). Moreover, the attachment function of DEL1 has been shown to be 
involved the immune system, whereby DEL1 expression by endothelial cells 
induced leukocyte adhesion and inflammatory recruitment (Chol et al., 2008). 
DEL1 expression by apoptotic cells enhanced phagocytosis by immune cells by 
promoting attachment to phagocytic cells expressing αvβ3 integrin (Hanayama 
et al., 2004). 
 
DEL1 is involved in both foetal and adult differentiation via integrin signalling due 
to the similarity between DEL1 amnio acid sequence and the notch receptor 
ligands, known to inhibit terminal differentiation of a wide range of cell types 
(Penata et al., 1998). In Xenopus embryogenesis, DEL1 is essential for dorsal 
development whereby DEL1 knockdown is sufficient to cause ventralisation of 
embryos via the attenuation of BMP-signalling (Arakanawa et al., 2007). DEL1 is 
expressed by the keratinocytes in the dermal papilla and has been recently 
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shown to induce follicle development in mice skin by unknown mechanisms 
(Hsu et al., 2008). 
 
In chondrocytes, the expression of DEL1 has been observed in foetal tissue. An 
upregulation of DEL1 expression has been previously reported in high density 
culture but not 2D culture of foetal chondrocytes (Stokes et al., 2002). The 
expression level and biological significance of DEL1 in adult chondrocytes, 
however, have not yet been investigated. Due to the established complex effect 
of integrin signalling on chondrocyte development and differentiation, as well as 
the recent observations of changes in DEL1 expression in response to 2D 
culture, DEL1 has become a candidate for continuing research in chondrocyte 
phenotypic regulation. 
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1.8 Aims 
 
Due to a current gap in knowledge, I aimed to study the regulation of 
chondrocytic phenotype and mechanotransduction responses as a result of 2D 
culture. We proposed to identify the mechanism of DEL1–induced de-
differentiation via Twist and the corresponding changes in morphology, actin 
organisation and mechanotransduction.  
 
1 Quantify the changes in chondrocyte phentoype occurring in response to 
2D culture including cell shape, actin organisation and expression battery. 
 
2 Study the mechanotransduction responses of freshly isolated and 2D 
cultured chondrocytes in response to hyperomsmotic challenge and 
pharmacologically-induced [Ca2+]i   rise. 
 
3 Investigate the role of DEL1 expression on chondrocyte phenotype 
regulation and mechanotransduction. 
 
4 Investigate the signalling pathway of DEL1.  
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2 Materials and methods 
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2.1 Materials 
 
2.1.1 Tissue Culture 
 
Table 2.1: Tissue culture reagents. 
Name Company Catalogue Number 
Absolute Ethanol VWR, Poole, UK 200-578-6 
Low-melt Agarose Invitrogen, Paisley 
UK 
 
Dulbecco’s Modified Eagle 
Medium (DMEM) 
Sigma-Aldrich, Poole, 
UK 
D6171 
DMEM Powder Sigma-Aldrich, Poole, 
UK 
D5523 
Foetal Calf Serum Gibco, Paisley, UK 16170-078 
L-Glutamine Sigma-Aldrich, Poole, 
UK 
G-5763 
MTT Kit Sigma-Aldrich, Poole, 
UK 
CGD1-1KT 
Penicillin / Streptomycin Solution Sigma-Aldrich, Poole, 
UK 
P0781 
Trypan Blue Sigma-Aldrich, Poole, 
UK 
T 8154 
1X Trypsin-DMEM Gibco, Paisley, UK 25300-062 
Bone Morphogenetic Protein 2 
(BMP2) 
Heidelberg, Germany H00000650-P01 
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2.1.2 Molecular Biology 
 
Table 2.2: Reagents used in molecular biology studies. 
Name Company Catalogue Number 
Absolute Ethanol VWR, Poole, UK 200-578-6 
Agarose Invitrogen, Paisley 
UK 
10975-035 
Custom Designed siRNA Ambion, 
Cambridgeshire, UK 
16100 
FAM-Labelled Negative Control 
siRNA 
Ambion, 
Cambridgeshire, UK 
4620 
HiPerfect Transfection Reagent Qiagen, West Sussex, 
UK 
301704 
Nucleic Acid Markers 
100bp ladder 
200bp ladder 
Invitrogen, Paisley 
UK 
 
10416-014 
15628-019 
ImPromII Reverse Transcription 
System 
Promega, USA A3800 
Phenol Sigma-Aldrich, Poole, 
UK 
108-95-2 
Phosphate Buffer Saline Sigma-Aldrich, Poole, 
UK 
P-4417 
Primer Oligonucleotides MWG, Ebersberg, 
Germany 
C09041/X 
Positive Control (anti-GAPD) 
siRNA 
Ambion, 
Cambridgeshire, UK 
AM4605 
RNeasy Minikit Qiagen, West Sussex, 
UK 
74014 
GoTaq Polymerase Master Mix Promega, USA M7502 
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2.1.3 Actin Cytoskeleton studies 
 
Table 2.3: Reagents used to study the actin cytoskeleton. 
Name Company Catalogue Number 
Bovine Serum Albumin Sigma-Aldrich, Poole, UK 85041C 
Paraformaldehyde Sigma-Aldrich, Poole, UK P6148 
Phosphate Buffer Saline Sigma-Aldrich, Poole, UK P-4417 
Triton X100 VWR, Poole, UK VW8887-4 
 
 
2.1.4 Antibodies used in protein identification experiments 
 
Table 2.4: Reagents used to study the actin cytoskeleton. 
Name Company Catalogue Number 
Rabbit anti-Akt New England Biolabs, 
Hertfordshire, UK 
2938 
Rabbit anti-p-Akt New England Biolabs, 
Hertfordshire, UK 
3787 
Mouse anti-DEL1 
polyclonal 
Stratech, Suffolk, UK P-4417 
Goat anti-Rabbit, HRP 
conjugated 
New England Biolabs, 
Hertfordshire, UK 
7074 
Goat anti-Mouse, HRP 
conjugated 
New England Biolabs, 
Hertfordshire, UK 
7059 
Immobilon Western 
Chemiluminescent HRP 
Substrate 
Millipore, Watford, UK WBKLS0500 
Immobilin-P membrane Millipore, Watford, UK IPVH20200 
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2.1.5 Fluorophores 
 
Table 2.5 Fluorophores used. 
Name Company Catalogue Number 
Calcein AM Invitrogen, Paisley 
UK 
C1430 
Cy3 (conjugated to anti-DEL1 
siRNA) 
Ambion, 
Cambridgeshire, UK 
AM16211 
FAM-Labelled Negative Control 
siRNA 
Ambion, 
Cambridgeshire, UK 
4620 
Fluo-4 Invitrogen, Paisley 
UK 
A12379 
Alexa 488 (conjugated to 
phalloidin) 
Invitrogen, Paisley 
UK 
F23917 
TO-PRO3 Invitrogen, Paisley 
UK 
T 3605 
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2.1.6 Pharmacological and inhibitory reagents 
 
Table 2.6: Pharmacological agents used in calcium signalling determination. 
 Target 
Working 
concentration Comments references 
REV5901 
cysteinyl-
leukotriene 
receptors 50µM 
Inhibitor of 
RVD and 
Lipoxygenase 
(Musser et al., 1987; Van 
Inwegen et al., 1987; 
Bush & Hall, 2001a) 
U73122 PLCβ3 100µM Highly selective (Hou et al., 2004) 
Wortmannin PI5K 1µM Inhibits PI3K (Liu et al., 2001) 
Rottlerin PKC 100µM 
Activates K+ 
channels (Gschwendt et al., 1994) 
Neomycin PIP2 10mM 
Used at 55µM 
in culture as 
antibiotic (James et al., 2004) 
Ruthenium 
Red TRPV 10µM 
Inhibits RyR 
and NCX (Gunthorpe et al., 2002) 
R-Etodolac β-catenin 500µM - (Behari et al., 2007) 
Gadolinium SACC 100µM - (Sackin, 1995) 
Ionomycin 
mobile 
calcium 
carrier 3µM 
greater 
selectivity for 
Ca2+ over Mg2+ (Liu & Hermann, 1978) 
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2.2 Culture Media and Experimental Salines 
 
The tissue culture media used was Dulbecco’s Modified Eagle Medium (DMEM; 
Sigma) supplemented with 1% penicillin/streptomycin solution under asceptic 
conditions. For work on freshly isolated chondrocytes, the osmolarity of DMEM 
was adjusted to 380mOsm/kg H2O (mOsm) by the addition of filter-sterilised 
50mM sodium chloride (NaCl). Media used for long term culture purposes 
contained 1% penicillin/streptomycin solution, filter-sterilised 20mM L-Glutamine 
(an essential amino acid; as instructed by manufacturer), 10% Foetal Calf 
Serum (FCS), filter-sterilised 50µg/ml Ascorbic Acid (necessary for matrix 
synthesis) and 50mM NaCl (necessary to adjust the osmolarity to 380 mOsm). 
In experiments requiring the supplementation with Bone Morphogenetic Protein 
2 (BMP2), 14-day 2D cultured chondrocytes were treated with 500ng/ml of 
BMP2 for 7 days to allow phenotypic switch (Minina et al., 2001). For all volume 
regulation experiments, a bottle of powder DMEM was dissolved in double 
distilled water containing 15mM HEPES and the pH adjusted to 7.40±0.05. The 
osmolarity was measured using Vapro™ vapour pressure osmometer and 
adjusted using NaCl to 380±5mOsm and 700±5mOsm for Isomotic and 
hyperosmotic media, respectively (Kerrigan et al., 2006). 
 
As phenol red in media interferes with calcium measurement, experiments were 
performed using basic physiological saline (BPS) containing (in mM); HEPES 
(15), glucose (10), potassium chloride (KCl; 5), magnesium chloride (MgCl2; 1) 
and calcium chloride (CaCl2; 1). The pH was adjusted to 7.40 ±0.05 and the 
osmolarity measured using Vapro™ vapour pressure osmometer and adjusted 
by the addition of NaCl.  When performing calcium-free experiments, calcium 
chloride was replaced with 2mM EGTA and when performing sodium-free 
experiments, the osmolarity was adjusted by the addition of choline chloride 
(Dascalu et al., 1996).  
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2.3 Chondrocyte isolation and culture 
 
Bovine metacarpal and metatarsal joints of freshly slaughtered 18-21 month old 
female animals were obtained from the local abattoir (with permission) and full-
depth cartilage isolated into 280mOsm DMEM supplemented with 1% 
penicillin/streptomycin solution under aseptic conditions and chondrocytes 
isolated as previously described (Hall et al., 1996). Cartilage explants were 
incubated overnight in 380mOsm DMEM (to mimic the osmolarity of cartilage 
and reduce the changes that may occur due to the osmolarity of the media) 
supplemented with 1% penicillin/streptomycin solution and 0.8mg/mL 
collagenase. The collagenase treatment resulted in the degradation of the ECM, 
thereby releasing chondrocytes into the medium.  
 
Following incubation for 18 hours, undigested material was removed by passing 
the suspension through a sterile (autoclaved) tea strainer followed by a 40µm 
sterile cell strainer and subsequently chondrocytes washed twice by 
centrifugation at room temperature at 600g for 10 minutes. Finally the 
supernatant was discarded, the pellet resuspended in 380mOsm DMEM and 
chondrocyte cell suspension aliquoted onto appropriate substrate (6, 12 or 24-
well plates) and used within 2-8 hours.  
 
Chondrocytes maintained in monolayer culture were resuspended in long-term 
culture media (Section 2.2) and a 100µl sample was counted by mixing it with 
100µl of trypan blue, loading the mixture onto a haemocytometer and observing 
under a light microscope. In order to optimise the culture conditions, 
chondrocytes were seeded and subcultured upon confluence for up to 21 days 
at three different culture densities; High Density (HD; 2x105 cell/cm2), 
Intermediate Density (MD; 1x105 cell/cm2) and Low Density (LD; 2x104 cell/cm2) 
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in 25 or 75cm2 vented tissue culture flasks and incubated at 37°C in a 5% 
carbon dioxide humidified incubator.  
 
Upon reaching 80% confluence, chondrocytes from one flask were lifted and 
split into several new flasks. Briefly, the supplemented media was removed and 
chondrocytes incubated in 0.05% trypsin-EDTA solution (380mOsm/kg H2O) for 
5-10 min at 37°C, thus inducing cell rounding and subsequent detachment from 
the substrate as observed under a light microscope. The action of trypsin was 
reduced by dilution in fresh culture media and cells were washed twice by 
centrifugation at 600g for 10 minutes. Finally chondrocytes were resuspended in 
fresh culture media, counted and re-seeded at the original cell density for further 
culture or the use in required experimentation. 
  
Chondrocytes were counted and assayed for viability at the end of every 
passage using trypan blue staining and a growth curve constructed. A 
logarithmic growth curve of Log cell number Log(N) was plotted against time in 
days (t) and the regression line calculated: 
! 
N = N
0
" 2
G" t  
Applying log to both sides of the equation, the doubling time was calculated from 
the gradients of the equation of the best fit lines: 
! 
" log(N) = log(N0) +G # log(2) # t  
 
The gradient of the equation of the line best fit was therefore the product of the 
Growth rate (G) and log(2). The time needed for the cells to double in number, 
doubling time, was calculated as the inverse of the growth rate (shown in 
Section 3.2.1). LD was deemed most suitable and thus utilised for all further 
culture experiments whereby chondrocytes were subcultured on days 9, 14 and 
21 post seeding and termed P1, P2 and P3 chondrocytes, respectively. 
 
The number of joints used in each experiment is denoted (N) and the number of 
cells, where applicable, (n). 
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2.4 Expression Profiling of Expanded Chondrocytes 
 
2.4.1 RNA extraction, Reverse transcription and Polymerase Chain 
Reaction (PCR) 
The change in expression of key differentiation genes was studied by extracting 
RNA from freshly isolated and 2D cultured chondrocytes at the end of each 
passage and on days 2, 4, 6 and 8 of 2D culture using RNeasy Mini Kit 
(Qiagen). Briefly, chondrocytes were treated with 0.05% Trypsin-EDTA for 5 min 
at 37°C causing detachment from the substrate (plastic). The suspension was 
diluted with culture media (DMEM; 380mOsm/kg) and chondrocytes washed 
twice by centrifugation at 600g. Following the final centrifugation, the pellet was 
lysed with RLT cell lysis buffer and 350 µl of the lysate mixed with 350µl of 70% 
ethanol, loaded on an RNeasy column, subjected to centrifugation at 8,000g for 
30 seconds, washed by centrifugation with SW1 and twice with RPL buffer and 
RNA attached to the column subsequently eluted in 50µl nuclease-free water.  
 
RNA was quantified by measuring the absorbance at 260nm using a 
spectrophotometer (1 absorbance unit corresponds to 40µg/ml RNA; as 
recommended by Qiagen) and 1µg of each sample was reverse-transcribed 
using ImPromII Reverse Transcription (RT) System (Promega) as per 
manufacturer’s instructions. 0.5µg PolyT and 0.5µg random primers were mixed 
with 1µg of the RNA and 20u RNase inhibitor and heated to 70°C for 5 minutes 
to allow denaturation of the RNA secondary structures. The mixture was then 
quickly cooled on ice to allow the hybridisation of the primer oligonucleotides to 
the RNA sequences. Upon incubation on ice, 0.5mM dNTP, 4µl reaction buffer 
and 1µl reverse transcriptase were added to the primer-RNA solution and the 
reaction proceeded at 42°C overnight in the presence of 5mM MgCl2 until 
stopped by heat inactivation at 70°C for 15 minutes. 
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Primers used in the study were designed for mammalian genomic sequences 
and thus deemed suitable for bovine material (Table 2.7). Published sequences 
were used (Park et al., 2005) or novel sequences designed. Briefly, gene 
sequences of bovine and human origin were obtained from the National Center 
for Biotechnology Information (NCBI) website and aligned using clustalx 
allignment tool to obtain conserved (consensus) sequence for which primers 
were designed using primer3 online tools (Rozen & Skaletsky, 2000). All primers 
were designed such that the PCR products had a product size of >50bp suitable 
for visualisation on 2% agarose gels and a primer melting temperature of 58-
60°C. Selected primers were tested for specifity by running an online alignment 
search using Basic Local Alignment Search Tool (BLAST) on the NCBI website. 
 
Polymerase chain reaction (PCR) was used to assay the expression of key 
genes during chondrocyte expansion. 2µl of the reverse transcriptase reaction 
containing cDNA were used in the GoTaq® Green Master Mix containing 0.2µM 
of each primer, and PCR cycles run as recommended by manufacturer’s 
protocol (Table 2.8). The PCR products were loaded on 2% agarose gels 
(suitable for the size of amplicons) made up in 1X Tris-Borate-EDTA (TBE) 
Buffer and the gel subsequently subjected to a constant voltage of 150V for 2 
hours prior to being stained with 1% Ethidium bromide in TBE buffer, washed in 
distilled water and imaged using by video capture under UV excitation.  
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Table 2.7: Sequences of PCR primer pairs 
Primers were either obtained from previous publications by others or designed using online 
Primer3 tool. Primers were deemed suitable for mammalian genes and checked for specificity 
using the online Basic Local Allignment Sequence Tool (BLAST). 
 
 
Gene Sequence Tm 
(°C) 
Size of 
Product 
(bp) 
Design 
GAPD    
forward AGAACGGGAAGCTTGTCATC† 57.3 
Po
si
tiv
e 
C
on
tro
l 
backward TGAGCTTGACAAAGTGGTCGT 58.3 
 
 
743 
 
Pimer3 
DEL1    
forward AGTGAAAGGCACCAATGAAGAC 58.3 
back GTCCTGATTTCATACCCAGAGG 59.3 
 
 
200 
Primer3 
collagen II    
forward AGCAGGTTCACATATACCGTTCTG 60.6 
back CGATCATAGTCTTGCCCCACTT 59.9 
 
 
73 
(Park et al., 
2005) 
collagen I    
forward ACATGCCGAGACTTGAGACTCA 60.3 
M
at
rix
 P
ro
te
in
s 
back GCATCCATAGTACATCCTTGGTTAGG 62.2 
 
 
86 
(Park et al., 
2005) 
SOX9    
forward ACGCCGAGCTCAGCAAGA 59.3 
back CACGAACGGCCGCTTCT 58.3 
 
 
71 
(Park et al., 
2005) 
 
 
Twist     
forward GGCAAGCGCGGCAAGAAG 60.9 
Tr
an
sc
rip
tio
n 
Fa
ct
or
s 
back CGAGAAGGCGTAGCTGAG 57.9 
 
 
351 
 
Primer3 
                                                 
† TT in humans, TC in cows 
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Table 2.8: Steps involved in Polymerase Chain Reaction (PCR) amplification. 
cDNA, obtained from reverse transcription, was initially denatured by heating at 95°C for 2 
minutes, annealing at the average melting temperature (Tm) of primers (58°C) and extended at 
72°C for 2 min with a denaturation step, annealing step and extension step repeated 35 times. A 
final extension step at 72°C for 5 minutes was followed by incubation at 4°C. PCR resulted in 
exponential amplification of DNA. 
 
 
Step Duration 
(minutes) 
Temperature 
(°C) 
Repetition 
Initial Denaturation Step 2 94 1x 
Denaturation Step 1 94 
Annealing Step 1 58 
Extension Step 2 72 
 
 
35x 
Final Extension Step 5 72 1x 
Holding Step ∞ 4 1x 
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2.4.2 Gel Densitometery Optimisation 
Quantitative PCR was used to assay changes in expression by gel 
densitometery. In order to optimise the relationship between the intensity of 
band on an ethidium bromide-stained gel and the amount of DNA in the band, a 
2% agarose gel was loaded with known amounts of 100bp DNA ladder (2ng-
300ng) and imaged. Scion Image version Alpha4.0 (Scion) was used to quantify 
the intensity of the DNA bands (I) and background emission (IB), the product of 
the difference between which and the area of the DNA band (A) was plotted 
against the amount of DNA in ng was plotted to demonstrate the linear 
relationship (ng DNA vs. [I-IB].A). The relationship was shown to be linear for 
DNA amounts that do not exceed 120ng (suitable for PCR; Figure 2.1). 
 
2.4.3 GAPD suitability as an internal PCR positive control 
Primers for Glyceraldehyde 3-phosphate dehydrogenase (GAPD; also known as 
GAPDH; a housekeeping enzyme that catalyzes the sixth step of glycolysis) 
were included in all PCR reactions as an internal positive control. As GAPD 
expression levels were used as a reference to measure significant changes in 
the expression of other genes, the expression of GAPD was monitored during 
culture. No significant change (p>0.05) in the amount of GAPD in the PCR 
reaction (calculated as [I-IB].A) was observed in response to 2D culture (Figure 
2.2), thus demonstrating the suitability of GAPD as a positive control. 
 
For the measurement of the expression of key genes upon culture, image were 
imported into Scion Image Alpha4.0 Image software and the intensity of the 
background, and the intensity and area of the bands corresponding to the gene 
of interest were measured. Moreover, the intensity and area of the band 
corresponding to the internal positive control was also measured. The value of 
(I-IB).A of every band was calculated, and that was divided over the value of (I-
IB).A for the band corresponding to GAPD internal control (Figure 2.3).  
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Figure 2.1: The linear relationship between the band intensity and size vs. the amount of 
DNA present 
Known amounts of DNA (2-150ng) was run on a 2% agarose gel and the band intensity and size 
([I-IB].A) calculated by Scion Image Alpha4.0. The mean intensity of background was subtracted 
from the mean intensity of the band and subsequently multiplied by the area of the band. This 
product value was plotted against the amount of DNA in the band and the relationship was found 
to be linear for amounts of DNA <120ng. Data was pooled from 6 individual experiments. Values 
shown as mean ± s.e.m. R2 = 0.936. 
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Figure 2.2: The level of expression of Glyceraldehyde 3-phosphate dehydrogenase 
(GAPD) during culture 
The level of expression of a housekeeping gene, GAPD, was used in subsequent quantitative 
RT-PCR experiments as a positive control to study changes in expression of key genes during 
culture. RNA was isolated and reverse transcribed from freshly isolated chondrocytes (P0), after 
9 days in culture (P1), after 14 days in culture (P2) and after 21 days in culture (P3) and PCR 
carried out using GAPD primers and the gel imaged and analysed as described. There was no 
significant change in GAPD expression throughout culture. Data was pooled from 7 individual 
experiments, N=6. Values shown as mean ± s.e.m (P>0.05). 
 
 
 
 
N/S 
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Figure 2.3: A representative image of an ethidium bromide-stained DNA gel 
Products of a multiplex PCR reaction were loaded onto a 2% agarose gel and subjected to 
electrophoresis. Two genes were amplified in each PCR reaction, GAPD (internal positive 
control; with a size 743bp) and a gene of interest (200bp). Using Scion Image Alpha4.0, a region 
of interest was selected around each band and Scion Image Alpha4.0 used to measure the 
intensity and area of these bands (dashed rectangle). These data were used in the quantification 
of the amount of DNA present. 
 
 
P0 P1 P2 
600bp 
200bp 
GAPD 
Gene of Interest 
100bp 
ladder 
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2.5 Confocal Microscopy 
 
Images were acquired using a Leica SP2 TCS CLSM and Leica Software 
version 2.61 as previously described (Kerrigan & Hall, 2005) using grey 
resolution of 8 bit, pinhole radius of 1.00 Airy Unit to match to the diameter of 
objective used, beam splitter 488/543/633, laser speed of 400 Hz and the 
dipping lens HCX APO L U-V-1 63.0x 90 W. 
 
The different fluorophores used in the experiments posessed different excitation 
and emission properties (Table 2.9). For the 3D reconstruction of images of 
chondrocytes for volume analysis, z-stack series of image slices were taken at 
1µm intervals in depth whereas for localisation and actin experiments higher 
resolution images were acquired using Nyquist settings that were deemed 
suitable for deconvolution using Hygens 3.3 (SVI). Images were imported into 
Hygens 3.3, the image properties entered and deconvolution performed using 
default settings prior to reassembling the series using the Imaris version 6.3.1 
(Bitplane). 
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Table 2.9: Fluorophores used in confocal microscopy for imaging and cell volume 
calculation. 
Settings employed for image acquisition using Confocal Laser Scanning Microscope (CLSM) 
depended on the fluorophores used and the complexity of the analysis ensued. Nyquist settings 
were used for actin and small interfering RNA (siRNA) experiments, whereas lower resolution 
images were required for volume and dimensional analysis. 
 
 
Dye TO-PRO3 
(1mM 
solution in 
DMSO) 
FAM 
(conjugated 
to negative 
control 
siRNA) 
Cy3 
(conjugated 
to anti-DEL1 
siRNA) 
Alexa 488 
(conjugated 
to phalloidin, 
0.5µg/ml) 
Calcein AM 
(1mg/ml 
solution in 
DMSO) 
Settings Nyquist Settings Other 
Maximum 
absorption 
(nm) 
575nm 494nm 550nm 488nm 495nm 
Maximum 
Emission 
599nm  520nm  570nm 519nm 525nm / 512-
540nm 
Light 
Source  
He/Ne 633  Kr 568  He/Ne 633 He/Ne 633 Kr 568 / 25% 
Laser 
Strength 
(%) 
35% 73% 73% 25% 25% 
Resolution 
 
1024x1024 1024x1024 1024x1024 1024x1024 512x512 
Line 
averaging 
 
4 
 
4 
 
4 
 
4 
 
1 
Use Cytoplasm 
and nucleus 
staining 
(working 
concentration 
2µM)  
Labelling of 
negative 
control 
siRNA 
Labelling of 
oligonucleotid
e molecules 
Labelling of 
phalloidin and 
subsequently 
the actin 
cytoskeleton 
Volume 
marker, 
Measuring 
cell volume 
(working 
concentration 
25µM) 
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2.6 siRNA design 
 
RNA interference (RNAi) is a novel molecular technique that is based on a 
natural antiviral mechanism that involves interruption of gene expression at the 
messenger RNA (mRNA) translation level (Wang & Metzlaff, 2005). Short (~21nt 
long) double stranded (ds) sequences of small interfering RNA (siRNA) 
employed in this technique bind to complementary sequences on the messenger 
and recruit the RNA-induced silencing complex (RISC) to degrade the message 
(Elbashir et al., 2001a; Figure 2.4). This results in a temporary knockdown of the 
expression which can last for up to 72 hours. Being a very specific technique 
when the target sequence is carefully designed, RNAi is gaining increasing 
interest in molecular medicine as a gene therapy technique for knocking down 
dominant mutated genes in hereditary diseases including retinitis pigmentosa 
(Kiang et al., 2005) and viral sequences in infections including AIDS (Cullen, 
2005). In chondrocytes, RNAi was used to study the role of various proteins 
including SOX9 (Wenke et al., 2009), p16 (Zhou et al., 2004) and NKCC1 
(Qusous et al., in press). 
 
Nevertheless, RNAi, like other similar techniques of gene therapy, still faces 
several drawbacks. Designing a suitable vector, which protects siRNA from the 
action of nucleases and delivers high concentrations to particular tissues, is still 
a hurdle. Moreover, unlike gene knockout, RNAi has a transient effect which 
does not possess the potential to cure permanent or chronic diseases. This 
requires construction of new vectors that integrate DNA sequences encoding 
siRNA into the host genome (Bridge et al., 2003; Lee et al., 2003b; Tomar et al., 
2003), carrying the risk of causing insertional mutations that may lead to 
neoplasia. Finally, siRNA can instigate a non-specific cytokine response that 
involves inflammation and cell apoptosis in a mechanism similar to that triggered 
by a viral infection (Bridge et al., 2003). 
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Figure 2.4: The natural anti-viral mechanism that led to the discovery of RNAi. 
Viral dsRNA sequences are degraded by dsRNA-specific nuclease called “Dicer” into short (21nt) 
sequences termed siRNA. These short sequences form the RISC complex with at least four proteins and a 
nuclease in the presence of ATP. Nuclease in the RISC complex degrades complementary viral mRNA 
sequences. In RNAi technology, siRNA are synthesised and transfected into cells, thereby recruiting RNA-
induced Silencing Complex (RISC) and inducing knockdown of complimentary mRNA sequences. Adapted 
from Denli & Hannon, 2003. 
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The biological roles of DEL1 and Twist were determined by inhibiting the 
expression of active proteins using siRNA technology to knock down the 
expression of the protein at the mRNA level. The sequence and position of 
specific nucleotides in the siRNA molecule are crucial factors in determining the 
efficacy of the knockdown for reasons that have not been fully ascertained 
(Elbashir et al., 2001a; Elbashir et al., 2001b; Reynolds et al., 2004; Ui-Tei et al., 
2004). 
 
The predicted sequences of the bovine DEL1 and Twist were retrieved from the 
National Centre for Biotechnology Information (NCBI) online database and 
Ambion’s online siRNA Target Finder (on the website of Ambion, 
Cambridgeshire, UK) and were used to generate all possible siRNA sequences 
according to guidelines discussed by Elbashir et al., 2001c. The parameters of 
the online tool were further refined to match the properties of effective siRNA 
sequences as observed by others (Elbashir et al., 2001c; Reynolds et al., 2004), 
whereby the GC content was set on a maximum of 50% and stretches of 4 or 
more identical nucleotides were avoided (Reynolds et al., 2004). All sequences 
were exported into an Excel analyser workbook which analysed the sense 
sequence of potential siRNA molecules and rated them based on the criteria of 
rational siRNA design (Table 2.10) and sequences scoring below 6 were 
excluded (Reynolds et al., 2004). The target sequences of the remaining 
candidates were subjected to a homology search to ensure specificity using 
BLAST analysis on the NCBI website. Selected siRNA sequences are shown in 
Table 2.11.  
 
Anti-DEL1 and anti-Twist siRNA were purchased from Ambion (Cambridgeshire, 
UK) and 5’-end of the sense strand modified such that it was conjugated to Cy3 
dye. Negative control 5’-carboxyfluorescein-labelled (FAM) siRNA, comprising a 
‘scrambled’ sequence that did not resemble coding sequences, and Positive 
control anti-GAPD siRNA were also purchased from Ambion, (Cambridgeshire, 
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UK). Negative control siRNA was used in experiments to determine localisation 
of siRNA molecules whereas anti-GAPD positive control siRNA was used to 
determine transfection efficiency by inducing cell death.  
 
 
 
 
 
 
 
 
Table 2.10: Criteria of the rational siRNA design.  
siRNA sequences possessing the properties of rational siRNA design induce efficient 
knockdown. Sequences generated by Ambion online tool have appropriate GC content and no 
internal repeats. An Excel analyser was created to rate sense sequences according to the 
criteria above whereby sequences scoring below 6 were excluded (Reynolds et al., 2004). 
 
 
Description Score 
Moderate to low (30%-52%) GC Content 1 point 
At least 3 A/Us at positions 15-19 1 point each 
A at position 19 1 point 
A at position 3 1 point 
U at position 10 1 point 
G/C at position 19 -1 point 
G at position 13 -1 point 
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Table 2.11: Sequences of siRNA sequences used in knockdown experiments. 
The sequences of siRNA molecules were designed according to parameters previously 
described by others. Target sequences possessed a low GC content and no stretches of of 4 or 
more identical nucleotides prior to being rated according to the rational siRNA design criteria. 
The specificity of chosen target sequences was ensured by performing an online homology 
search. 
 
 
A
nt
i-
D
EL
1 
Target sequence                     5’- AATCGGCTTATTTGTTTATTT 
Sense strand               5’- UCGGCUUAUUUGUUUAUUUUU 
Antisense strand               5’- AAAUAAACAAAUAAGCCGAUU 
A
nt
i-
Tw
is
t 
Target Sequence                      5’-AAGAACACCTTTAGAAATAAA 
Sense strand               5’- GAACACCUUUAGAAAUAAAUU 
Antisense strand               5’ UUUAUUUCUAAAGGUGUUCUU 
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2.7 siRNA and transfection 
 
2.7.1 Optimisation of MTT viability assay 
 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was used as 
a viability assay to study anti-GAPD siRNA transfection efficiency, whereby 
MTT, yellow in colour, is reduced to purple formazan in the mitochondria of living 
(non transfected) chondrocytes.  
 
Firstly and to confirm the linear relationship between the number of cells and the 
absorbance of reduced MTT, 0.1x volume of MTT solution (5mg/ml in RPMI 
media) was added to the culture media and chondrocytes seeded at different 
desnsities (0-1x105cells/cm2) and incubated for three hours at 37°C. 
Subsequetly, media were aspirated and reduced MTT crystals dissolved in 
equal volume of MTT solvent, dimethyl sulfoxide (DMSO). The absorbance of 
the solution was measured at 570nm and the background at 690nm and the 
difference found to be directly proportional to the number of cells catalysing the 
reduction of MTT (Figure 2.5). 
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Figure 2.5: Linear relationship between the absorbance of reduced MTT crystals and the 
total cell number. 
Chondrocytes were seeded at different desnsities into each well of a 12-well plate and incubated 
for three hours in the presence of 0.5mg/ml MTT solution. The media was subsequently 
aspirated and replaced with MTT solvent (DMSO) and the amount of MTT reduced measured by 
spectrophotometery at 570nm. A direct linear relationship was determined between the 
absorbance of reduced MTT and the number of cells. Data was pooled from three experiments. 
N=3. Values shown as mean ± s.e.m. R2 value = 0.978. 
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2.7.2 Transfection and transfection efficiency quantification 
 
Anti-GAPD siRNA inhibited the inability to produce ATP and inducing cellular 
death. The efficiency of the transfection was assayed after 48h as 
recommended by the manufacturer by measuring anti-GAPD siRNA-induced cell 
death using MTT viability test performed according to manufacturer’s protocol 
(Sigma-Aldrich).  
 
Freshly isolated and 2D cultured chondrocytes were assayed for transfection 
using HiPerfect Transfection reagent (primarily used for cell line; Qiagen) 
according to manufacturer’s protocol by mixing different concentrations of 
positive control anti-GAPD siRNA (1, 5 or 10nM) with different amounts of the 
transfection reagent (3, 6 or 9µl/ml) in serum-free media and allowing 
complexes to form for 5 minutes at room temperature. Chondrocytes were 
seeded onto a 12-well plates at LD culture density (2x104cells/cm2) and 
transfected in suspension by dropwise loading of siRNA-HiPerfect complexes. 
 
Chondrocytes were incubated for 48 hours at 37°C in a humidified incubator 
prior to measurement of anti-GAPD siRNA-induced cell death using MTT assay. 
0.1x volume of 5mg/ml MTT solution was added to the culture and chondrocytes 
incubated for 3 hours at 37°C prior to the removal of media containing excess 
MTT and the dissolution of formazan in DMSO and the measurement of 
absorbance at 570nm and 690nm.  
 
Optimum transfection conditions were highly dependent on the phenotypic state 
of chondrocytes and therefore passage number. Although HiPerfect is 
recommended for the use with cell lines, satisfactory transfection efficiencies 
were obtained with freshly isolated chondrocytes optimally transfected with 
10nM siRNA and 3µl/ml of HiPerfect and yielding 63.73±6.86% transfection 
efficiency (Figure 2.6). Upon 2D culture, however, significant differences in 
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transfection efficiencies were observed under similar conditions (Figure 2.7-
Figure 2.8). Optimum transfection efficiencies were achieved with 10nM siRNA 
and 9µl/ml HiPerfect for P1 (71.38±4.24%), whereas no significant differences 
were observed in P2 chondrocytes with different complex combinations (1nM 
siRNA and 3µl/ml HiPerfect; 61.91±4.35%). Due to the high cost of the 
transfection reagent and the positive control siRNA, transfection efficiency 
experiments were performed once for every passage. 
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Figure 2.6: Transfection efficiency of freshly isolated chondrocytes (P0) 
Chondrocytes were seeded and transfected in suspension with complexes of anti-GAPD positive 
control siRNA and HiPerfect transfection reagent, prepared at different concentrations. 
Chondrocytes were incubated for 48 hours and subsequently 0.1x volume MTT solution added 
and incubated for a further 3 hours. The media containing excess MTT was aspirated and 
replaced with MTT solvent and absorbance of reduced MTT was measured. Highest 
Transfection efficiency 63.7% (‡) in freshly isolated chondrocytes was obtained using 10nM 
siRNA and 3µl/ml HiPerfect. Experiment was performed once, N=3. Values shown as mean ± 
s.e.m. T-test p-values were deemed significant when p<0.05 (*) and p<0.01 (**). 
 
* 
‡ 
µl/ml 
µl/ml 
µl/ml 
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Figure 2.7: Transfection efficiency monolayer expanded chondrocytes after 9 days in 
culture (P1) 
Chondrocytes were seeded and transfected in suspension with complexes of anti-GAPD positive 
control siRNA for 48 hours prior to performing a MTT viability assay. Chondrocytes were 
incubated with 0.5mg/ml MTT for 3 hours prior to aspiration of media and dissolution of 
formazan crystals in DMSO and measurement of solution absorbance. Highest Transfection 
efficiency of P2 chondrocytes was obtained using 5nM siRNA and 9µl/ml, transfection efficiency 
of 71.4% (‡). Experiment was performed once, N=3. Values shown as mean ± s.e.m. T-test p-
values were deemed significant when p<0.05 (*) and p<0.01 (**). 
** 
‡ 
µl/ml 
µl/ml 
µl/ml 
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Figure 2.8: Transfection efficiency monolayer expanded chondrocytes after 14 days in 
culture (P2). 
Chondrocytes were seeded and transfected in suspension with complexes of anti-GAPD positive 
control siRNA and MTT viability assay performed. Chondrocytes were incubated for 48 hours 
and subsequently 0.1x volume MTT solution added and incubated for a further 3 hours. The 
media containing excess MTT was aspirated and replaced with MTT solvent and absorbance of 
reduced MTT was measured. No significant differences in the transfection efficiency of P3 were 
observed in response to different complex combination and thus 1nM siRNA complexed with 
3µl/ml HiPerfect (yielding a transfection efficiency of 61.4%) was chosen due to economic 
reasons (‡). Experiment was performed once, N=3. Values shown as mean ± s.e.m.  
 
‡ 
N/S 
µl/ml 
µl/ml 
µl/ml 
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2.7.3 Uptake and localisation of siRNA 
The uptake and localisation of the siRNA molecules was also confirmed by 
confocal microscopy using FAM-labelled negative control siRNA molecules 
transfected using the optimum conditions obtained from the GAPD-transfection 
and MTT assay. Chondrocytes were transfected in suspension and incubated 
for 48 hour prior to being fixed using ice-cold 3% formaldehyde for 20 minutes at 
37°C, washed three times in ice-cold PBS to remove formaldehyde and then 
quenched for 10 minutes in ice-cold 50mM NH4Cl. Chondrocytes were 
permeabilised using 0.1% Triton X100 in PBS for 5 minutes and then dipped in 
100mM Glycine to stop the permeabilisation followed by washing three times in 
ice-cold PBS and incubation with 2µM TO-PRO3 for 45 minutes at room 
temperature. After the incubation period, chondrocytes were washed three times 
with ice-cold PBS and visualised using Confocal Laser Scaning Microscopy 
(CLSM). siRNA molecules were observed to be peri-nuclearly localised as 
described by the manufacturer (Figure 2.9). 
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Figure 2.9: Confocal Z-stack series of images of chondrocytes after 48 hours of 
transfection with 10nM FAM-labelled negative control siRNA (green) and 3µ l/ml of 
HiPerfect. 
Chondrocytes were fixed using 3% formaldehyde solution, permeabilised in Triton X100 and 
stained with 2µM TO-PRO3 (blue). Z-stack images were acquired using confocal laser scanning 
microscopy (CLSM) where perinuclear localisation of the siRNA moleculesw as observed (Panel 
A). Z-stack series were reassembled in Imaris 6.3.1 (Bitplane) with a threshold level of 10% and 
20% for TO-PRO3 and FAM, respectively, and 3D wire frame isosurface surpass applied (Panel 
B). Image was taken with water-immersion lens, x63. 
A B 
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2.8 Actin organisation 
For actin labelling, chondrocytes were fixed using ice-cold 3% formaldehyde for 
20 minutes at 37°C, washed three times in ice-cold PBS to remove excess 
formaldehyde and then quenched for 10 minutes in ice-cold 50mM NH4Cl. 
Chondrocytes were subsequently permeabilised using 0.1% Triton X100 in PBS 
for 5 minutes and then dipped in 100mM Glycine to stop permeabilisation prior 
to being washed three times in ice-cold PBS and then labelled with Alexa 488-
phalloidin in the dark for 45 minutes. After the incubation period, chondrocytes 
were washed three times with ice-cold PBS and z-stack images (series) of 
chondrocytes were acquired using confocal laser scanning microscopy and 
Nyquist settings.  
Images of actin cystoskeleton were imported into Hygens 3.3 (SVI; Hilversum, 
The Netherlands) and deconvolved using default settings, imported into Imaris  
6.3.1 (Biplane; Zurich, Switzerland) where images were created. The organ-
isation of the actin cytoskeleton was studied using ImagePro 7.0 (Media 
Cybernetics; Maryland, USA) and fluorescence intensity determined using 
Linear Profiling across the cell diameter. The fluorescence profiling of individual 
chondrocytes was plotted against standardised cell diameter (%) and 
transcellular peaks in fluorescence corresponded to individual actin structures 
termed ‘striation units’ (StU), the count of which providing a representation of the 
number of filaments within the cellular body (Figure 2.10). 
 
Mean of fluorescence of chondrocytes within the same passage was calculated 
and plotted against 10% increments in standardised cell diameter, and the first 
and last peaks in fluorescence (observed between 0-20% and 80-100% 
standardised cell diameter, respectively) were deemed cortical actin 
condensations. Binomial best fit curves for the mean cortical actin fluorescence 
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were plotted and average fluorescence across the standardised diameter of 
chondrocytes represented by linear regression line functions (Figure 2.11). The 
equations were integrated against the diameter to produce areas under the 
fluorescence curve used to estimate the ratio of cortical to filamentous actin as 
shown. 
 
For cortical actin, the equation for best fit curve was integrated as follows. 
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For filamentous actin, the calculation was as follows. 
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Figure 2.10 Representative diagram of fluorescence of actin-phalloidin-alexa 488 
complexes across standardised cellular dimensions. 
Confocal images of a P3 2D cultured chondrocyte stained for actin with phalloidin-alexa 488 was 
chosen at random for representative purposes (inset), deconvolved and reassembled in Image 
Pro as previously described. The fluorescence intensity was measured across the cell and 
plotted against the standardised cellular diameter (%). The first and last peaks were deamed 
cortical, a straight line representing background fluorescence plotted, and the number of peaks 
above that line counted and each deemed a striation unit. 
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Figure 2.11: Representative mean fluorescence of phalloidin-alexa 488 across 
standardised cell diameter 2D cultured chondrocytes. 
P3 chondrocytes chosen for illustrative purposes whereby chondrocytes were fixed and stained 
with phalloidin-alexa488 to detect the organisation of the actin cytoskeleton. Images were 
analysed using ImagePro to produce actin fluorescence against standardised cell diameter of P3 
chondrocytes (Panel A). These data were used to plot a best fit binomial function representing 
the first and last peaks (cortical) and a best fit line for the remaining peaks (filamentous actin). 
The equations of the graphs were integrated to mathematically calculate the areas under the 
cortical and filamentous parts of the plot and consequently the ratio of cortical and filamentous 
actin (representation in Panel B). N=4, n=36. Data shown as mean ± s.e.m.  
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2.9 Volume, cellular dimensions and Sphericity of 
chondrocytes 
 
2.9.1 Optimisation of Imaris Isosurface Feature using beads 
In order to study changes in cellular morphology and quantify cellular 
dimensions in response to 2D culture, confocal microscopy was used in 
conjunction with the isosurface surpass feature on Imaris. The isosurface 
feature was used to create 3D polygon ‘objects’ surrounding individual cells in 
series of images and was initially optimised using glass beads of known volume 
(520µm3) by studying the apparent volume obtained with 10% minimal threshold 
intervals. Voxel sizes were obtained from the series properties using Leica Lite 
and entered in the isosurface surpass wizard and objects closed at border.  
A direct linear relationship was found between the threshold percentage and the 
apparent ‘object’ volume, and line regression performed to mathematically 
ascertain the percentage threshold yielding the correct volume.  This value was 
determined at 60% threshold (Figure 2.12). 
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Figure 2.12: Apparent volume of beads analysed using Imaris 6.3.1 using 10-90% 
threshold. 
Fluorcent beads of a known volume (520µm3) were imaged using confocal laser scanning 
microscopy and the images imported into Imaris 6.3.1 (Bitplane) as previously described and the 
apparent volume acquired at 10% threshold intervals. Linear regression was used to calculate 
the value at which the apparent volume acquired by Imaris equalled the real volume and that 
was found to be at 60% threshold. Data shown as mean ± s.e.m. R2 value = 0.952. 
(µ
m
3 )
 
3 
 
 
70 
 
2.9.2 Chondrocyte Cell Dimesion and Volume Acquisition  
 
During 2D cultures, chondrocytes undergo drastic changes in morphology from 
a sphere-like shape into a ‘flat’ fibroblast-like shape. The change in morphology 
of chondrocytes during culture was observed by studying the cell dimensions 
including depth (a), width (b), length (c), and sphericity (ψ), defined as the ratio 
of the surface area of a sphere with the same volume as a given chondrocyte 
cell to the surface area of the chondrocytes, where V is the volume of the 
chondrocytes and A is the surface area of the perfect sphere. 
 
! 
" =
#
1
3$(6V )
2
3
A
 
 
Due to the change in cellular morphology upon 2D culture, a threshold of 60% 
was deemed unsuitable for ‘flat’ chondrocytes as an isosurface object merely 
encompassed the nucleus (Figure 2.13). The depth of the nucleus at 60% 
threshold was termed ‘nuclear coefficient’ (aη) and was used to standardise the 
apparent dimensions (b10% and c10%) and volume (V10%) of chondrocytes 
obtained at 10% threshold. The following formulae were based on the 
assumption that the depth of a round nucleus of a chondrocyte is approximately 
equal to that of the ‘flat’ chondrocyte. 
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Figure 2.13: Illustrative diagram of isosurface objects created using Imaris (Bitplane) at 
10% and 60% threshold. 
P3 chondrocyte was chosen at random for illustrative purposes. Chondrocytes were loaded with 
5µM Calcein-AM (green) and incubated for 30 min prior to image acquisition and a step size of 
1µm (Panel A). The series were reassembled in Imaris 6.3.1 (Bitplane) and the isosurface 
function used to create ‘objects’ at 60% threshold (Panel B; red) and 10% threshold (Panel B; 
green). A threshold of 60% was deemed suitable for obtaining real volumes for round objects as 
optimised by using beads of known volume. A threshold of 60% in ‘flat’ (2D cultured 
chondrocytes) only yielded an object surrounding the nuclear structure, the depth of which 
termed nuclear coefficient and thereafter used for the standardisation of the dimensions and 
volume of objects created at 10% threshold. 
A 
B 
 
 
72 
 
2.9.3 RVI experiments 
The capacity of chondrocytes to demonstrate RVI was studied by applying a 
42% hyperosmotic challenge as previously described (Kerrigan et al., 2006) and 
acquiring z-stack images (series) using confocal laser scanning microscopy 
which were subsequently reassembled in Imaris version 6.3.1 (Bitplane). 
Chondrocytes were seeded two hours prior to imaging and incubated in the dark 
with 5µM calcein AM at 37°C for 30 minutes. The medium containing excess 
calcein AM was aspirated and replaced with isosmotic (380mOsm) media 
prepared as previously described and baseline Z-stack images of chondrocytes 
acquired using CLSM. 1x volume of hyperosmotic media (700mOsm) was 
subsequently added raising the osmolarity to 540mOsm as determined by 
Vapro™ vapour pressure osmometer and images were acquired 1.5, 3, 5, 10 
and 20 minutes post challenge. Images were reassembled in Imaris version 
6.3.1 (Bitplane) and isosurface objects created at 60% and 10% threshold for 
freshly isolated and 2D cultured chondrocytes, respectively. Volume values were 
exported into Excel where changes were calculated relative to baseline values 
(obtained prior to hyperosmotic challenge) and plotted against time following 
hyperosmotic challenge. 
Gradients of the lines that best fit the volume recovery points were obtained and 
used for the calculation of half the time required for chondrocyte to regulate 
100% of initial volume in response to the challenge (t½).  
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2.10  Calcium imaging 
 
Differences in intracellular calcium ([Ca2+]i) signalling between freshly isolated 
and cultured chondrocytes were determined using a fluorescence plate reader in 
conjunction with the calcium indicator dye fluo-4 AM, a calcium indicator that 
provides a rapid and proven method of imaging intracellular calcium flux (Gandhi 
et al., 2000). To study changes in [Ca2+]i, chondrocytes were seeded onto a 12-
well plate at LD and allowed to adhere prior to incubation with 3µM Fluo-4 AM 
for 30 minutes at 37°C, and subsequently media was replaced with BPS to 
remove excess dye. 
 
Firstly, the loading speed was optimised in order to reduce the effects of fluid 
flow (Yellowley et al., 1997; Yellowley et al., 1999) on calcium response. 
Calcium-bound fluo-4 AM was excited at 494nm and the basal fluorescence 
measured at 520nm bandpass prior to BPS injection at three individual speeds 
(420, 360 & 260 µl/s) and recording fluorescence every 14 seconds for 10 
minutes (Figure 2.14). At both 420µl/s and 360µl/s, there was an immediate rise 
in [Ca2+]i  of an average of 4.52±0.34% (p>0.05) whereas the effects of fluid flow 
were diminished at 260µl/s as seen by the slight rise in calcium of 1.19±0.3%. 
These data concluded that 260µl/s was the injection speed deemed most 
suitable for further experiments (Figure 2.14) 
 
To further optimise the protocol for Ca2+-fluo-4 fluorescence measurement, 
Ionomycin, a calcium salt which facilitates Ca2+ transport across the cell 
membrane, was used at 3µM as a positive control (Liu & Hermann, 1978) and 
2µl/ml DMSO (drug solvent) as a negative control. A DMSO solution induced a 
1.34±0.6% rise in [Ca2+]i  which was not significantly different from the effects 
induced by fluid flow (p>0.05) whereas Ionomycin caused an influx of Ca2+ 
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raising [Ca2+]i  levels by 6.5±0.6%. These data confirmed that the methodology 
devised above is suitable for the purposes of this research (Figure 2.15). 
 
Previous work in our group has shown that 50µM Alpha-pentyl-3-(2-
quinolinylmethoxy)-benzene-methanol (REV5901) loading induced a rise in 
[Ca2+]i (Ali et al., in press) and REV5901 was therefore used as a 
pharmacological inducer of [Ca2+]i  rise. For the purposes of investigating 
individual channel and/or signalling molecule contribution to the calcium rise, 
various inhibitors were employed (Table 2.6). Sodium Calcium Exchanger (NCX) 
was inhibited by the use of Na+-free physiological BPS (Sanchez & Wilkins, 
2004) adjusted to 380mOsm using choline chloride (Dascalu, 1996). Stretch-
activated cation channels (SACC) and transient receptor potential ion channels 
(TRP); were inhibited by the use of 100µM Gd3+; (Kerrigan & Hall, 2008) or 
10µM Ruthenium Red; (Gunthorpe et al., 2002), respectively. Pharmacological 
inhibitors were added to culture media with fluo-4 and incubated for 30 minutes 
before being replaced with BPS (containing the inhibitor) and loading 1x volume 
100µM REV5901 solution supplemented with the same inhibitor. 
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Figure 2.14: The effects of fluid flow on calcium signalling. 
Freshly isolated chondrocytes were seeded at LD onto a 12 well plate and incubated in DMEM 
containing 3µM Fluo-4 AM for thirty minutes in the dark to allow fluorophore uptake and sufficient 
attachment. After the incubation period, the media containing excess dye was aspirated and 
replaced with 500µl calcium solution and an initial reading recorded. 500µl of the same calcium 
solution was injected at different speeds and the fluorescence measured every 14 seconds for 
10 minutes. Experiment was performed once, N=3. Values shown as mean ± s.e.m. T-test p-
values were p<0.05 (*) and p<0.01 (**). 
 
* 
** 
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Figure 2.15: Effects of Ionomycin and negative control DMSO solution on [Ca2+]i  in 
freshly isolated chondrocytes. 
The methodology devised for the calculation of changes in [Ca2+]i  was assayed using Ionomycin, 
an Ionophore used to passively raise [Ca2+]i . Chondrocytes were loaded with 3µM Fluo4 for 30 
minutes and baseline [Ca2+]i  measured prior to loading of 3µM ionomycin or 2µl/ml DMSO. A 
DMSO solution induced a 1.34±0.6% rise in [Ca2+]i  (equivalent to the rise induce by fluid flow), 
whereas Ionomycin caused an influx of Ca2+ raising [Ca2+]i  levels by 6.5±0.6% thus indicating 
that the methodology is suitable for the purposes of this research. N=3, experiment repeated 6 
times. Data shown as means ± s.e.m. T-test p-values were p<0.05 (*) and p<0.01 (**). 
 
** 
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2.11  Chondrocyte Attachment Assay 
 
The role of extracellular attachment protein, DEL1, was studied by assaying for 
the rate of attachment of freshly isolated and 2D cultured chondrocytes on 
plastic substrate. Chondrocytes were isolated (using collagenase for freshly 
isolated and trypsin for 2D cultured chondrocytes), washed by centrifugation, 
seeded at a density of 2x104 cells/cm2 (LD) and allowed to attach for 1, 2 and 4 
hours in a humidified incubator at 37°C and 5% CO2.  
 
After the incubation period, media containing unattached chondrocytes were 
replaced with fresh media containing 0.5mg/ml MTT solution and chondrocytes 
incubated for 3 hours to allow for the reduction of MTT in the mitochondria. 
Excess MTT was removed and MTT solvent (DMSO) used to solubilise the 
reduced formazan crystals, and the absorbance measured at 570nm and 690nm 
(for the background) and used to quantify the number of attaching chondrocytes. 
The values obtained from different incubation times were used to evaluate the 
number of attached chondrocytes at each time point and thus calculate the rate 
of attachment by linear regression of number of attaching chondrocytes vs. time 
(hours). 
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2.12  Cellular protein isolation and analysis 
 
2.12.1 Intracellular cell signal proteins 
 
A potential cellular pathway activated by the ligand-receptor interaction between 
DEL1 and integrins was studied by observing the activation of protein kinase Akt 
by phophorylation within the pathway. Protein kinases were isolated and studied 
by polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting using 
antibodies against phosphorylated and unphosphorylated forms of Akt (Silvestre 
et al., 2005). Akt phosphorylation was studied as previously described 
(Sanchez-Sanchez et al., 2004) by cell lysis of 3x105 chondrocytes in 50µl Akt 
lysis buffer (20mM Tris-HCl, 120mM NaCl, 1% Trition X100, 10% glycerol, 1mM 
sodium pyrophosphate, 20mM sodium fluoride, 1mM sodium orthovanadate, 
pH=7.5 containing protease inhibitor) prior to boiling with 50µl 2x SDS-PAGE 
sample buffer at 95°C for 5 minutes. A sample from the extracts was diluted by a 
factor of 5 prior to assay using Bradford reagent due to the incompatibility of the 
latter with Triton in the former, protein samples were subsequently assayed and 
diluted to 2.5mg/ml and stored at -80°C until further use. 
 
2.12.2 Extracellular DEL1 protein isolation 
 
DEL1 production levels were confirmed but not quantified (due to the quality of 
the anti-DEL1 polyclonal antibody) in freshly isolated and 2D cultured 
chondrocytes using western blots and anti-DEL1 polyclonal antibody (Stratech 
Scientific, Suffolk). To maximise the yield of DEL1 available in the media, 2x104 
cells/cm2 2D culture chondrocytes were seeded in 25cm2 flasks, cultured for 7 
days and media subsequently assayed for the production of DEL1. Conversely, 
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freshly isolated chondrocytes were seeded at a higher density of 3.5x105 
cell/cm2, equivalent to the product of 7 (number of days of incubation for 2D 
cultured chondrocytes) and 5x104 cell/cm2 (the average density of 2D cultured 
chondrocytes within one passage period) and media isolated after 24 hour 
incubation. The amount of proteins produced by chondrocytes was measured by 
Bradford assay, the concentration calculated and samples diluted to 2.5mg/ml. 
 
2.12.3 SDS-PAGE  
 
Protein samples were separated in 5.7% stacking and 12.5% resolving 
polyacrylamide gels. Briefly, 6.7ml of acrylamide-bisacrylamide solution were 
dissolved in 8.0ml of water, 100µl of 20% SDS, 5ml of 4x resolving buffer (1.5M 
Tris-HCl, pH=8.8) and 10µl of TEMED. 150µl of freshly prepared 10% 
ammonium persulphate were added to the polyacrylamide solution  which was 
allowed to set between two glass plates at room temperature under isobutanol 
layer to prevent oxidation. Isobutanol was removed and the gel washed twice 
with distilled water before overlaying the stacking gel prepared with 1.5ml of 
acrylamide-bisacrylamide solution, 4.4ml of water, 40µl of 20% SDS, 2ml of 4x 
stacking buffer (0.5M Tris-HCl, pH=6.8), 8µl of TEMED and 40µl of freshly 
prepared 10% ammonium persulphate. 
 
Samples were prepared for SDS-PAGE by the addition of 1x volume of 2xSDS-
PAGE loading buffer (20% glycerol, 4% SDS, 10% 2-mercaptoethanol and 
0.005% bromophenol blue in stacking buffer) and the sample heated to 95°C for 
5 minutes in a heating block. Wells were loaded with 100µg each, the tank filled 
with running buffer (25mM Tris-HCl, 0.2M glycine, 0.1% SDS, pH=8.3) and the 
gel subjected to 25mAmp/gel for one hour.  
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Protein gels were either visualised using coomassie blue staining or western 
immunoblotting. For the former, gels were stained in filtered staining solution 
(50% methanol, 10% acetic acid. 0.25% coomassie blue) with gentle shaking for 
3 hours. To destain, the staining solution was decanted and sufficient destaining 
solution (5% acetic acid and 10% methanol) was added and replaced when 
necessary. 
 
2.12.4 Western Blot 
 
Western blot was performed in a semi-dry transfer assembly and Immobilon™-P 
(Millipore, Watford, UK) transfer membrane according to manufacturer’s 
instructions. The transfer membrane was cut to the dimensions of the gel, 
wetted in 100% methanol for 15 seconds, placed in water for 2 minutes, and 
soaked in anode buffer II (25mM Tris-HCl, 10% methanol, pH=10.4) for at least 
5 minutes. The gel was prepared for transfer by immersing in cathode buffer 
(25mM Tris base, 40mM glycine, 10% methanol, pH=9.4) and allowed to 
equilibrate for 15 minutes. Two sheets of filter paper were saturated in anode 
buffer I (0.3M Tris-HCl, 10% methanol, pH=10.4) and placed on the anode 
electrode plate followed by one sheet of filter paper saturated in anode buffer II, 
the membrane and the gel in that order. Three sheets of filter paper were wetted 
in cathode buffer and placed between the gel and the cathode electrode plate 
and the electrode leads connected and a fixed current of 100mA applied for one 
hour. The blotted membrane was later dried by incubation at 37°C for one hour 
and stored for future use at 4°C.  
 
Western immunoblotting of Akt proteins was performed according to antibody 
manufacturer’s instructions. Briefly, after transfer, the blot membrane was 
washed with Tris-buffered saline (TBS; 50mM Tris base, 0.15M NaCl, pH=7.6) 
for 5 minutes at room temperature, blocked in blocking buffer (5% non-fat milk, 
0.1% Tween 20 in TBS) for 1 hour at room temperature and then washed three 
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times in TBS/T (0.1% Tween 20 in TBS) for 5 minutes each. The membrane was 
incubated in 10ml of TBS/T containing 10µl of the primary antibody with gentle 
agitation overnight at 4°C and then washed three times in TBS/T for 5 minutes 
each at room temperature. The blot was then incubated in 10ml of TBS/T 
containing 5µl goat Horseradish Peroxidase (HRP) conjugated anti-rabbit IgG at 
room temperature for one hour and subsequently washed 3 times with TBS/T for 
5 minutes each. Upon hybrdisation, the blot was incubated in 10ml 1:1 
luminol:hydrogen peroxide solution for 5 minutes, drained and exposed to x-ray 
film. The films were exposed to the membrane for 30 seconds prior to the former 
being developed and fixed in developing and fixing solutions (Kodak, Herts) for 2 
minutes each. The time for exposure was adjusted if necessary. 
 
For DEL1 western blot detection experiments, membranes were blocked in 10ml 
of 5% non-fat milk in 0.2% PBS/T (0.2% Tween 20 in PBS) at 4°C overnight and 
10µl of anti-DEL1 polyclonal antibody (Stratech Scientific Ltd., Suffolk, UK) were 
added to the blocking buffer and the membrane incubated at 4°C overnight. 
Following incubation, the membrane was washed three times for 10 minutes 
each in 0.2% PBST prior to incubation in 10 ml of 5% non-fat milk in 0.1% PBST 
(0.1% Tween 20 in PBS) containing 2µl rabbit HRP-conjugated anti-mouse IgG 
at room temperature for one hour. The blot was subsequently washed 4 times 
with 0.2% PBST for 10 minutes each and incubated in 10ml 1:1 
luminol:hydrogen peroxide solution for 5 minutes, drained and exposed to x-ray 
film. 
 
Membranes were stripped for further use in the recommended buffer (100mM β-
mercaptoethanol, 2% SDS, 62.5mM Tris/HCl, pH=6.7) and incubated at 50°C for 
30 minutes followed by 2x wash in TBS/T for one hour each prior to drying at 
37°C for 1 hour and storing at 4°C for further use. 
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2.12 Statistical Analysis 
  
All statistical analysis and plotting of graphs were performed using Microsoft® 
Excel 2004. Equations of linear and binomial regression graphs were obtained 
using the ‘trendline’ feature and R2 values given for every equation. 
 
All values are shown as mean ± standard error of the mean (s.e.m) unless 
otherwise stated. Two-tailed homoscredastic Student’s T-tests were carried out 
to determine whether two sets of values are different and deemed significantly 
different if the p value was p<0.05 (*) or p<0.01 (**). 
 
All experiments were repeated as described in each legend. In order to reduce 
the effects of any genetic variation, experiments were performed with 
chondrocytes obtained from as many animals as possible. The number of 
individual joints utilised for each experiment was denoted (N) and the number of 
cells studied, where applicable, was denoted (n). 
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3 Experimental Chapter: The influence of chondrocyte 
expansion on phenotype, morphology and 
dedifferentiation. 
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3.1 Chapter introduction 
 
Chondrocytes in adult cartilage do not undergo cell division, but upon isolation 
and introduction to serum-enriched media, chondrocytes are released from G0, 
a process termed ‘expansion’ (Chen et al., 2003; Kino-oka et al., 2005). Several 
methodologies for chondrocyte isolation and culture have been developed with a 
wide range of culture seeding densities (Table 3.1). Culture is performed using 
media containing 4.5g/L glucose, 10% serum, 2mM L-glutamine and 50µg/ml 
ascorbic acid (Reginato et al., 1994) and occasionally other additional 
supplements including vitamin D3 (Harmand et al., 1984). For purposes of 
expansion and subsequent re-introduction into patients, chondrocytes are 
cultured in monolayers or 3D matrices composed of hydrogels (Reginato et al., 
1994), agarose (Spirito et al., 1993), collagen substrates (Ana M. Schor, 2001), 
pellet models (Johnstone et al., 1998; Yoo et al., 1998) or alginate beads (Guo 
et al., 1989; Shakibaei & De Souza, 1997). 
 
Changes in chondrocyte morphology, phenotype and expression in response to 
in vitro expansion have been the subject of extensive studies as previously 
discussed (Benya et al., 1981; Benya & Shaffer, 1982a). When cultured in 
monolayers (in 2D) or treated with retinoic acid, the most apparent change is a 
switch from spherical/ellipsoid to spread/attached morphology as observed as 
early as the 5th day in culture (Shakibaei et al., 1997), a process that could be 
reversed upon re-introduction of 2D cultured chondrocytes into 3D support 
(Benya & Shaffer, 1982b). These changes have not been quantified in the 
literature in dimensional terms and have been found to be independent of other 
changes in chondrocytic phenotype (Horton & Hassell, 1986). 
 
It has been noted, however, that accompanying changes in actin organisation 
contributed to potent modulation of chondrocytic phenotype where disruption of 
actin filaments using cytochalasin D and dihydrocytochalasin B recaptured 
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chondrocyte-specific phenotype (Benya, 1988; Benya et al., 1988; Loty et al., 
2000). A switch in actin organization from cortical localization in freshly isolated 
chondroctes to higly filamentous in 2D cultured chondrocytes has been widely 
observed (Mallein-Gerin et al., 1991; Idowu et al., 2000; Zwicky & Baici, 2000), 
but not fully quantified. Moreover, organisation of filamentous actin in response 
to retinoic acid treatment (Mallein-Gerin et al., 1991), Gd3+ incubation (Perkins et 
al., 2005) and actin depolymerising drugs have been associated with changes in 
morphology (Takigawa et al., 1984), a switch in ‘expression battery’ (Brown & 
Benya, 1988; Newman & Watt, 1988; Loty et al., 2000; Kim et al., 2003) and the 
capacity to exhibit RVD and RVI (Kerrigan & Hall, 2005; Kerrigan et al., 2006). 
 
A decline in the expression of chondrocyte-specific type II collagen upon 
monolayer culture has been largely documented (Huh et al., 2003; Schulze-
Tanzil et al., 2004; Darling & Athanasiou, 2005) and is used, often in conjunction 
with changes in type I collagen expression, as a phenotypic marker. Moreover, 
transcription factor SOX9 has been shown to play a role in chondrocyte 
differentiation and to be decreased in expression in response to 2D culture 
(Stokes et al., 2002; Tallheden et al., 2004). Additional genes which increased in 
expression upon expansion include Twist, CD44, cadherin 11 (Stokes et al., 
2002), insulin-like growth factor binding protein 3 (Schnabel et al., 2002; Stokes 
et al., 2002), cox-2 (Huh et al., 2003), TNF-R1 (Schnabel et al., 2002) and 
integrins α5, αvβ3 and α3 (Diaz-Romero et al., 2005). Other genes that are 
downregulated upon expansion include α1, LPS-R (Diaz-Romero et al., 2005), 
aggercan, insulin-like growth factor 2, BMP6, and types IX, XI collagen (Stokes 
et al., 2002)  and type X collagen (Tallheden et al., 2004). 
 
Therefore, In order to provide a background of intensive knowledge into the 
changes in chondrocytic phenotype, experiments were conducted to 
quantitatively study changes in cell shape and actin organisation in addition to 
key molecular markers of chondrocyte phenotype to further our knowledge of 
the mechanism of loss of phenotype in 2D expansion. 
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Aims of Experimental Chapter 
 
1 Optimise 2D culture methodology of chondrocytes. 
 
2 Study changes in cell volume, shape and dimensions in response to 2D 
culture. 
 
3 Quantify changes in the ‘expression battery’ upon expansion. 
 
4 Quantify changes in the actin cytoskeletal organisation in response to 2D 
culture. 
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Table 3.1: Range of seeding densities used in the literature for in vitro expansion of 
chondrocytes. 
Culture Seeding Density Reference 
5x103 cell/cm2  Haisch et al., 2006 
1.5x104 cell/cm2  Schnabel et al., 2002; Darling & Athanasiou, 2005 
2x104 cell/cm2  Waymouth, 1974 
5x104 cell/cm2  Huh et al., 2003; Diaz-Romero et al., 2005 
1x105 cell/cm2  Stokes et al., 2002 
2x105 cell/cm2   Johansen et al., 2001; Hamilton et al., 2005a; 
Hamilton et al., 2005b 
3x105 cell/cm2  Perkins et al., 2005 
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3.2 Results 
 
3.2.1 Expansion and Growth Rates 
 
Chondrocytes were isolated from bovine metacarpal and metatarsal joints into 
DMEM and prepared as previously described (see Materials and Methods). 
Briefly, cartilage explants were washed in DMEM and subsequently incubated in 
0.5mg/ml collagenase in 380mOsm DMEM for 18 hours.  Isolated chondrocytes 
were washed and seeded at different densities in culture media containing 10% 
FCS, 1% P/S, 50µg/ml ascorbic acid and 20mM glutamine to determine the 
optimal conditions for culture for all future experiments. Chondrocytes were 
subcultured for up to three weeks until 80% confluency was achieved, 
whereupon chondrocytes were trypsin-lifted, counted and re-seeded at the same 
density (Figure 3.1).  
 
Chondrocytes cultured at High Density (HD) did not show an increase in cell 
number by the end of the first passage (day 9; Figure 3.1). This was most likely 
due to contact and density inhibition mechanisms inhibiting cell growth 
(Freshney, 2001). Conversely, chondrocytes cultured at Intermediate Density 
(MD) exhibited an increase of 47.50±29.44% in cell number during the first 
passage (9 days) and subsequently, as chondrocytes adopted a fibroblast-like 
morphology, ceased to increase in number. Conversely, chondrocytes cultured 
at 2x104cells/cm2 (Low Density; LD) demonstrated a steady increase in cell 
number (r2>0.9) during the entire culture period and therefore this culture density 
was selected for all expansion experiments. In order to determine the maximum 
culture time, chondrocytes plated at LD were cultured until cellular senescence 
was reached upon culture to passage number 8 (60 days in culture) as observed 
by the inhibition of further cellular division.  
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After 2 days of introduction to culture, chondrocytes were collected and cell 
viability assayed by trypan blue and a haemocytometer. When chondrocytes 
were seeded at HD or MD, there was a mean viability of 90.39±4.01% or 
90.06±5.46%, respectively (Figure 3.2). Converely, cell viability decreased to 
71.02±8.66% in response to culture at 2x104cells/cm2 (LD).  
 
These data suggested that despite a reduction in chondrocyte viability, LD was 
favourable choice for 2D cell culture and was used thereafter as part of a 
standard culture technique (Table 3.2). 
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Figure 3.1: Growth curve of bovine articular chondrocyte upon in vitro culture. 
Chondrocytes were isolated using 0.8mg/ml collagenase in 380mOsm DMEM overnight and 
seeded at different densities (High density, HD; Mean Density MD; and Low Desntity, LD) into 
380mOsm media supplemented with 1% penicillin/streptomycin, 20mM L-Glutamine, 10% FCS, 
50µg/ml Ascorbic Acid. Cells were subcultured upon 80% confluence, counted and re-seeded at 
the same density. A growth curve was plotted of log total cell number vs. time and a linear 
regression used to calculate growth rate and doubling time. There was a steady increase in cell 
number only when cultured at LD. Data were pooled from 23 individual experiments, N=12. Data 
shown as mean ± s.e.m. R2 for LD = 0.998. 
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Figure 3.2: Viability assay in response to in vitro 2D culture. 
The viability of chondrocytes cultured at the different densities investigated was obtained by 
trypan blue viability test. 2 days following the initiation of culture, chondrocytes in suspension 
were isolated and counted using a haemocytometer. In high density (HD) and intermediate 
density (MD) culture protocols, there was 90.06±5.46% and 90.39±4.01% viability, whereas low 
density (LD) culture yielded a reduction in cell viability to 71.02±8.66%. N=6. Data were pooled 
from 23 individual experiments and shown as mean ± s.e.m. T-test p-values were deemed 
significant when p<0.05 (*). N/S, non significant.  
 
 
* N/S 
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Table 3.2: Summary of culture properties of chondrocytes cultured at literature-based 
seeding densities. 
It was necessary to establish the culture conditions including culture seeding density in order to 
ensure reproducibility of results. Three seeding densities previously used in the literature were 
assayed for cell growth and viability using trypan blue. Chondrocytes cultured at high density 
(HD) exhibited high viability upon two days in culture but did not increase significantly in number 
whereas at intermediate density (MD) there was a slight initial rise in cell number which was 
abolished upon further culture. In low density (LD) cultures, there was 71.0±4.0% viability by the 
second day in culture and a steady rate of cell growth with a doubling time of 3.7±0.2 days. T-
test p-values were deemed significant when p<0.05 (*) and p<0.01 (**) 
 
 
 
Doubling 
time 
(days) 
R2 value Viability 
 (%) 
Seeding Density 
(cell/cm2) 
HD -31±1.0 
 
 
0.23 
 
 
 
90.4±8.7 
 
2x105 (Johansen et al., 2001; 
Hamilton et al., 2005a; 
Hamilton et al., 2005b) 
 
MD 19±0.9 
 
0.12 
 
90.1±5.5 
 
1x105 (Stokes et al., 2002) 
LD 3.7±0.2 
 
0.99 
 
71.0±4.0 (*) 
 
2x104 (Waymouth, 1974) 
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3.2.2 Morphology, shape and volume of freshly isolated and expanded 
chondrocytes 
 
Currently, the process of chondrocyte de-differentiation and the relationship 
between phenotype and morphology, essential data that will underpin all 
replacement technologies, is not fully understood, and this process was 
therefore investigated. For the purposes of studying the morphology and cellular 
dimensions of chondrocytes upon culture, freshly isolated and 2D cultured 
chondrocytes were incubated with 5µM calcein-AM for 30 minutes at 37°C and 
3D images acquired by CLSM (Materials and Methods). Z-stacks were acquired 
at 1µm depth intervals and reassembled in Imaris 6.3.1 to create a 3D polygon-
based isosurface ‘object’ for each cell (Figure 3.3). The volume, sphericity (ϕ), 
depth (a; µm), width (b; µm) and length (c; µm) of every chondrocyte were 
determined and exported into Microsoft Excel for statistical analysis. 
 
Within 9 days of culture, chondrocytes lost their round morphology and acquired 
a ‘flat’ fibroblast-like structure as seen by CLSM (Figure 3.3). There was a 
decrease in cell depth (a) in reponse to culture from 4.08±0.11µm in freshly 
isolated chondrocytes to 2.24±0.19, 1.96±0.10 and 2.20±0.13 in P1, P2 and P3 
chondrocytes, respectively (p<0.05). Conversely, a significant increase (p<0.05) 
in cell length was observed upon 9 days in culture from 6.04±0.10 to 
12.51±1.82µm with no further change upon longer culture periods. No change, 
however was observed in cell width in response to 2D culture with an average 
diameter of 5.17±0.08, 5.19±0.66, 4.60±0.25 and 5.17±0.96µm in freshly 
isolated, P1, P2 and P3 chondrocytes, respectively (p>0.05). 
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Correspondingly, these changes were confirmed by quantitatively comparing the 
sphericity of the cells whereby a perfect sphere has a sphericity value ϕ=1, and 
values less than 1 indicated a deviation in any of the three principal navigation 
vectors (a, b and c). Freshly isolated chondrocytes exhibited a sphericity factor 
of 0.74±0.02 which significantly decreased (p<0.05) during the first passage to 
0.52±0.03 with no further changes observed during the culture period (Figure 
3.4; p>0.05). 
 
Having determined changes in chondrocyte dimensions, it was necessary to 
study changes in resting cell volume. Previously acquired data assumed a high 
level of sphericity for volume calculation (Bush & Hall, 2001), which as it was 
shown to change upon culture, a new method for volume analysis for 2D 
cultured chondrocytes was devised. Values for cell volume of individual 
chondrocytes were acquired using Imaris and values for 2D cultured 
standardised against the nuclear coefficient as previously described (Materials 
and Methods). Moreover, chondrocyte cell volumes were mathematically 
calculated from cellular dimensions using the formula for spheroids below. 
 
! 
V =
4
3
" # a # b # c  
 
When obtained using Imaris, freshly isolated chondrocytes possessed a volume 
of 474.72±32.08µm3 and a mathematically calculated volume of 
522.27±34.16µm3 with no significant differences (p>0.05). Upon 2D culture, 
however, there was a significant increase (p<0.05) in chondrocyte cell volume to 
673.38±39.59µm3, 724.77±39.59µm3 and 725.20±35.55µm3 in P1, P2 and P3 
chondrocytes, respectively, as determined by Imaris. No significant differences 
were observed between volumes of chondrocytes cultured for different periods 
and no significant differences were observed between values acquired from 
Imaris and those mathematically calculated (p>0.05; Table 3.3). 
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Figure 3.3: Morphology of freshly isolated and 2D cultured chondrocytes as seen under 
confocal microscopy. 
Chondrocytes were freshly isolated (panel A) as previously described, cultured for 9, 14 or 21 
days (panels B, C or D, respectively) and the loaded with 5µm calcein-AM for 30 minutes at 
37°C in the dark. Chondrocytes were imaged as previously described and the series of images 
reassembled in Imaris as an Isosurface surpass (corresponding panels E-H) at 60% threshold 
for freshly isolated chondrocytes and 10% threshold for 2D cultured chondrocytes. Changes in 
the morphology of chondrocytes were onserved as early as 9 days post culture with a loss of a 
spherical cell shape. Images acquired using x63 dipping lens. 
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Figure 3.4: Cellular dimensions and sphericity of chondrocytes as quantified using Imaris 
Isosurface Surpass utility. 
Series of images of chondrocytes acquired using confocal microscopy were reassembled in 
Imaris and isosurface ‘objects’ were created as described in materials and methods. Imaris was 
subsequently employed to determine the depth, width and length of each object (denoted a, b 
and c). There was a significant ∼2-fold increase and decrease in chondrocyte length and depth, 
respectively. Moreover, there was a significant decrease in sphericity upon 9 days of culture, 
indicating a switch in morphology from as early as the first passage. Data pooled from 16 
individual experiments. N=4, n=119. Data shown as mean ± s.e.m. T-test p-values were deemed 
significant when p<0.05 (*) and p<0.01 (**). 
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Table 3.3: Cell volume changes in freshly isolated and 2D cultured chondrocytes as 
acquired by Imaris and calculated mathematically. 
We have devised a new protocol for the assay of cell volume in 2D cultured chondrocytes by 
standardising the volume of 2D cultured chondrocytes as obtained using Imaris (Bitplane) at 
10% threshold against the nuclear coefficient (depth of nucleus acquired at 60% threshold). To 
confirm the validity of the protocol, the volumes obtained using Imaris were compared to those 
mathematically calculated using cellular dimensions. It was observed that there was no 
significant difference in the values obtained by both methods (p>0.05) and that both methods 
demonstrated an increase in chondrocyte cell volume upon 2D culture. N=4, n=119. Data shown 
as mean ± s.e.m. T-test p-values were deemed significant when p<0.05 (*) and p<0.01 (**); 
relative to P0. 
 
 
 Cell Volume as 
acquired from Imaris 
(µm3) 
Cell Volume as 
mathematically 
calculated (µm3) 
Freshly Isolated (P0) 474.72 ± 32.08 522.27 ± 34.16 
P1 673.38 ± 39.59 (**) 610.21 ± 35.87 (**) 
P2 724.77 ± 33.03 (**) 662.80 ± 30.20 (**) 
P3 725.20 ± 35.55 (**) 642.67 ± 31.51 (**) 
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3.2.3 Phenotype and expression profiling of cultured chondrocytes 
 
Having determined the morphological changes which occur during culture, it was 
then necessary to determine changes in the key markers of the chondrocyte 
phenotype so these changes could be correlated. RNA was isolated from 
chondrocytes as previously described (Materials and Methods). Briefly, 
chondrocytes were treated with trypsin-EDTA to allow detachment, washed and 
incubated on ice in RLT lysis buffer (Qiagen, Poole) for 5 min. RNA was 
extracted from the lysate using RNeasy kit (Qiagen, Poole), quantified using UV 
spectrophotometery and reverse transcribed using ImPromII RT system 
(Promega, USA) as previously described. cDNA was subjected to PCR to 
determine the expression levels of key genes (types I and II collagens and 
SOX9) relative to GAPD expression levels (internal multiplexed positive control). 
The ratio of type II collagen to type I collagen (col2:col1) expression was 
determined as a marker for the state of differentiation as previously published 
(Benya & Shaffer, 1982b; Baici et al., 1988a; Benya, 1988), whereby a high ratio 
is indicative of the chondrocytic phenotype. 
 
A significant overproduction of collagen was observed as early as the first 
passage with relative expression level of type I collagen increasing from 
1.00±0.064 to 2.70±0.63 after 9 days in culture (p<0.01). Expression level of 
type II collagen increased transiently within 9 days of culture from 0.98±0.13 to 
1.58±0.15 (p<0.05) and subsequently returned to baseline levels after 14 days 
of culture with no significant differences observed (p>0.05). The ratio of type II 
collagen to type I collagen expression was therefore reduced by a factor of ~2 
from as early as the first passage to 0.58±0.15 indicating an early onset switch 
of phenotype that was maintained for the remainder of the culture period with no 
futher significant change (p>0.05; Figure 3.5). 
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Expression of the chondrocytic transcription factor SOX9, a key regulator of 
chondrocytic phenotype was also studied upon culture to confirm the data 
obtained from the collagen ratio for the purpose of determining the switch in 
chondrocyte phenotype. A significant yet transient 1.75±0.40-fold increase in 
SOX9 expression (p<0.05) was observed within 9 days of culture. Expression 
levels of SOX9 expression declined upon further culture to baseline levels 
(p>0.05). This increase was associated with that of collagen indicating a 
potential role for SOX9 in type II collagen expression, and together the transient 
rise in type II collagen and SOX9 expression levels suggested that 
dedifferentiation occurred in a 2-step trend. 
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Figure 3.5 The expression profiling of chondrocytes before and throughout culture 
RNA was isolated from freshly isolated and 2D-cultured chondrocytes, reverse transcribed and 
subjected to PCR. The amount of DNA in the PCR products was calculated from the intensity 
and size of the bands and calculated relative to amount of GAPD product. Changes in 
expression of key genes compared to amounts in freshly isolated chondrocytes (P0) and were 
recorded upon confluence after 9 days in culture (P1), 14 days in culture (P2) and 21 days in 
culture (P3). The level of expression of SOX9 declined upon culture despite the transient 
increase in P1. Both the expression levels of types II and I collagen increased during 2D 
expansion, but the ratio of type II collagen to type I collagen expression decreased significantly 
during the first few days of culture. Transient increase in SOX9 and type II collagen during P1 
suggested that the loss of phenotype might be a multi-step process. Experiment repeated 6 
times. N= 6. Values shown as mean ± s.e.m. T-test p-values were p<0.05 (*) and p<0.01 (**). 
** 
** 
* * 
* * 
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3.2.4 The regulation of actin cytoskeletal organisation upon 2D culture 
 
The actin cytoskeleton has been shown to be a key regulator of cell morphology, 
cell homeostasis and has been shown to induce volume regulatory mechanisms 
in chondrocytes (Kerrigan & Hall, 2005; Kerrigan et al., 2006). Therefore, 
changes in the chondrocyte actin cytoskeletal organisation were studied in 
response to 2D culture in vitro. Chondrocytes were subcultured upon 80% 
confluence, seeded at that density and allowed to attach overnight before being 
fixed in 3% formaldehyde solution. The actin cytoskeleton was labelled as 
previously described using phalloidin-alexa 488 and images acquired under 
Nyquist settings suitable for deconvolution (Kerrigan et al., 2006). Images were 
analysed using ImagePro 7.0 (Maryland, USA) and the fluorescence intensity 
obtained throughout the cellular structure and plotted against the standardised 
cellular diameter to study the localization of the actin structures. The number of  
actin striation units (StU) within the cytoplasm of individual chondrocytes, shown 
as ‘peaks’ across baseline background, was obtained for further analysis of the 
‘branching’ properties of actin filaments. 
 
In freshly isolated chondrocytes, actin structures were mainly condensed 
towards the cell periphery, whereas upon 9 days of culture, actin filaments were 
formed throughout the cytoplasmic body as seen by confocal microscopy 
(Figure 3.6). There was an average of 1±1StU/cell across the cell cytoplasm of 
freshly isolated chondrocytes, whereas after 10 days in 2D culture, the number 
increased to 5±2StU/cell. There was no significant change to the number of 
striation units upon further culture with 6±1Stu/cell and 5±1StU/cell in P2 and P3 
chondrocytes, respectively, thus confirming the loss of a differentiated, 
predominantly cortical actin structure within 9 days of culture (i.e. first passage; 
Figure 3.7). 
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Figure 3.6: Actin organisation in freshly isolated and 2D cultured chondrocytes as seen 
with confocal microscopy. 
Freshly isolated and 2D cultured chondrocytes were allowed to attach prior to fixing in 3% 
formaldehyde and staining with phalloidin-alexa 488 (green). Freshly isolated chondrocytes 
(panel A) acquired a round morphology with predominantly cortical actin structures, whereas 
upon 2D culture (panels B, C and D for P1, P2 and P3, respectively), filaments in the cell body 
were observed. Images acquired using 63x dipping lense. 
 
 
 
 
A B 
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Figure 3.7: The number of actin striation units across the cell cytoplasm of freshly 
isolated and 2D cultured chondrocytes, 
The fluorescence of actin-phalloidin-alexa 488 complexes was plotted against the standardised 
cell diameter and the number of peaks counted as a representative of actin striation units (StU). 
Freshly isolated chondrocytes possessed a mean of 1±1 StU/cell whereas upon culture there 
was an increase in the number of filaments reaching 5±2 StU/cell within 9 days of culture (P1). 
There was no significant change in the number of striation units upon further culture. Experiment 
repeated 3 times. N=6, n=127. Data shown as mean ± s.e.m. T-test p-values were deemed 
significant when p<0.01 (**). N/S, non significant. 
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To further investigate changes in actin organisation upon 2D culture, the values 
of actin-phalloidin 488 fluorescence at 10% standardised cell length intervals for 
all chondrocytes from one passage were obtained and the mean plotted against 
standard cell length as a representative of actin localisation in different 
passages. Distinct peaks were observed at both ends of the plot corresponding 
to plasma membrane-localised cortical actin structures in chondrocytes from all 
passage and the area under the curve representing actin fluorescence against 
standardised cell length was calculated by mathematical integration of the 
equations of the graphs (Materials and Methods).  
 
Graphs were divided into three distinct regions corresponding to 2 cortical 
(binomial) and one cytoplasmic (linear) actin and the percentage of cortical and 
filamentous actin recorded for freshly isolated and 2D cultured chondrocytes 
(Figure 3.8). In freshly isolated chondrocytes 85.00±4.25% of actin structures 
were deemed cortical and upon 9 days in culture there was a significant 
decrease in the contribution of submembraneous actin structures (p<0.05) with 
only 45.00±2.25% cortical actin in P1 chondrocytes. No further significant 
changes in actin ratio were observed upon further culture with 47.00±2.35% and 
46±2.30% cortical actin in P2 and P3 chondrocytes, respectively. 
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Figure 3.8: Percentage of cortical and filamentous actin structures in freshly isolated and 
2D cultured chondrocytes. 
Freshly isolated and 2D cultured chondrocytes were fixed and actin-phalloidin-alexa488 
complexes assayed for fluorescence using confocal microscopy. The mean actin fluorescence of 
chondrocytes from one passage was plotted against 10% increments of standardised cell 
diameter and the area under the graoh integrated for two binomial curves (cortical) and an 
intermediate linear graph (filamentous). Actin organisation in freshly isolated chondrocytes was 
predominantly cortical with only 15% filamentous. The percentage of filamentous actin sharply 
increased upon culture rising to 45% in 9 days. Further change in actin organisation was not 
observed. N=6, n=119. Data shown as mean ± s.e.m. T-test p-values were p<0.05 (*) and 
p<0.01 (**). N/S, non significant. 
 
 
  
* 
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3.3 Chapter Discussion 
 
It has been well documented that in vitro culture of chondrocytes in 2D 
monolayers induces a switch in phenotype from ‘differentiated’ to ‘fibroblast-like’ 
dedifferentiated. These changes are evident by the loss of the round cellular 
shape, the acquisition of flattened irregular morphology and the decrease in type 
II to type I collagen expression ratio (Benya & Shaffer, 1982b; Stokes et al., 
2001). Therefore, the loss of the chondrocytic phenotype is a major setback to 
chondrocyte expansion and thus cartilage engineering. These distinct changes 
were studied in response to a standardised cell culture technique to further our 
understanding of chondrocyte phenotype and 2D culture-induced loss of 
differentiation.  
 
Firstly, the culture methodology was optimised by growing freshly isolated 
chondrocytes at different seeding densities in serum-enriched media and 
studying the growth rates. At HD, chondrocytes did not undergo any cell growth 
possibly due to contact inhibition (Stoker, 1973) whereas chondrocytes cultured 
at MD increased only slightly in number prior to acquiring a ‘flat’ morphology 
which may have also promoted contact inhibition. Chondrocytes cultured at LD 
divided at a steady rate of 0.27 doublings/day (the equivalent of a doubling time 
of 3.66 days) as previously reported (Frondoza et al., 1996; Lee et al., 2003a). 
Moreover, it appeared that chondrocytes cultured at LD exhibited significantly 
larger cell death when compared to MD and HD cultures, which is possibly 
attributed to cell-to-cell interactions promoting cellular survival (Table 3.2). 
Similar observations have been reported upon high density culture in porcine 
hepatocytes whereby >90% viability initially achieved was followed by a decline 
with time (Chen et al., 2002). 
 
 
 
108 
The first and most apparent effect of monolayer culture was the loss of the 
round morphology quantified by studying the sphericity, Ψ, of chondrocytes 
(defined as the ratio of the surface area of a sphere with the same volume as a 
given chondrocyte to the surface area of the chondrocyte). By the 9th day in 
monolayer, a drop in sphericity was observed with no change occuring upon 
further culture, thereby indicating the complete loss of morphology as early as 
the first passage. These data were consistent with the literature, suggesting a 
change in morphology after the 6th day in culture (Shakibaei et al., 1997). This 
switch in morphology was further confirmed by studying accompanying changes 
in cellular dimensions whereby, upon culture, there was a 1.84-fold decrease in 
cell depth (a) and 1.97-fold increase in cell length (c) confirming that the loss of 
sphericity was attributed to a ‘flat’ morphology with irregular cellular shape 
(Figure 3.4). 
 
Interestingly, in response to culture, an increase in chondrocyte cell volume was 
observed from 474.72±32.08µm3 in freshly isolated chondrocytes to 
673.38±39.59µm3 following 9 days in monolayer. Whilst the former values for 
volume of freshly isolated chondrocytes were in accordance with those reported 
in the literature (Bush & Hall, 2001b), changes in cell volume of 2D cultured 
chondrocytes were not previously investigated due to the limitation of 
fluorescence technology that required the use of spherical fluorescent beads for 
the optimization of the methodology. A new method for obtaining volume for 
non-spherical ‘objects’ was devised using Imaris version 6.3.1 (Bitplane) and the 
depth of the nucleus (termed ‘Nuclear Coefficient’; aη), obtained using standard 
methodology for volume acquisition at 60% threshold for round objects, to 
standardise the dimensions and cell volume obtained at 10% threshold. 
Increase in cell volume may be attributed to (but not exclusively) actin 
reorganisation as actin reorganisation in epithelial cells has been shown to 
cause cellular enlargement (Boland et al., 1996). Another potential reason for 
the increase in chondrocyte cell volume is the culture-induced release from 
maturational arrest otherwise observed in OA and hypertrophic chondrocytes 
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(Pullig et al., 2000; Sandell & Aigner, 2001; Serra & Chang, 2003; Ho et al., 
2009). 
 
One of the other prominent changes in chondrocytes associated with the switch 
in morphology was observed in the form of the reorganisation of the actin 
cytoskeleton where an increase in actin filaments across the cell cytoplasm has 
been previously observed but not quantified. Intracellular actin filaments 
developed in response to 2D culture with an increase from 1±1StU/cell in freshly 
isolated chondrocytes to 5±1StU/cell following 9 days in culture and a general 
increase in percentage filamentous actin from 15% to 55% (Figure 3.8). 
 
The cause-and-effect properties of volume, morphology, actin organisation and 
expression battery of chondrocytes have been under intensive investigation. It 
has been widely documented that reversal of the actin organisation using actin-
depolymerising drugs (including cytochalasin B and D) reverts the expression 
back to type II collagen and thus recaptures a differentiated phenotype (Brown & 
Benya, 1988; Mallein-Gerin et al., 1991; Pirttiniemi & Kantomaa, 1998) 
independently of cell shape (Benya et al., 1988). Furthermore, actin has been 
shown to influence volume regulatory mechanisms with latrunculin B (actin 
polymerising drug) inducing RVI in freshly isolated chondrocytes by the 
activation of NKCC (Kerrigan et al., 2006) and it is therefore possible that the 
increase in chondrocyte cell volume in response to 2D culture is induced by the 
reorganisation of the actin cytoskeleton. 
 
Finally, modification in the expression ‘battery’ of chondrocytes in response to 
2D culture was documented by RT-PCR and densitometery analysis. The ratio 
of type II to type I collagen has long been used as a marker of chondrocyte 
differentiation (Benya & Shaffer, 1982b; Baici et al., 1988a; Idowu et al., 2000) 
and we have similarly reported a 0.58±0.15-fold decline in col2:col1 within the 
first passage (9 days of culture) which decreased insignificantly upon further 
culture reaching 0.39±0.1 in P3 2D cultured chondrocytes.  Interestingly, the 
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fluctuations in the expression levels of individual collagens demonstrated more 
distinct changes within 2D cultured chondrocytes. The expression of the 
chondrocyte-specific type II collagen transiently yet significantly increased after 
9 days in culture prior to returning to baseline levels observed in freshly isolated 
chondrocytes upon further culture. Conversely, type I collagen expression levels 
increased by 2.70±0.63-fold in P1 chondrocytes and remained elevated for the 
remainder of culture as previously reported (Stokes et al., 2002), thus 
contributing to the decrease in col2:col1 expression ratio. These data, however, 
demonstrated that the loss of phenotype may occur in 2 steps when phenotype 
is defined according to expression levels of collagens. P1 chondrocytes 
upregulated the expression of both collagens prior to the ultimate suppression of 
type II collagen expression and this is consistent with previous findings where an 
increase in type II collagen expression in the first 3 passages of high-density 
porcine auricular chondrocyte culture was observed (Haisch et al., 2006). 
Similar observations were reported upon culture of porcine auricular 
chondrocytes where a transient upregulation of type II collagen was observed up 
to the 12th day in culture (Haisch et al., 2006). 
 
SOX9 expression levels were also used as a marker of chondrocyte 
differentiation as a decline in SOX9-mediated transcription has been reported to 
play a role in chondrocytic phenotype (Stokes et al., 2002; Tallheden et al., 
2004). It was, however, observed that the level of SOX9 expression increased 
by a factor of 1.75±0.40-fold following 9 days in culture (simultaneously to the 
rise in type II collagen expression) and subsequently declined upon further 
culture to 0.69±0.14 relative to freshly isolated chondrocytes. SOX9 has been 
shown to regulate the expression of type II collagen in chondrocytes (Hattori et 
al., 2008), the increase of which was therefore attributed to an upregulation in 
SOX9 expression in P1 chondrocytes. 
 
Together, these data have confirmed and quantified changes documented in 
response to 2D culture, and although the exact order of events observed cannot 
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be concluded (Figure 3.9), these differences were considered ‘markers’ of 
dedifferentiation necessary for future experiments. Moreover, these data 
suggested the existence of a distinct phenotype in P1 chondrocytes previously 
undefined and thereafter termed ‘mesodifferentiated‡’. 
                                                 
‡ Greek, from mesos, middle. 
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Figure 3.9: Model of the significant changes  (p<0.05) in phenotypic markers in response 
to 2D culture. 
 
The effect of 2D culture on chondrocytic phenotype was quantified and observed over a 21-day 
period. A new phenotype termed ‘mesodifferentiated’, which has not been previously described, 
was observed upon 9 days in culture. An increase in cell length (c; violet) and volume (orange), 
the decrease in cell depth (a; pink) and development of filamentous actin (StU; dark green) were 
observed in response to expansion. There was an increase in expression of type I collagen (red) 
resulting in an overall decrease in col2:col1 expression (green) which was maintained upon 
further culture. There was however a transient rise in SOX9 (blue) and type II collagen (yellow) 
in mesodifferentiated chondrocytes. Values are shown as mean ± s.e.m. All values shown were 
significantly different  (p<0.05) from baseline levels observed in freshly isolated chondrocytes. 
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4 Experimental Chapter: The mechanotransduction 
properties of 2D cultured chondrocytes. 
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4.1 Chapter Introduction 
 
Chondrocytes receive no direct nervous or vascular support and are neverthe-
less able to ‘sense’ and respond to external stimuli (Stockwell, 1991a) using a 
group of mechanisms, termed ‘mechanotransduction’. External stimuli that 
induce a mechanotransduction response include fluid flow (Yellowley et al., 
1997), fluctuations in osmotic environment (Hall, 1998b), changes in pressure 
(Roberts et al., 2001) and deformations in the cell membrane (Roberts et al., 
2001), all of which occur upon joint loading. Chondrocytes feed back in 
response to such stimuli by various mechanisms including volume regulatory 
mechanisms and/or Ca2+ signalling pathways. 
 
4.1.1 RVI 
Regulatory Volume Increase (RVI) is one of the mechanisms by which some 
types of cells maintain constant volume and intracellular ionic strength that 
supports physiological processes and optimal metabolism (O'Neill, 1999). Upon 
an increase in extracellular ionic concentration, passive water outflux occurs 
followed by cell shrinkage and activation of certain membrane transporters 
including the NKCC (Qusous et al., in press; O’Neill, 1999). Membrane 
transporters involved in RVI pump ions across the plasma membrane into the 
cell cytoplasm resulting in water influx and gradual restoration of cell volume 
(O'Neill, 1999). Experiments aimed at investigating the capacity to exhibit RVI 
are conducted by subjecting cells to a hyperosmotic solution and recording 
changes in cellular volume. In chondrocytes, it has been shown that only 6% of 
freshly isolated and in situ chondrocytes exhibited RVI whereas 54% of 2D 
cultured chondrocytes possessed the capacity to regulate their volume in 
response to a hyperosmotic challenge (Kerrigan et al., 2006). Therefore, the 
capacity of chondrocytes to exhibit RVI was further investigated in 2D 
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chondrocytes as a novel key mechanotransduction marker of chondrocyte 
dedifferentiation in response to expansion. 
 
4.1.2 Calcium Signalling 
The role of calcium within mechanotransduction is that of an intracellular 
secondary messenger. Transient rises in [Ca2+]i  have been observed in 
response to mechanical stimuli including, both steady (Yellowley et al., 1997) 
and oscilliating pressure forces (Edlich et al., 2001), REV5901-loading (Ali et al., 
in press), hyperomsotic (Sanchez & Wilkins, 2004; Dascalu et al.,, 1996) and 
hypo-osmotic (Sanchez et al., 2003; Pritchard et al.,, 2004; Kerrigan and Hall, 
2008) challenges. Calcium enters the cytoplasm of chondrocytes through cell 
membrane calcium channels (including SACC, NCX or members of the TRPV) 
or via IP3-induced release from intracellular stores (Yellowley et al., 1999). 
Moreover, previous studies have shown that an increase in [Ca2+]i  in response 
to hypo-osmotic challenge was additionally mediated by SACC and TRPV 
channel activation (Sanchez et al., 2003). In contrast, only NCX was involved in 
hyperosmotic challenge-induce [Ca2+]i  rise (Sanchez & Wilkins, 2004) and these 
channels were therefore studied.  
 
REV5901 is an antagonist of cysteinyl-leukotriene receptors (a family of G-
protein coupled receptor; GPCR) in porcine epithelial cells (Van Inwegen et al., 
1987), an inhibitor of rat neutrophil 5-LO (Musser et al., 1987) and an inhibitor of 
RVD in articular chondrocytes (Hall & Bush, 2001). It was also recently observed 
within our research group that REV5901-loading induced a sustained rise in 
[Ca2+]I, thus making REV5901 a suitable pharmacological inducer of [Ca2+]i  rise 
necessary to study [Ca2+]i  responses in chondrocytes. The mode of action of 
REV5901 has not been investigated (Ali et al., in press). In response to 
histamine or parathyroid hormone exposure, a rise in [Ca2+]i  was induced by 
PKC activation and IP3 generation, both of which are downstream elements of 
GCPR (Iannotti et al., 1990; Horwitz et al., 1996). A known G-protein coupled 
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receptor-mediated pathway was thus proposed and studied in 2D cultured 
chondrocytes using appropriate pharmacological inhibitors.  
 
 
Aims of Experimental Chapter 
 
1 Study the cellular response to hyperosmotic challenge in freshly isolated 
and 2D cultured chondrocytes as a potential marker of phenotype. 
 
2 Develop the use of REV5901 as a pharmacological inducer of calcium 
responses. 
 
3 Using REV5901-induced [Ca2+]i rise, investigate changes in individual 
channel contribution in response to 2D culture .  
 
4 Investigate the REV5901-mediated signalling pathway responsible for 
inducing a rise in [Ca2+]i . 
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4.2 Results 
 
4.2.1 Regulatory volume increase (RVI) in freshly isolated and 2D 
expanded chondrocytes 
 
Previous work has shown that the capacity for chondrocytes to exhibit RVI in 
response to hyperosmotic challenge during culture thus providing a novel assay 
for the determination of phenotype and mechanotransduction (Kerrigan et al., 
2006). Freshly isolated and 2D-cultured chondrocytes were subjected to a 
hyperosmotic challenge (380-540mOsm) and z-stack images acquired at 0 
(isosmotic) and subsequently at 1.5, 3, 5, 10 and 20 minutes post challenge by 
CLSM, as previously described (see Materials & Methods). Images were 
reassembled in Imaris 6.3.1 and an isosurface surpass applied and cell volume 
determined.  
 
Following an increase in extracellular osmolarity, freshly isolated chondrocytes 
decreased in volume to 0.79±0.05 of their original volume at time 1.5 minutes 
and underwent further volume loss readily over the following 20 minutes, 
reaching 0.67±0.04 the original volume after 20mins (Figure 4.1A). Conversely, 
P1, P2 and P3 chondrocytes decreased in volume by 1.5 minutes to 
0.87±0.03%, 0.88±0.02 and 0.86±0.03% respectively which whilst not 
significantly different to each other (p>0.05) was significantly different (p<0.05) 
from freshly isolated chondrocytes. Unlike freshly isolated chondrocytes P1-P3 
chondrocytes exhibited RVI (p<0.05) whereby at 20mins post-osmotic challenge 
they had recovered 0.99±0.01, 0.99±0.03% and 0.99±0.03% of their original 
respectively volume, respectively (Figure 4.1B-D). 
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Figure 4.1: The capacity of freshly isolated and 2D expanded chondrocytes to exhibit RVI 
in response to hyperosmotic conditions. 
Freshly isolated, P1, P2 and P3 chondrocytes (Panels A, B, C and D, respectively) were loaded 
with 5µM calcein-AM and imaged using CLSM before and up to 20 minutes following a 42% 
hyperosmotic challenge. Freshly isolated chondrocytes did not exhibit RVI whereas P1, P2 and 
P3 2D cultured chondrocytes reaquired 99.6%, 99.8% and 99.7% of their original volume by 20 
minutes, respectively. N=4, n=119. Data shown as mean ± s.e.m. T-test p-values were p<0.01 
(**). 
A B 
C D 
** ** 
** ** 
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 A logarithmic rate of volume regulation was observed in P2 and P3 whereas the 
rate followed a linear trend in P1 chondrocytes (Figure 4.1B). Therefore, the 
trend of RVI in P2 and P3 was deemed ‘bi-phasic’ including ‘robust’ RVI 
between 1.5 and 5 minutes and ‘slow’ RVI between 5 and 20 minutes post 
challenge. P1 chondrocytes, however, solely exhibited ‘slow’ RVI throughout the 
volume recapture time (1.5->20 minutes) thus lacking ‘bi-phasic’ volume 
regulation seen in other 2D expanded cultured passages. The gradient of the 
lines representing ‘slow’ and/or ‘robust’ RVI were used to calculate half the time 
required for chondrocytes to regain 100% of their original volume (denoted t½). 
Slight yet insignificant differences (p>0.5) in t½ of ‘slow’ RVI were observed with 
a value of 9.6±0.6, 10.1±0.7 and 10.9±0.5 minutes in P1, P2 and P3, 
respectively. t½ values for ‘robust’ RVI in P2 and P3 chondrocytes were 3.5±0.5 
and 2.8±0.5 minutes respectively with no significant differences observed 
(p>0.5).  
 
As previous work by others showed heterogeneity in the response to mechano-
stimulation including hyperosmotic challenges (Kerrigan et al., 2006), a box plot 
was created to study the distribution of population of chondrocytes according to 
percentage volume recovery within every passage. It was observed that P1 
chondrocytes exhibited lower and upper quartile values of 97.10% and 102.90% 
volume recovery, respectively. These values were spanned over a larger range 
(p<0.05) upon further culture to 92.15 – 106.31% and 88.04 – 105.90% in P2 
and P3 2D cultured chondrocytes, respectively. To further support these 
findings, the percentage of chondrocytes exhibiting 90-110% interquartile 
volume recovery was obtained for 2D cultured chondrocytes. 91.48% of P1 
chondrocytes exhibited interquartile volume recovery whereas only 53.85% and 
50.23% of P2 and P3 chondrocytes, respectively, showed RVI within the 
corresponding range values with no significant difference between P2 and P3 
chondrocytes (p>0.05; Figure 4.2). These data indicated a distinct switch in 
chondrocyte mechanotransduction after 9 days in culture and yet another 
pattern of RVI exhibited after 14 days in culture (Table 4.1). 
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Figure 4.2: Box plot of 2D expanded chondrocytes against percentage volume recovery at 
time 20 minutes. 
Variations in response to hyperosmotic challenge within every passage were studied by a box 
plot of the maximum recovery values (at t=20 minutes). P1 chondrocytes demonstrated an 
interpercentile volume recovery range of 97.10% – 102.9% whereas P2 and P3 chondrocytes 
showed a larger range of 92.51% – 106.31% and 88.04% – 105.90%, respectively. These data 
showed a transient increase in population homogeneity upon culture (P1 chondrocytes). N=4, 
n=119, experiment repeated 6 times. Data shown as median and interpercentile range ± 
maximum or minimum value. 
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Table 4.1: Volume regulatory properties of freshly isolated and 2D cultured chondrocytes. 
Freshly isolated chondrocytes were characterised by their inability to volume regulate in 
response to hyperosmotic challenge whereas upon culture, P1 chondrocytes exhibited a 
homogenous ‘slow’ RVI response with a t½ of 9.6±0.9 min and an interpercentile range of 
17.76±13.66% volume recovery. Upon further culture, however, P2 and P3 chondrocytes 
exhibited bi-phasic volume regulation with slow and robust  RVI. P2 and P3 chondrocytes were 
also characterised by an increase in the heterogeneity of the response to osmotic challenge. 
 
 
Cell Type P0 P1 P2 P3 
Minimal Percentage 
Volume (%) 79.7±4.7 87.5±2.6 83.4±2.2 81.9±2.7 
Percentage Volume 
Recovery (%) N/A 99.6±2.9 99.8±2.5 99.7±3.1 
Robust RVI t½ (min) N/A N/A 3.5±1.0 2.8±0.9 
Slow RVI t½ (min) N/A 9.6±0.9 10.1±1.0 10.9±1.0 
Interquartile range of 
Percentage Recovery ± 
average whiskers (%) 17.76±13.66 5.80±1.09 13.30±16.53 17.86±17.81 
 
Percentage of cells 
Exhibiting interquartile 
Percentage Recovery 
(%) 
 
 
 
72.72 
 
 
 
91.48 
 
 
 
53.85 
 
 
 
50.23 
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4.2.2 Calcium mechanotransduction and Homeostasis 
As mechanotransduction is linked to phenotype, changes in calcium homeo-
stasis were investigated in response to 2D culture, whereby REV5901 was used 
as a pharmacological inducer of [Ca2+]i  rise. 
 
4.2.2.1 The effect of REV5901 on [Ca2+]i  homeostasis 
Preliminary work in our research group showed a significant and sustained 
increase in [Ca2+]i  in both freshly isolated and 2D expanded chondrocytes in 
response to 50µM REV5901 loading (Ali et al., in press). In conjunction with 
previous work that has demonstrated the influence of REV5901 on volume 
regulation, these initial findings indicated an effect of REV5901 on calcium 
signalling and thus potentially mechanotransduction.  
 
To determine how REV5901 affected calcium signalling, freshly isolated and 2D 
cultured chondrocytes were incubated with 3µM fluo-4 in BPS in the dark for 30 
minutes and 37°C. Upon loading a negative control solution (DMSO carrier), 
freshly isolated chondrocytes exhibited 1.67±0.32% increase in [Ca2+]i  levels 
(Figure 4.3A) whereas 2D cultured chondrocytes showed 1.60±0.50%, 
1.70±0.81% and 1.60±0.32% increases in P1, P2 and P3 2D cultured 
chondrocytes, respectively, in response to fluid flow. When perfused with a final 
concentration of 50µM REV5901, however, both freshly isolated and 2D cultured 
chondrocytes exhibited a significant and sustained rise in [Ca2+]i   levels. Freshly 
isolated chondrocytes demonstrated increased sensitivity to REV5901-loading 
reaching a maximum increase in [Ca2+]i  of 38.0±5.7% compared to P1, P2 and 
P3 which reached a maximum [Ca2+]i  increase (recorded at the end of the 
experiment; t=5 minutes) of 12.5±0.60%, 12.8±1.70% and 18.9±0.81%, 
respectively (Figure 4.3B). These data confirmed initial personal observations 
that suggested a role for REV5901 in the regulation of intracellular calcium 
homeostasis. 
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Figure 4.3: The effect of REV5901 loading on freshly isolated and 2D cultured 
chondrocytes. 
Freshly isolated and 2D cultured chondrocytes were incubated with 3µM fluo-4 in BPS for 30 
min prior to loading of 50µM REV5901 and measurement of maximal [Ca2+]i  change. Loading of 
REV5901-free BPS induced a negligible calcium rise of an average of 1.5% (Panel A). In 
response to REV5901 loading, however, there was a sustained rise in [Ca2+]i  whereby freshly 
isolated chondrocytes exhibited higher sensitivity to REV5901 than 2D expanded chondrocytes 
with a maximum increase of 37.97±1.35% and 12.47±0.61% in P0 and P1 chondrocytes, 
respectively, with no significant change in response to further culture. N=6, experiment repeated 
4 times. Data shown as mean ± s.e.m. T-test p-values were p<0.01 (**). N/S, non significant. 
** 
N/S 
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4.2.2.2 Individual calcium channels contribution to calcium signalling and 
profiling 
The ability of REV5901 to induce a rise in [Ca2+]i rendered it a suitable 
pharmacological reagent for studying calcium channel activities and store 
participation in freshly isolated and 2D cultured chondrocytes to further enhance 
our understanding of potential changes in calcium signalling upon 2D expansion. 
Therefore to meet this objective, it was necessary to determine the source of the 
rise and the channels involved. 
 
4.2.2.2.1 Extracellular vs. intracellular store calcium contribution to REV5901-
mediated calcium rise 
 
The contribution of the extracellular calcium influx and intracellular calcium store 
release in response to REV5901 loading was studied in response to 2D culture-
induced loss of phenotype. 2mM EGTA solutions were used to differentiate 
between calcium influx and calcium release from intracellular stores by chelating 
extracellular calcium ions. Freshly isolated and 2D cultured chondrocytes were 
loaded with 3µM fluo-4 and incubated in the dark for 30 minutes prior to 
aspirating excess fluo-4 and loading chondrocytes in Ca2+-free BPS containing 
2mM EGTA. Subsequently, 50µM REV5901 in Ca2+-free BPS was loaded and 
[Ca2+]I levels measured as previously described.  
 
In the absence of extracellular calcium, there was a decrease in REV5901-
mediated [Ca2+]i  rise, indicating that store contributed for 27.86±3.15% [Ca2+]i  
rise. In contrast, intracellular stores contributed for only 1.97±0.77%, 
3.78±0.78% and 2.01±0.72% rise in P1, P2 and P3, respectively (Figure 4.4) 
with no significant changes (p>0.05). These data indicated a 2D culture-induced 
reduction in intracellular calcium store contribution to REV5901-mediated 
calcium rise in the absence of extracellular calcium ions.  
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Figure 4.4: Effect of extracellular calcium removal on REV5901-induced calcium rise in 
freshly isolated and 2D cultured chondrocytes. 
Freshly isolated and 2D cultured chondrocytes were incubated with 3µM fluo-4 in BPS for 30 
minutes prior to loading of 50µM REV5901 and measurement of maximal [Ca2+]i  change in the 
presence of 2mM EGTA. In freshly isolated chondrocytes, there was a maximal [Ca2+]i  rise of 
27.86±3.15% which dropped upon 2D culture to 1.97±0.77%, 3.78±0.78% and 2.01±0.72% in 
P1, P2 and P3 chondrocytes, respectively. These data induicated a reduction in store 
contribution to REV5901-mediared [Ca2+]i rise upon 2D culture. N=6, experiment repeated 4 
times. Data shown as means ± s.e.m. T-test p-values were p<0.01 (**). N/S, non significant. 
 
** 
N/S 
** 
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4.2.2.2.2 Transmembrane channels contribution to REV5901-mediated calcium 
rise 
 
As the level of REV5901-induced transmembrane Ca2+ influx was not affected 
by 2D culture, membrane channel-dependent [Ca2+]i  regulation was investigated 
as a key mechanotransduction pathway using pharmacological or chemical 
inhibitors to calcium influx. Individual groups of calcium channels were chosen 
including NCX, SACC and TRPV channels as previous work has suggested their 
involvement in osmotic challenge-induced [Ca2+]i  rise (Sanchez et al., 2003; 
Sanchez & Wilkins, 2004). Freshly isolated and 2D cultured chondrocytes were 
loaded with fluo-4 and incubated in the dark for 30 minutes with or without 
appropriate inhibitory conditions (Table 2.6) and subsequently REV5901 loaded 
and [Ca2+]I levels measured as previously described.  
 
Significant differences in the sensitivity to pharmacological inhibition of calcium 
channels were observed between freshly isolated and cultured chondrocytes but 
not between 2D cultured chondrocytes from different passages, thereby 
indicating changes in channel physiology upon 2D culture. No significant 
differences (p>0.5) were observed in the sensitivity of freshly isolated and 2D 
cultured chondrocytes to ruthenium red inhibition of the TRPV channels with 
46.36±6.66, 49.32±6.87%, 51.15±14.07 and 55.13±22.75% inhibition of total 
[Ca2+]i rise in freshly isolated, P1, P2 and P3 2D cultured chondrocytes, 
respectively.  
 
The sensitivity of chondrocytes to the absence of extracellular Na+ was reduced 
upon culture from 84.03±9.22% inhibition of total [Ca2+]i  rise in freshly isolated 
chondrocytes to 57.86±2.76% in P1 2D cultured chondrocytes indicating a loss 
of dependency on NCX function upon culture with no further significant change 
upon subsequent culture (57.42±11.95% and 55.41±8.00% in P2 and P3 
chondrocytes, respectively; p>0.05). Conversely, in the presence of Gd3+, the 
inhibition of total [Ca2+]i rise in chondrocytes was increased upon culture from 
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33.01±4.03% in freshly isolated to 57.21±1.53% in P1 2D cultured chondrocytes, 
respectively (Figure 4.5) and no significant change was observed in response to 
further culture with inhibition values of 54.22±5.24% and 50.80±1.54% in P2 and 
P3 2D cultured chondrocytes (p>0.05). 
 
These data have demonstrated a distinct switch in the regulation of expression 
and/or activity calcium channels upon 2D culture of chondrocytes as observed 
by stimulation using REV5901. It was concluded that while freshly isolated 
chondrocytes depended predominantly on calcium release from intracellular 
stores and to a less extent on NCX channel, REV5901 induced a predominantly 
SACC-mediated rise in [Ca2+]i  in 2D cultured chondrocytes. 
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Figure 4.5: [Ca2+]i  rise inhibition profiling in freshly isolated and 2D cultured 
chondrocytes. 
The dependency of freshly isolated and 2D cultured chondrocytes on individual calcium 
channels was investigated by loading chondrocytes with 3µM fluo-4 in appropriate inhibitory 
conditions prior to loading 50µM REV5901 and measurement of [Ca2+]i changes. Percentage 
inhibition of total [Ca2+]i  rise in the presence of Ruthenium Red did not change upon culture, 
whereas inhibition of NCX and stretch-sensitive calcium channels were reduced and increased, 
respectively. These data indicated a change in channel expression/activity in response to 2D 
culture. N=6, experiment repeated 4 times. Data shown as means ± s.e.m. T-test p-values were 
p<0.05 (*). N/S, non significant. 
 
 
N/S 
* 
* 
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4.2.2.3 The mechanism of effect of REV5901 on intracellular calcium 
concentration [Ca2+]i  
REV5901 is typically used as an inhibitor of RVD mechanisms in freshly isolated 
chondrocytes possibly via actin re-organisation (Bush and Hall, 2001; 
Nadelcheva et al., in press). As 2D cultured chondrocytes exhibited a reduced 
intracellular calcium response to REV5901, the pathway of action of REV5901 
loading on [Ca2+]i  homeostasis was further investigated in freshly isolated  
chondrocytes to investigate all mechanisms which may not exist in 2D cultured 
counterparts. The proposed G-protein-induced pathway for REV5901-induced 
[Ca2+]I rise using individual pharmacological agents against the individual 
proteins downstream of the receptor (Table 2.6). Chondrocytes were loaded with 
3µM Fluo-4 in basic physiological saline (BPS) containing individual 
pharmacological agents for 30 minutes prior to REV5901 loading and 
measurement of intracellular calcium changes.  
 
1µM Wartmannin, an inhibitor of PI5K (Liu et al., 2001), did not cause inhibition 
of the REV5901-mediated calcium rise, indicating the lack of contribution by the 
PIP3/PI5K pathway to [Ca2+]i  levels. Neomycin sequestering of PIP2 molecules 
reduced the initial calcium ‘burst’ with maximum [Ca2+]i  rise of 23.79±2.21%, 
whereas 100µM U73122 (inhibitor PLCβ3) decreased the rate of [Ca2+]i  rise 
thus reaching a final [Ca2+]i  increase of 23.09±2.70%. Finally, incubation with 
100µM Rottlerin reduced REV5901-induced [Ca2+]i  rise to  2.27±3.30% 
inhibition of the calcium rise demonstrating the dependency of the pathway on 
PKC activity (Figure 4.6). 
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Figure 4.6: Changes in [Ca2+]I  in response to REV5901 loading in the presence of 
pharmacological inhibitors to G-protein downstream elements. 
Freshly isolated chondrocytes were incubated with 3µM fluo-4 and suitable pharmacological 
agents required to inhibit signalling molecules downstream of G-proteins. Upon 30 minute 
incubation, media containing excess fluo-4 were replaced with BMP containing pharmacological 
agents and baseline bound [Ca2+]i  measured prior to loading 50µM REV5901 in BPS. Rottlerin 
reduced the maximal calcium rise to 2.27% compared to REV5901 control. Both U73122 and 
neomycin caused an overall inhibition of 45% with neomycin also causing a distinctive reduction 
in the original burst of [Ca2+]i. N=4, experiment repeated 6 times. Data shown as means ± s.e.m. 
T-test p-values were p<0.01 (**). N/S, non significant. 
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The rate of calcium increase with and without pharmacological reagents was 
further studied by dividing the change in percentage fluorescence over the time 
of measurement. REV5901 solution induced an increase in [Ca2+]i  at a rate of  
3.81±0.42%/min which was reduced in the presence of EGTA and U73122 to 
0.95±0.10%/min and 1.75±0.19%/min, respectively (Table 4.2). In the presence 
of Rottlerin, however, the initial rise was followed by a gradual slight decrease at 
0.39±0.04%/min. Exclusively to treatment with of Neomycin, the initial calcium 
rise was delayed by up to 28.8 seconds post REV5901 loading increasing 
gradually at the same rate (3.85±0.42%/min) as a neomycin-free REV5901 
solution (Table 4.2). 
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Table 4.2: Impact of loading of various solutions on [Ca2+]i levels. 
The effect of pharmacological inhibitors of signalling molecules on REV5901-induced [Ca2+]i  rise 
was investigated in freshly isolated chondrocytes to confirm the proposed G-protein-mediated 
pathway. EGTA inhibited the calcium rise by 57.53% whereas U73122 and neomycin induced an 
inhibition of 42.47%, 46.57% and 43.55%, respectively, indicating that both PLCβ3 and IP3 are 
necessary for intracellular calcium release from stores. Moreover, despite no effect on the rate of 
calcium rise in response to treatment with neomycin, there was a 28.8 second delay in the 
calcium rise which was not observed with the use of any other pharmacological inhibitor. While 
Wartmannin did not cause a significant change in the calcium response, Rottlerin abolished the 
REV5901-mediate [Ca2+]i  rise by 89.03%. N=4, experiment repeated 6 times. Data shown as 
means ± s.e.m. T-test p-values against REV5901 control were p<0.05 (*) and p<0.01 (**). 
 
 
Initial Rise 
(%, t=80.8s) 
Maximum Rise 
(%) 
Rate of 
Change 
(%/min) 
Delay 
in 
Rise 
(s) 
DMSO Control -0.11 ±0.20 1.30 ±0.26 ** -0.14 ±0.02 ** 0 
3µM Ionomycin 2.20 ±0.69 6.70 ±2.70 1.19 ±0.13 0 
50µM REV5901 6.23 ±1.30 33.78  ±0.66 3.81 ±0.42 0 
+ 2mM 
EGTA 4.40 ±0.12 27.86 ±1.43 * 0.95 ±0.10 * 0 
+ 100µM 
U73122 3.68 ±1.91 23.09 ±2.70 * 1.75 ±0.19 * 0 
+ 10mM 
Neomycin -1.32 ±1.66 23.78 ±2.21 * 3.90 ±0.43 * 28.8 
+ 100µM 
Rottlerin 3.71 ±0.50 2.27 ±0.61 * -0.39 ±0.04 ** 0 
+ 1µM 
Wartmannin 4.10 ±1.00 32.32 ±1.20 4.00 ±0.44 0 
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4.3 Chapter Discussion 
 
Mechanotransduction is the term used to describe the processes by which 
chondrocytes ‘respond’ to extracellular mechanical stimuli by initiating cellular 
signalling pathways often involving the regulation of [Ca2+]i  levels. Examples of 
these extracellular stimuli include pressure, fluid flow and oscillations in 
extracellular ionic environment. Previous work has shown RVI and Gd3+-
sensitive calcium rise (in response to hypo-osmotic conditions) were exclusive to 
2D cultured chondrocytes indicating a switch in the cellular response to external 
stimuli upon loss of phenotype (Kerrigan and Hall, 2008). Therefore, 
chondrocyte response to hyperosmotic challenge and chondrocyte calcium 
signalling were studied as key markers of chondrocyte phenotype. 
 
The capacity of chondrocytes to exhibit RVI in response to a hyperosmotic 
challenge was studied as a key marker of differentiation. It was previously 
observed that freshly isolated chondrocytes did not exhibit RVI whereas upon 
2D culture, RVI is activated and principally mediated by the NKCC (Kerrigan et 
al., 2006; Qusous et al., in press). Furthermore, volume regulatory mechanisms 
have been previously classified into ‘slow’ and ‘robust’ (Kerrigan & Hall, 2008) 
but passage-dependency was not investigated. We have shown that P1 
chondrocytes exhibited linear volume recovery deemed ‘slow’ RVI over the 
course of the experiment recovering at a t½ of 9.60±0.9 minutes. Conversely, 
P2 and P3 chondrocytes exhibited logarithmic volume recovery deemed 
‘biphasic’ with robust RVI at a rate of t½ of 3.5±1.0 and 2.8±0.39 minutes, 
respectively, followed by slow RVI at a rate of t½ of 10.1±1.0 and 10.9±1.0 
(Table 4.1).  
 
These data confirm previous work by others who suggested that cultured 
chondrocytes undergo a switch in mechanotransduction responses (Kerrigan et 
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al., 2006; Kerrigan & Hall, 2008), and our earlier observations that an 
intermediate dedifferentiated phenotype (termed ‘mesodifferentiated’) existed in 
P1 chondrocytes prior to final dedifferentiation upon further culture. The 
difference in RVI response in P1 could be mediated by the NKCC as previous 
work has shown that bumentanide-sensitive RVI can be induced in freshly 
isolated chondrocytes by actin depolymerisation (Kerrigan et al., 2006). No 
change in NKCC expression was reported in response to 2D culture (Stokes et 
al., 2002) and it is therefore conceivable that a change in NKCC activity, 
possibly regulated by actin organisation, rather than expression, is accountable 
for the lack of robust RVI in P1 chondrocytes.  
 
Furthermore, chondrocytes have been found not to exhibit RVI in situ in 
response to hyperosmotic conditions, and therefore cell shrinkage provided 
chondrocytes with protective mechanism from joint articulation (Parker et al., in 
press). It is therefore possible that differentiated chondrocytes do not exhibit RVI 
to maximise these benefits of cellular shrinkage which may lose significance 
upon loss of the differentiated state. This might furthermore explain the 
existence of a small population of chondrocytes possessing a volume of 
2500µm3 in degenerate cartilage tissue (Bush & Hall, 2005) where loss of 
phenotype occurs. 
 
The variation within chondrocyte populations of the same passage number was 
observed using box plot analysis, which indicated a more homogenous 
response in P1 chondrocytes when compared to freshly isolated chondrocytes, 
P2 or P3 chondrocytes (Figure 4.2). Chondrocytes in situ possess a wide range 
of cell volume (Bush and Hall, 2001) and are exposed to different extents of 
mechanical stimuli (Urban, 1994). Our results showed that freshly isolated 
chondrocytes appear to constitute a heterogeneous population as observed by 
the response to hyperosmotic conditions. The loss of heterogeneity upon 
introduction to culture may be attributed to what appears to be a relatively 
selective culture technique and thus a more homogenous response in 
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mesodifferentiated chondrocytes. Upon further culture, chondrocytes appear to 
dedifferentiate into another heterogeneous population capable of a wide range 
of response to a hyperosmotic challenge. 
 
Intracellular calcium is a key regulator of various intracellular functions including 
mechanotransduction, and changes in [Ca2+]i  levels have been observed in 
response to various other mechanical stimuli. Previous work has shown that 
incubation with REV5901 induced an immediate and sustained elevation in 
[Ca2+]I (Ali et al., in press), thereby suggesting a potential mechanism by which 
REV5901 inhibits other cellular functions including RVD and 5-Lipoxygenase 
activity. The ability of REV5901 to induce a rise in [Ca2+]i  rendered it a suitable 
pharmacological candidate for modulation of [Ca2+]i  levels for further studies 
aimed at using calcium homeostasis mechanisms as a marker of phenotype. 
 
Changes in [Ca2+]i signalling in response to expansion were studied using 
REV5901 as an inducer of [Ca2+]i rise and it was observed that there was a 
decrease in REV5901-induced intracellular store-mediated calcium release in 
response to 2D culture. Previous work has shown that mechanical pressure 
enhanced the sensitivity of IP3R channel (Zhang et al., 2006) possibly due to 
chondroprotective calcium mechanisms (Amin et al., 2008). Therefore, it is 
suggested that, like the loss of mechanical stimuli, the loss of phenotype may 
decrease sensitivity of intracellular calcium stores to REV5901 in 2D cultured 
chondrocytes. Conversely, an increase in store operation, via various stimuli 
including IP3 receptor upregulation, has been seen in response to culture of 
both myocytes and smooth muscle cells (Dreja et al., 2001; Berra-Romani et al., 
2008). 
 
No change in extracellular calcium influx was observed in REV5901 treated 2D 
chondrocytes despite changes in individual channel contribution to calcium influx 
as determined by using calcium channel inhibitors (Figure 4.4). Incubation with 
75µM ruthenium red prior to REV5901 loading induced a 46.36±2.53% inhibition 
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in [Ca2+]i  rise which did undergo any significant change upon culture, suggesting 
no change in the role of TRPV channels in calcium homeostasis upon 2D 
culture. Nevertheless, Previous work has shown that TRPV1 is upregulated in 
response to expansion (van Rossum & Patterson, 2009) and that TRPV4 
regulated SOX9 expression and thus played a role in chondrocyte differentiation 
(Muramatsu et al., 2007). Our work was limited by the non-specific inhibitory 
effects of ruthenium red on all members of TRPV channels as well as others 
including NCX (Gunthorpe et al., 2002). 
 
Changes in the capacity of NCX and SACC to regulate REV5901-mediated rise 
in [Ca2+]i  in response to culture were more prominent. The use of sodium-free 
BPS induced a 84.03±3.50% inhibition, whereas upon culture there was a 
reduction in calcium inhibition to 55.413±1.13%. Conversely, the sensitivity of 
REV5901-induced [Ca2+]i  rise to Gd3+ inhibition increased upon 2D culture from 
33.02±1.53% to 50.80±1.22% confirming previous reports that SACC is involved 
in chondrocyte dedifferentiation (Perkins et al., 2005; Kerrigan & Hall, 2008). 
 
The REV5901-induced signalling pathway was investigated in freshly isolated 
chondrocytes using pharmacological inhibitors of selected intracellular proteins / 
molecules involved in known Ca2+ regulatory signals. GCPR have been shown 
to induce the activation of G-proteins including Gα and Gq, both of which are 
capable of inducing a [Ca2+]i  rise via IP3 production in various cell types 
including leukocytes and epithelial cells (Verghese et al., 1986; Muallem & 
Wilkie, 1999; Liu & Wu, 2004). The necessity of IP3 in REV5901 calcium 
modulation was confirmed by prior incubation with 10mM neomycin (James et 
al., 2004) where it was observed that despite the lack of change in the rate of 
[Ca2+]i  rise, neomycin induced a ∼30 second delay in the calcium response to 
REV5901 and thus a decrease in final [Ca2+]i  rise. Nevertheless, the reason for 
a steady rise in [Ca2+]i  was possibly the over-production of IP3 during the 30 
second delay to compensate for the sequestering of PIP2 molecules by 
neomycin. 
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Incubation with, wartmannin, an inhibitor of PI5K at 100nM (Liu et al., 2001), 
prior to REV5901-loading did not have a significant effect on [Ca2+]i  rise, thereby 
indicating that REV5901-induced [Ca2+]i rise was not PI5K-dependent and 
therefore not mediated by Gq-PI5K pathway. The significance of Gα-PLCβ3 
pathway in REV5901-induced [Ca2+]i  was investigated using U73122, a 
pharmacological inhibitor of PLCβ3 at 100µM (Hou et al., 2004) and a 2.18-fold 
reduction in the rate of [Ca2+]i  rise was obtained, thus confirming that REV5901 
acts on G-protein α signal via PLCβ3 (Figure 4.7). Similarly, the role of IP3 in 
[Ca2+]i  has been previously seen in chondrocytes in response to a hypo-osmotic 
challenge (Sanchez et al., 2003). 
 
The signalling pathway was further investigated by the inhibition of PKC using 
100µM Rottlerin (Gschwendt et al., 1994) which reduced the [Ca2+]i rise to 
2.27±0.61%. The inhibitory effect of Rottlerin may, however, be grossly 
overestimated as recent reports have demonstrated an inhibitory effect of 
Rottlerin on other kinase and non-kinase proteins in vitro (Davies et al., 2000) 
including potassium channels (Zakharov et al., 2005). Nevertheless, It was, 
therefore, concluded that REV5901 induced (but not exclusively) the activation 
of GCPR which in turn stimulated diacylglycerol (DAG) release by PLCβ3 and 
the activation of PKC, thus augmenting the signal and promoting the 
accumulation of IP3 molecules required for [Ca2+]i  release from intracellular 
stores by IP3 receptors (IP3R; Figure 4.7).  
 
Most noticeable variations in the effects of pharmacological inhibitors were 
difference in the magnitude of inhibition between U73122, neomycin and 
Rottlerin. Both U73122 and neomycin reduced the [Ca2+]i  rise to ∼23.00%, a 
non-significantly different value to that obtained in the presence of 2mM EGTA 
in PBS, thus suggesting that IP3 was not necessary for calcium influx across the 
plasma membrane. The use of Rottlerin, however, demonstrated an augmented 
inhibitory effect on [Ca2+]i  rise, thus indicating that PKC is involved in the store-
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independent direct activation of calcium channels. Potential channel targets of 
PKC activation may include TRPV1 as recent reports have shown that the 
phospohorylation of TRPV1 requires PKC, protein kinase A and protein 
phosphatase 2B in embryonic kidney cell line (van Rossum & Patterson, 2009). 
The expression of TRPV1 has been confirmed in both freshly isolated and 2D 
cultured chondrocytes (Gavenis et al., 2009). 
 
In conclusion, these data have quantified changes in mechanotransduction 
responses to expansion. In contrast to freshly isolated chondrocytes, 2D 
cultured chondrocytes exhibited RVI with a distinct response trend in P1 
chondrocytes confirming the existence of a different phenotype in the first 9 days 
of culture. REV5901-induced rise in [Ca2+]i  was investigated and a reduction in 
store-sensitivity observed upon culture. Moreover, the role of NCX, SACC and 
possibly TRPV1 has been suggested in chondrocyte homeostasis with changes 
in individual contributions reported in response to 2D culture. Finally, these data 
have documented changes in mechanotransduction upon 2D culture, thereby 
indicating that these responses may be used as phenotypic markers of a 
differentiated chondrocyte phenotype to ensure optimal performance of 
expanded chondrocytes in artificial cartilage. 
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Figure 4.7: Representative diagram of currently known intracellular calcium signalling 
pathways. 
REV5901 has been shown to be an antagonist to cysteinyl leukotrine receptor, a member of G-
protein coupled receptors superfamily. Two potential pathways of action for G-proteins on [Ca2+]i  
were proposed and investigated; the PLCβ3 and PI5K pathways. We have confirmed that 
PLCβ3 pathway is not involved in REV5901-mediated calcium rise as inhibition of PI5K using 
Wartmannin (War) did not inhibit the calcium rise (pathway shaded in grey). Conversely, the use 
of U73122 (U7), Rottlerin (Rot) or Neomycin (Neo) negatively influenced the maximum change 
in [Ca2+]i  recorded, suggesting that [Ca
2+]i  manipulating properties of REV5901 acted via the 
PLCβ3 pathway. 
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5 Experimental Chapter: The role of DEL1 in 2D 
chondrocytes expansion  
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5.1 Chapter introduction 
 
Integrin signalling has been the subject of intensive studies over the last 2 
decades since the term was first used to describe cell surface receptors which 
mediate cellular adhesion and interaction with the extracellular matrix (Tamkun 
et al., 1986; Ruoslahti & Pierschbacher, 1987).  Integrins are transmembrane 
dimers composed of α and/or β chains non-covalently bound together with 
ligand specificity determined by the combination of the chains (Hemler, 1990; 
Hynes, 1992). In chondrocytes of healthy cartilage, several integrins have been 
found to be expressed with especially elevated levels of α1β1, α5β1 (fibronectin 
recpetor; FnR) and αvβ5 in addition to α3β1 and αvβ3 (Woods et al., 1994). 
Conversely, chondrocytes from OA cartilage expressed elevated levels of α2, 
α4 and β2 chains (Ostergaard et al., 1998) with a reduction in β1 chains 
inversely related to the progression of OA (Lapadula et al., 1997, 1998). Upon 
isolation, chondrocytes have been shown to possess elevated levels of α2, α5, 
α6, αv and β1 chains (Durr et al., 1993) whereas upon monolayer culture there 
was a decrease in α1 and an increase in α2-6 chains and α5β1 heterodimers 
(Enomoto-Iwamoto et al., 1997; Diaz-Romero et al., 2005). These findings 
indicate a role for integrins in the maintenance of chondrocyte homeostasis in 
different conditions and thus the regulation of chondrocytic phenotype. 
 
Integrin signalling induces a set of cellular functions including differentiation, 
morphology switch, actin organtisation, growth and survival as well as cellular 
attachment, the initial and most anticipated function (Aszodi et al., 2003; 
Zemmyo et al., 2003; Bengtsson et al., 2005). α2β1 chains were identified as 
essential for chondrocyte attachment on type II collagen-coated plates whereas 
α5β1 chains were required for attachment on fibronectin-coated plates 
(Enomoto-Iwamoto et al., 1997) or on a monolayer of fibroblasts 
(Ramachandrula et al., 1992). It was observed that α2, α3 and β1 chains are 
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involved in mediating a signal that promotes collagen X production with the β1 
being additionally involved in actin polymerisation and survival (Hirsch et al., 
1997), maintanance of spherical morphology (Shakibaei et al., 1997), and 
enhancing TGF-induced differentiated phenotype (Scully et al., 2001). 
Conversely, α5β1 heterodimer has been shown to induce collagenase and 
stromelysin production in synovial fibroblasts (Werb et al., 1989), coordinate 
cartilage differentiation in mouse embryos (Garciadiego-Cazares et al., 2004), 
mediate a switch to fibroblast-like morphology (Ramachandrula et al., 1992) and 
proliferation in articular chondrocytes (Enomoto-Iwamoto et al., 1997). 
 
DEL1 is a 52-kDa extracellular matrix integrin ligand composed of two 
carbohydrate-binding discoidin domains and two EGF-like Ca2+-binding repeats, 
the second of which contains an RGD motif (Hidai et al., 1998). DEL1 is 
expressed by endothelial cells during embryological vascular development and 
has been shown to be expressed in angiogenic neoplastic tissue (Aoka et al., 
2002), ischemic tissue (Ho et al., 2004) and human foetal chondrocytes (Stokes 
et al., 2002). Similarly to another member of the EGF-like repeats and discoidin 
I-like proteins (Lactadherin; EDIL1), DEL1 activity requires the interaction with 
integrin αvβ3 (Penta et al., 1999; Silvestre et al., 2005) and upon DEL1 ligation, 
integrins undergo aggregation and induce phophorylation of downstream 
signalling proteins  (Penta et al., 1999). 
 
The expression level of DEL1 in adult chondrocytes and biological significance 
of DEL1/integrin interaction has not been previously investigated. As expansion 
for tissue engineering purposes requires a 3D matrix that would provide the 
correct integrin signals (van der Kraan et al., 2002), we have studied the role of 
DEL1 in bovine articular chondrocyte 2D expansion in this experimental chapter. 
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Aims of Experimental Chapter 
 
1 Study the level of DEL1 expression in response to 2D culture. 
 
2 Successfully perform DEL1 knockdown using the designed siRNA 
molecules 
 
3 Study the role of DEL1 in attachment. 
 
4 Investigate the effect of DEL1 knockdown on phenotypic markers including: 
i. Expression battery of chondrocytes 
ii. RVI response 
iii. REV5901-mediated rise in [Ca2+]i   
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5.2 Results 
 
5.2.1 The expression level of DEL1 in response to 2D culture of 
chondrocytes 
 
As previously mentioned, the loss of DEL1 upregulation in 2D cultured foetal 
chondrocytes suggested a potentially important role in the regulation of the 
chondrocytic phenotype (Stokes et al., 2002), and therefore the next part of the 
project was to determine the bio-significance of DEL1 in 2D cultured 
chondrocytes. Freshly isolated and 2D cultured chondrocytes were collected by 
centrifugation and RNA isolated and reverse transcribed as previously 
described. The level of DEL1 transcription was subsequently studied by PCR 
and densitometery DNA electrophoresis (Materials and Methods). 
 
There was a 2.48±0.34-fold increase in the level of DEL1 expression upon 9 
days of culture (p<0.05) and subsequently declined in culture reaching 
0.68±0.04 and 0.86±0.08 of baseline levels in P2 and P3 chondrocytes, 
respectively (Figure 5.1), with no significant changes observed (p>0.05). The 
increase in DEL1 expression in P1 chondrocytes was simultaneous to the 1.75-
fold increase in SOX9 expression and the switch in type II:I collagen expression 
ratio as previously discussed (Section 3.2.3). These data, therefore, suggested 
a potential role for DEL1 in phenotype loss and an association between the 
expression of DEL1 and SOX9. 
 
To further elucidate the time of the rise in DEL1 expression in the first passage, 
RNA was isolated from 2D cultured chondrocytes after 2, 4 and 6 days in culture 
and RT-PCR analysis performed as previously described. The level of DEL1 
expression increased upon 2 days in culture reaching 12.19±1.67-fold increase 
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compared to freshly isolated chondrocytes and declined to 10.44±1.43, 
6.02±0.82 and 2.48±0.34-fold increase after 4, 6 and 9 days, respectively 
(Figure 5.2A).  
 
Changes in the ratio of type II:I collagen expression were observed to be of later 
onset than those in DEL1 expression, whereby no significant change in collagen 
expression ratio was observed by the 2nd day in culture with a value of 
1.12±0.15 as standardised against freshly isolated chondrocytes. The switch in 
collagen ratio expression, however, only occurred by the 4th day in culture 
(Figure 5.2B) with a decrease to 0.67±0.11 in the expression ratio, which further 
declined to 0.30±0.10 and 0.39±0.10 upon 6 and 9 days in culture, respectively. 
These data suggested a switch in collagen phenotype of chondrocytes following 
a 12.19±0.15-fold increase in DEL1 expression at the commencement of culture. 
 
The expression and secretion of DEL1 proteins was confirmed by western blot 
but not quantified due to the poor quality of anti-DEL1 polyclonal preparation. 
Media from chondrocytes were collected as previously described (Materials and 
Methods) and subjected to 12.5% polyacrylamide SDS-PAGE and gels blotted 
on membrane and probed for DEL1 expression. DEL1 proteins were detected in 
freshly isolated and 2D cultured chondrocytes (Figure 5.3) confirming the 
expression of DEL1 in adult bovine chondrocytes. 
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Figure 5.1: Changes in the expression of DEL1 in chondrocytes upon 2D culture. 
RNA was isolated from freshly isolated and 2D-cultured chondrocytes for 9 (P1) days, 14 (P2) 
and 21 (P3) days, reverse transcribed and subjected to PCR. The amount of DNA in the PCR 
products was calculated from the intensity and size of the bands and calculated relative to 
amount of GAPD product. The level of expression of SOX9 declined upon culture despite the 
transient increase in P1 (panel B) whereas the ratio of type II:I collagen expression decreased 
significantly upon culture. DEL1 expression levels were associated with those of SOX9 with a 
transient ~2.5-fold-increase in P1 chondrocytes (p<0.05) with a decrease to baseline levels upon 
further culture. N=7, experiment repeated 6 times Values shown as mean ± s.e.m. T-test p-
values were p<0.05 (*) and p<0.01 (**). N/S, non significant. 
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Figure 5.2: Changes in DEL1 and collagen expression ratio within the first 9 days of 2D 
culture. 
RNA was isolated from freshly isolated and 2D-cultured chondrocytes after 2, 4 6 and 9 (P1) 
days in culture. RNA was reverse transcribed and subjected to PCR. Changes in expression 
DEL1 and col2:col1 expression were quantified relative to expression levels in freshly isolated 
chondrocytes (P0). A more extensive study to assay changes within the first 9 days of culture 
showed a 12.19±1.67-fold rise in DEL1 expression from as early as 2 days (Panel A) in culture 
and a significant decrease in type II:I collagen ratio observed by 4th day in culture (Panel B). 
N=7, experiment repeated 6 times. Values shown as mean ± s.e.m. T-test p-values were p<0.05 
(*) and p<0.01 (**). N/S, non significant. 
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Figure 5.3: Western blot image of chondrocyte supernatant assayed for DEL1 protein. 
Media supernatants from freshly isolated (P0) and 2D cultured chondrocytes (P1, P2 and P3) 
were isolated and assayed by bradford reagent prior to being resolved on 12.5% polyacrylamide 
SDS-PAGE. Western blot was performed and the membranes probed using anti-DEL1 
polyclonal antibodies. DEL1 proteins were detected in both freshly isolated and 2D cultured 
chondrocytes but images were not quantifiable due to the poor quality of the antibodies. N=4, 
experiment repeated 2 times.  
P0 P1 P2 P3 
53.7kDa 
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5.2.2 DEL1 knockdown using RNAi technology 
 
To investigate the role of DEL1 on chondrocytic phenotype, RNAi technology 
was employed by transfecting freshly isolated chondrocytes with anti-DEL1 
siRNA molecules prior culture-stimulated DEL1 rise. Firstly, to study the efficacy 
and duration of the siRNA molecules designed, freshly isolated chondrocytes 
were transfected in suspension with 10nM and 3µl/ml HiPerfect transfection 
reagent, as previously described, and incubated in serum-free 380mOsm media 
at 37°C in a humidified 5% CO2 incubator. RNA was extracted after 2, 4, 6 and 9 
days and RT-PCR performed to assay the levels of DEL1 expression. 
 
Anti-DEL1 siRNA molecules achieved successful knockdown with the level of 
DEL1 expression reduced to 0.24±0.01-fold (relative to freshly isolated 
chondrocytes) after 2 days of transfection and the knockdown state was 
maintained for at least another 4 days reaching 0.24±0.01% and 0.39±0.02% 
with no significant differences (p>0.05) by the 4th and 6th days post-transfection. 
After 9 days of transfection, however, DEL1 expression resumed reaching 
1.51±0.08 baseline levels (p<0.05; Figure 5.4). These data confirmed the 
transience of siRNA-mediated knockdown observed to last for a mere 6 days 
post-transfection and demonstrated the efficacy of anti-DEL1 siRNA sequences 
designed. The effect of anti-DEL1 siRNA molecules on the growth curve of 
chondrocytes was assayed by trypan blue assay after 2, 4, and 6 days of culture 
and no significant difference was observed in the growth curve of anti-DEL1 
siRNA transfected, mock transfected, or non transfected chondrocytes (doubling 
times of 4.02, 3.66 and 3.73 days, respectively; p>0.05; Table 5.1). 
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Figure 5.4: The transience inhibition effect of anti-DEL1 siRNA transfection on DEL1 
mRNA levels. 
Freshly isolated chondrocytes were transfected in suspension using 10nM anti-DEL1 Cy3-
tagged siRNA (inset red; appears yellow due to overlay) freshly prepared with 3µl/ml HiPerfect 
Reagent and incubated in culture media for 6 hours prior to being imaged using confocal 
microscopy where siRNA molecules were observed around the nucleus of the Calcein-AM-
labelled chondrocyte (green). DEL1(-) chondrocytes were cultured for 2, 4, 6 and 9 days, RNA 
isolated and RT-PCR performed to assay changes in DEL1 expression in response to 
transfection. Upon 2 days of trasfection, DEL1 expression was significantly reduced to 0.24±0.01 
of baseline levels and remained diminished for another 4 days. DEL1 expression levels were 
restored upon 9 days in culture with 1.52±0.08% relative to freshly isolated chondrocytes. 
Values shown as mean ± s.e.m. N=4, experiment repeated 3 times. T-test p-values were p<0.01 
(**). N/S, non significant. 
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Table 5.1: Growth rate properties of P1 and DEL1(-)/P1 chondrocytes. 
The effect of siRNA transfection on the growth rate of chondrocytes was assayed by transfection 
of freshly isolated chondrocytes in suspension prior to introduction to culture and performing cell 
count every 2 days in culture using trypan blue and a haemocytometer. The rates of cell division 
and doubling times were obtained from a linear regression of Log(cell number) vs time in culture 
and no significant change in the growth rate was observed upon transfection or DEL1 
knockdown. N=4, experiment repeated 6 times. Data shown as means ± s.e.m. 
 
 
 
 
 
 
 
 
 
 
Doubling time 
(days) 
R2 value Viability 
(%) 
 
P1 
 
3.7±0.2 
 
 
0.99 
 
71.0±4.0 
 
DEL1(-)/P1 
 
4.0±0.3 
 
 
0.99 
 
65.2±5.5 
Mock-tranfected P1 
 
 
3.7±0.1 
 
 
0.91 
 
68.5±4.0 
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5.2.3 The role of DEL1 knockdown on chondrocytic phenotype, 
morphology and mechanotransduction 
 
Having determined a change in DEL1 expression following culture, the effect of 
DEL1 expression on phenotypic properties was studied by long-term knockdown 
of DEL1 using RNAi. Freshly isolated chondrocytes were transfected with anti-
DEL1 siRNA in suspension prior to commencing culture in serum-enriched 
media for 9 days (chondrocytes termed DEL1(-)/P1). Due to the transiency of 
the knockdown, chondrocytes were repeat-transfected after 6 days in culture to 
maintain the inhibition of DEL1 translation. Control chondrocytes employed in 
these experiments were P1 chondrocytes mock-transfected using negative 
control (scrambled) siRNA (Ambion). 
 
5.2.3.1 The role of DEL1 on chondrocyte attachment 
 
The role of DEL1, defined as a matrix adhesion protein, on cellular attachment in 
chondrocytes was investigated during 2D culture. Briefly, freshly isolated and 2D 
cultured chondrocytes (isolated by trypsinisation) were washed and seeded at 
LD as previously described. Chondrocytes were subsequently incubated for 1, 2 
or 4 hours at 37°C in a humidified CO2 incubator prior to removal of the media 
containing unattached cell suspension and the addition of fresh media 
containing 0.5mg/ml MTT and incubation for 3 hours at 37°C.The number of 
attached chondrocytes was ascertained by measuring the absorbance of 
reduced MTT as previously described (Materials and Methods). 
 
After one hour in 380mOsm media, 78.20±2.29% of freshly isolated 
chondrocytes seeded were attached whereas after 9 days in culture, 
55.00±2.74% of P1 chondrocytes underwent attachment in one hour of seeding. 
When cultured for longer periods, however, chondrocytes recovered their 
original quick-onset attachment properties with 87.5±3.35% and 91.2±3.35% 
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attachment after 1 hour of seeding in P2 and P3 2D cultured chondrocytes, 
respectively. The lack of initial attachment response (after 1 hour of seeding) in 
P1 2D cultured chondrocytes was associated with an over-expression of DEL1 
in 2D culture. Following incubation for 4 hour, attachment reached 105.40±2.19, 
98.33±7.16, 120.33±2.13 and 116.48±2.12 in P0, P1, P2 and P3 chondrocytes 
respectively, with no significant difference observed (p>0.05; Figure 5.5). 
 
The rate of attachment was additionally studied by linear regression of 
percentage attachment over time. Freshly isolated, P2 and P3 chondrocytes 
exhibited a rate of attachment of 10.13%/hour, whereas P1 chondrocytes 
possessed a significantly higher rate of 15.07%/hour (p<0.05), suggesting that 
despite a late onset attachment in P1 chondrocytes, a higher rate of attachment 
was exhibited in the presence of elevated levels of DEL1 expression. These 
data suggested a potential role for DEL1 in the regulation of P1-exculsive 
attachment profile characterised by an increased rate yet slow onset 
attachment. 
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5.2.3.1.1 The effect of DEL1 knockdown on the rate of attachment of 
chondrocytes 
 
Therefore, the necessity for DEL1 in attachment of chondrocytes was assayed 
upon continuous knockdown of P1 chondrocytes for 9 days prior to isolation by 
trypsinisation, seeding and performing MTT attachment assay as previously 
described. Initial attachment (upon 1 hour in culture) was significantly reduced 
from 55.0±2.74% in control P1 chondrocytes to 8.12±3.33% (p<0.05) and 
percentage attachment after 4 hours in culture from 98.33±7.16% to 
24.59±1.83% (p<0.05; Figure 5.6). These data have shown a decreased rate of 
attachment in the absence of DEL1 expression from 15.07%/hour in control 
chondrocytes to 5.12%/hour (p<0.05). It was thus concluded that an increase in 
release of DEL1 in P1, if time-dependent and therefore of late onset, is 
necessary for the attachment of chondrocytes for at least 9 days upon culture, 
thus contributing to higher attachment rates in P1 chondrocytes (Table 5.2). 
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Figure 5.5: Percentage attachment of freshly isolated and 2D cultured chondrocytes. 
Chondrocytes were isolated and cultured for 9, 14 and 21 days prior to isolation and seeding at 
culture density and incubation at 37°C in a humidified incubator. Following incubation for 1, 2 
and 4 hours, media containing unattached chondrocytes were aspirated and replaced with 
culture media containing 0.5mg/ml MTT to assay for cell viability as previously described. 
Freshly isolated (P0), P2 and P3 chondrocytes exhibited an early onset attachment with 
78.20±2.29%, 91.16±3.35% and 87.52±3.35% attachment within an hour of seeding, 
respectively, whereas only 55.00±12.74% of P1 chondrocytes attached under identical 
conditions (p<0.05). Following 4 hours of seeding, chondrocytes reached high levels of 
attachment with no significant differences observed in response to 2D culture (p>0.05) with 
105.40±12.19%, 98.32±12.12%, 110±17.07% and 105.93±17.07 attachment in freshly isolated, 
P1, P2 and P3 chondrocytes. Values shown as mean ± s.e.m. N=4, experiment repeated 3 
times. T-test p-values were p<0.05 (*). N/S, non significant. 
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Figure 5.6: Percentage attachment of chondrocytes against time in control and Del(-)/P1 
chondrocytes. 
To confirm the necessity for DEL1 in cellular attachment in P1 chondrocytes, freshly isolated 
chondrocytes were transfected with anti-DEL1 siRNA and cultured as previously described. 
Upon reaching P1, chondrocytes were collected by trypsin treatment and centrifugation, seeded 
at the culture density and incubated at 37°C prior to removal of the supernatant containing 
unattached cell suspsension at 1, 2 and 4 hours post-seeding. The number of attached 
chondrocytes was measured using 0.5mg/ml MTT as previously described. Upon DEL1 
knockdown there was a decrease in initial attachment from 55.00±2.74% in P1 mock transfected 
chondrocytes to 8.12±3.33% and in final attachment from 98.33±7.16 to 24.59±1.83 at 4 hours 
post seeding. N=4, experiment repeated 3 times. Data shown as means ± s.e.m. T-test p-values 
were p<0.01 (**). 
 
 
** ** 
** 
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Table 5.2: Summary of attachment properties of freshly isolated and 2D cultured 
chondrocytes. 
Freshly isolated (P0) and P2 and P3 chondrocytes exhibited quick onset attachment properties 
with 80.60% of chondrocytes attaching within 1 hour of seeding, whereas only 55.00±2.74% of 
P1 chondrocytes attached within the same time. After 4 hours in culture, however, P1 
chondrocytes reached a similar plateau of cellular attachment to the one observed in P0, P2 and 
P3 chondrocytes, thus demonstrating a higher rate of attachment. Upon DEL1 knockdown, 
however, there was a significant reduction in both intital attachment and attachment rate. N=10, 
experiment repeated 6 times. Data shown as means ± s.e.m. T-test p-values (against freshly 
isolated chondrocytes) were p<0.05 (*) and p<0.01 (**). 
 
 
Rate  
(Δ %/h) 
Initial 
Percentage 
attachment 
 
 
Onset 
Time for 
100% 
attachment 
(hour) 
 
 
Efficiency 
P0 10.13 80.60±2.29% Fast 1.92 Low 
P1 15.07 * 55.00±2.74% ** Slow 4.45 * High 
P2 10.13 80.60±3.35% Fast 1.92 Low 
P3 10.13 80.60±3.22% Fast 1.92 Low 
DEL1(-)/P1 5.1 ** 8.10±3.33 % ** Slow 18.51** Low 
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5.2.3.2 Chondrocyte Morphology 
 
To study the effect of DEL1 knockdown on chondrocyte morphology, DEL1(-)/P1 
chondrocytes were cultured under conditions of longterm DEL1 knockdown, 
loaded with 5µM calcein-AM to stain the cellular body and subsequently imaged 
using CLSM with 1µm depth steps. Images were loaded in Imaris 6.3.1, 
isosurface surpace ‘objects’ created around the cellular structures and cell 
dimensions obtained as previously described. 
 
No significant differences were observed in cell depth (a) of P1 chondrocytes 
upon knockdown with values of 2.24±0.19µm and 2.04±0.36µm in control P1 
chondrocytes and DEL1(-)/P1 counterparts, respectively (p>0.05). Furthermore 
cell width (b) of P1 chondrocytes was determined at 5.19±0.66µm and 
5.52±0.50µm upon knockdown with no significant changes observed (p>0.05). 
Finally, chondrocyte length (c) decreased upon knockdown from 12.51±1.82µm 
in mock transfected 2D cultured P1 chondrocytes to 11.12±1.00µm in DEL1(-
)/P1 chondrocytes with no significant differences observed (p>0.05; Figure 5.7).  
 
There was no significant change (p>0.05) in the sphericity upon knockdown with 
sphericity values determined at 0.52±0.03 and 0.50±0.03 in control P1 and 
DEL1(-)/P1 chondrocytes, indicating that the knockdown of DEL1 was not 
sufficient to restore chondrocytic ‘round’ morphology. There was, however, a 
significant decrease in cell volume in response to DEL1 knockdown from 
673.38±39.59 in mock transfected P1 chondrocytes to 440.02±46.74µm3  in 
DEL1(-)/P1 chondrocytes, rendering the latter of the two groups more similar to 
freshly isolated chondrocytes in size (p<0.05; Figure 5.7). These data indicated 
that DEL1 contributed to an increase in cell length upon culture and played a 
role in cell volume expansion upon 2D culture. 
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Figure 5.7: Changes in chondrocyte morphology and cellular dimension in response to 
long-term DEL1 knockdown. 
Series of images of chondrocytes acquired using confocal microscopy were reassembled in 
Imaris and isosurface ‘objects’ created as described (Materials and Methods). Imaris was 
subsequently employed to determine the depth, width and length of each object (denoted a, b 
and c). No significant changes were observed in the depth and width between control mock 
transfected and DEL1(-) chondrocytes but there was, however, a significant decrease in cell 
length in response to DEL1 knockdown (p<0.05). There was no significant change in the 
sphericity factor but a decrease in cell volume upon DEL1 knock down from 673.38±39.59 to 
440.02±46.74µm3 was observed, values previously observed in freshly isolated chondrocytes. 
Data pooled from 16 individual experiments. N=4, n=85. Data shown as mean ± s.e.m. T-test p-
values were p<0.05 (*) and p<0.01 (**). N/S, non significant. 
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5.2.3.3 Chondrocyte expression battery 
 
RNA was extracted from DEL1(-)/P1 chondrocytes upon confluence and 
subjected to RT-PCR to assay the expression of key genes in chondrocyte 
phenotype including types I and II collagens and SOX9. The level of expression 
of key genes was calculated using gel densitometery and was expressed 
relatively to the level of expression in freshly isolated chondrocytes.  
 
No significant changes were observed in the expression of type II collagen 
(p>0.05) between control chondrocytes and DEL1(-)/P1 with expression levels 
determined at 1.57±0.43 and 1.18±0.27 relative to freshly isolated chondrocytes. 
The level of type I collagen expression, however, was significantly reduced 
(p<0.05) from 2.71±0.63 to 1.08±0.34-fold in control and DEL1(-)/P1, 
respectively, with no significant differences between DEL1(-)/P1 and freshly 
isolated chondrocytes (p>0.05). Therefore, the ratio of type II to I collagen in 
DEL1(-)/P1 chondrocytes was determined at 1.14±0.15 and was not significantly 
different from that obtained for freshly isolated chondrocytes (p>0.05) but 
significantly elevated compared to the expression ratio in P1 chondrocytes 
(0.58±0.15; p<0.05). These data indicated that DEL1 knockdown maintained the 
collagen-dependent phenotype state of chondrocytes (Figure 5.8). 
 
There was however no change in the level of SOX9 expression in response to 
DEL1 knockdown with expression levels of 1.75±0.40 and 1.81±0.36-fold 
baseline in control P1 and DEL1(-)/P1 chondrocytes, respectively.  
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Figure 5.8: Changes in chondrocyte expression battery in response to DEL1 knockdown. 
RNA was isolated from freshly isolated, P1 2D-cultured  and DEL1(-)/P1 chondrocytes, reverse 
transcribed and subjected to PCR. The amount of DNA in the PCR products was calculated from 
the intensity and size of the bands and calculated relative to freshly isolated chondrocytes. No 
change in the level of expression of SOX9 and type II collagen upon DEL1 knockdown was 
observed, whereas a significant (2.62-fold) decrease in type I collagen expression was recorded 
in response to DEL1 knockdown. Therefore, the ratio of type II to I collagen expression 
increased significantly in response to DEL1 knockdown reaching 1.14 relative to freshly isolated 
chondrocytes. N=4, experiment repeated 4 times Values shown as mean ± s.e.m. T-test p-
values were p<0.05 (*) and p<0.01 (**). N/S, non significant.  
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5.2.3.4 The effect of DEL1 on actin organisation 
 
DEL1(-)/P1 and P1 chondrocytes were allowed to attach overnight prior to being 
fixed in 3% formaldehyde and stained for actin cytoskeleton using phalloidin-
alexa 488. Images were acquired using CLSM under Nyquest settings, 
deconvolved, reassembled in Imaris (Bitplane) and then fluorescence of actin-
phalloidin-alexa 488 complexes assayed using Image Pro version 7.0 
(Maryland, USA). The number of striation units (as the number of peaks in 
fluorescence across the cell body) in each chondrocyte was recorded, and the 
mean fluorescence plotted against 10% intervals of a standardised cell 
diameter. The areas under the graphs were mathematically calculated by the 
integration of the equations of the graphs, as previously described (Materials 
and Methods).  
 
DEL1 knockdown induced a significant increase in the mean number of striation 
units in P1 chondrocytes to 7±1StU/cell compared to 5±1StU/cell in control 
mock-transfected chondrocytes (p<0.05), and therefore the percentage of 
filamentous actin, correspondingly, increased from 45.0±2.3% in control 
chondrocytes to 48.0±2.4% in DEL1(-)/P1.  The increase in filamentous actin 
percentage, however, was deemed insignificant (p>0.05) suggesting that DEL1 
is involved in the intensification of the cortical localisation of actin. 
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Figure 5.9: Actin organisation upon DEL1 knockdown 
Mock transfected P1 and DEL1(-)/P1 chondrocytes were fixed. stained with actin-phalloidin-
alexa488 and assayed for fluorescence by linear profiling. There was a significant increase in 
the number of striation units (StU) in response to DEL1 knockdown (p<0.05) from 5±1 to 
7±1StU./cell (Panel B) and change in the percentage of cortical and filamentous actin (Panel A). 
N=6, n=102. Data shown as means ± s.e.m. T-test p-values were p<0.05 (*) and p<0.01 (**). 
N/S, non significant. 
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5.2.3.5 The role of DEL1 in volume regulatory mechanisms 
 
The effect of the expression of DEL1 in P1 chondrocytes on the internal ionic 
homeostasis was studied by subjecting DEL1(-)/P1 chondrocytes to a 
hyperosmotic challenge and recording changes in volume. Chondrocytes were 
loaded with 5µM Calcein-AM and incubated for 30 minutes prior to acquiring Z-
stack images at 1µm step size using CLSM. Chondrocytes were subjected to 
42% osmotic challenge and images acquired at 1.5, 3, 5,10 and 20 minutes post 
challenge. Images were subsequently reassembled in Imaris 6.3.1 (Bitplane) 
and volume obtained as previously described. 
 
Upon introduction to hyperosmotic conditions, DEL1(-)/P1 chondrocytes reduced 
in volume to 0.85±0.02-fold the original volume (compared to 0.88±0.03% in 
control cells; p>0.05) and underwent further gradual volume loss settling at 
0.77±0.04 at time 20 minutes. Control chondrocytes, however, exhibited ‘slow’ 
RVI recapturing 0.99±0.01-fold of the orignal volume by 20 minutes. These data 
show similarity in the response of freshly isolated and DEL1(-)/P1 chondrocytes 
to hyperosmotic conditions, indicating that DEL1 plays a role in the loss of 
chondrocyte-specific response to ionic environment upon culture.  
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Figure 5.10: RVI in DEL1(-)/P1 chondrocytes in response to hyperosmotic challenge. 
P0, mock transfected P1 and DEL1(-)/P1 chondrocytes were loaded with 5µM calein-AM and 
imaged using CLSM to obtain baseline cell volume and record changes for up to 20 minutes in 
response to a 42% hyperosmotic challenge. P1 chondrocytes reaquired 99.6±1.91% of their 
original volume by 20 minutes whereas DEL1(-)/P1 chondrocytes did not exhibit RVI with a final 
volume of 76.93±3.68% of original volume. N=3, n=43. Data shown as means ± s.e.m. T-test p-
values were p<0.01 (**). N/S, non significant. 
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5.2.3.6 The effect of DEL1 knockdown on calcium channel phenotyping in 
response to REV5901 
As changes in the contribution of intracellular stores and calcium membrane 
channels to REV5901-induced [Ca2+]i  rise have been observed in response to 
2D culture, the role of DEL1 in [Ca2+]i homeostasis was investigated. Freshly 
isolated, P1 and DEL1(-)/P1 chondrocytes were loaded with 3µM fluo-4 prior to 
perfusion in 50µM REV5901 and measurement of calcium changes in the 
presence of various inhibiting conditions (2mM EGTA to chelate extracellular 
calcium ions; Na+-free solution, NCX inhibition; Gd3+, inhibitor of SACC). The 
effect of REV5901 on DEL1(-)/P1 chondrocyte was not significantly different 
from that observed in P1 chondrocytes with maximal rise in [Ca2+]i  of 11.6±0.6% 
and 12.5±0.4% and no significant differences (p>0.05).  Moreover the rise in 
[Ca2+]i  in the presence of 2mM EGTA was not significantly different between 
DEL1(-)/P1 and control mock transfected chondrocytes with 3.69±1.04% and 
1.97±0.77%, respectively (Figure 5.12). 
 
Changes in the sensitivity to individual channel-inhibiting conditions were 
however more prominent. There was an increase in NCX inhibition in Na+-free 
conditions in Del(-)/P1 chondrocytes compared to control cells from 57.9±1.2% 
to 67.6±4.3% inhibition (p<0.05), rendering DEL1(-)/P1 more similar to freshly 
isolated chondrocytes with 84.0±3.4% inhibition (p>0.05; Figure 5.12). 
 
The sensitivity of Del(-)/P1 chondrocytes to Gd3+ inhibition of SACC, however, 
did not increase upon DEL1 knockdown unlike control P1 chondrocytes. Freshly 
isolated chondrocytes exhibited 33.0±9.2% inhibition to REV5901 loading in the 
presence of Gd3+ which increased upon culture reaching 57.2±5.4% in P1 
chondrocytes. In response to long-term DEL1 knockdown, sensitivity of 
chondrocytes to SACC inhibition using Gd3+ showed a similar trend to freshly 
isolated chondrocytes with a percentage inhibition of 24.9±6.0% (p<0.05; Figure 
5.12). These data indicated that the transient increase in DEL1 expression is 
required for the increase in activity and/or expression of SACC.  
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Figure 5.11: Contribution of store-mediated calcium release to REV5901-induced calcium 
rise. 
Freshly isolated, P1 and DEL1(-)/P1 chondrocytes were incubated with 3µM fluo-4 in BPS for 30 
min prior to loading of 50µM REV5901 and measurement of maximal [Ca2+]i  change with or 
without the presence of 2mM EGTA. The source of calcium rise in freshly isolated chondrocytes 
was predominantly mediated by intracellular store-release which significantly decreased upon 
culture. No change, however, was observed in the store-mediated [Ca2+]i  rise in response to 
DEL1 knockdown. N=6, experiment repeated 4 times. Data shown as means ± s.e.m. T-test p-
values were p<0.01 (**). N/S, non significant. 
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Figure 5.12: The sensitivity of DEL1(-) chondrocytes to calcium channel inhibitors. 
Freshly isolated, P1 and DEL1(-)/P1 chondrocytes were loaded with 3µM fluo-4 and appropriate 
calcium channel inhibitory conditions and baseline calcium-fluo-4 fluorescence measured. 
REV5901 was loaded in a final concentration of 50µM and fluorescence measured and 
differences in the effect of pharmacological inhibitors on the REV5901-mediated [Ca2+]i  rise 
recorded. There was an increase in NCX inhibition using Na+-free solution between control P1 
chondrocytes and DEL1(-)/P1 chondrocytes and a significant decrease in the inhibition of 
stretch-activated calcium channels in chondrocytes upon DEL1 knockdown from 57.02±0.19% to 
24.94±0.43%, thereby rendering DEL1(-)/P1 chondrocytes more similar to freshly isolated 
chondrocytes. N=4, data was pooled from 10 individual experiments. Data shown as means ± 
s.e.m. T-test p-values were p<0.05 (*) and p<0.01 (**). N/S, non significant. 
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5.3 Chapter Discussion 
 
DEL1 is an extracellular integrin ligand shown to have influence on attachment, 
differentiation and migration in other tissues including angiogenic neoplastic 
tissue (Aoka et al., 2002) and ischemic tissue (Ho et al., 2004). Despite reports 
in the literature indicating a role for integrin in the expression of type II collagen 
and members of SOX family (Lee and Kim et al., 2009), the expression of DEL1 
has only been previously shown in foetal chondrocytes (Stokes et al., 2002).  
 
We have confirmed the expression of DEL1 in adult bovine chondrocytes and 
shown a transient rise in DEL1 expression in P1 chondrocytes similarly to 
previously reported levels observed in hydrogel cultured foetal chondrocytes 
(Stokes et al., 2002) where phenotype is thought to be preserved for up to 180 
days (Reginato et al., 1994). The rise in DEL1 expression has been found to 
occur simultaneously with a transient rise in SOX9 and collagen II expression 
and the decline in col2:col1. Therefore to further our knowledge of the cause-
and-effect status of DEL1 rise, the expression of DEL1 and collagens was 
investigated at days 2, 4 , 6 and 9 of P1. 
 
It was observed that the rise in DEL1 expression occurred as early as the 2nd 
day in culture with ∼12-fold increase in expression followed by the decline in 
col2:col1 expression on the 4th day in culture (Figure 5.2). These data indicated 
a potential role for DEL1 in chondrocyte phenotype and confirmed earlier 
observations of mesodifferentiated phenotype. The role of DEL1 expression in 
chondrocyte phenotype was therefore further investigated using RNAi 
technology. 
 
The efficacy of the anti-DEL1 siRNA sequences designed was studied and 
knockdown confirmed to last for up to 6 days. In response to longterm DEL1 
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knockdown, there was a reduction in type I collagen expression and therefore an 
increase in col2:col1 to levels seen in freshly isolated chondrocytes (Figure 5.8). 
These data confirmed that the loss of phenotype appeared to require transient 
increase in DEL1 expression which may affect the expression of SOX9 and/or 
Twist (key regulators of collagen expression and chondrocytic phenotype). 
 
The role of DEL1 as an attachment protein was studied during 2D culture and it 
was observed that although DEL1 was present at higher concentrations in P1 
chondrocytes, the initial attachment was significantly reduced compared to that 
observed in freshly isolated and 2D cultured chondrocytes. This was possibly 
due to the time required for DEL1 protein accumulation post trypsinisation. It 
was noted, however, that attachment levels similar to those in P0, P2 and P3 
chondrocytes were obtained 4 hours post seeding, thus indicating an elevated 
rate of attachment in P1 chondrocytes. Moreover, in response to knockdown, 
there was a sharp decrease in both initial attachment and rate of attachment 
suggesting that DEL1 is necessary for attachment in P1 mesodifferentiated 
chondrocytes (Table 5.2). 
 
The effect of DEL1 on the chondrocyte differentiated phenotype was studied by 
longterm knockdown of DEL1. Upon DEL1 knockdown, a significant decrease in 
both types collagen I and II expression was observed with an overall increase in 
col2:col1 expression to values previously observed in freshly isolated 
chondrocytes (Figure 5.8). Therefore and despite having no effect on the 
expression levels of SOX9, DEL1 knockdown appeared to conserve a 
differentiated phenotype (as defined by col2:col1 expression) for at least 9 days 
in 2D culture.  
 
Cellular dimensions and actin organisation were studied in response to DEL1 
knockdown whereby an increase in the number of striation units was seen from 
5±2 in control mock transfected P1 chondrocytes to 7±1 in DEL1(-)/P1 
chondrocytes. The DEL1-mediated decrease in the number of striation units 
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could be caused by the recruitment of actin regulatory proteins and the creation 
of subcortical focal contacts (Schaller et al., 1992), thereby reducing the 
availability of monomeric G-actin molecules for the formation of actin filaments. 
A reduction in chondrocyte length (c) and a significant decrease in cell volume 
were additionally observed in DEL1(-)/P1 chondrocytes and could be possibly 
attributed to the accompanying changes in actin cytoskeletal organisation and 
thus volume regulatory mechanisms. Conversely, a significant increase in both 
stress fibres and actin localisation within the focal contact has been previously 
observed in response to DEL1 ligation in vascular smooth muscle cells (Razaee 
et al., 2002). 
 
Finally the effect of DEL1 knockdown on mechanotransduction processes 
previously studied (RVI and REV5901-induced [Ca2+]i rise) was investigated as 
a final confirmation of the effect of DEL1 on chondrocytic phenotype. In 
response to DEL1 knockdown followed by a hyperosmotic challenge, DEL1(-
)/P1 chondrocytes did not exhibit RVI unlike their control mock-transfected 
counterparts (Figure 5.10), rendering the former with a similar response to a 
hyperosmotic challenge to that observed in freshly isolated chondrocytes. Work 
by others has shown that the depolymerisation of actin using LB induced NKCC-
mediated RVI in freshly isolated chondrocytes (Kerrigan et al., 2006), and it 
appears that the increase in filamentous actin polymerisation in response to 
DEL1 knockdown inhibited RVI mechanisms observed in control P1 
chondrocytes (slow RVI). Consequently, it could be argued the abolishment of a 
RVI response upon knockdown may possibly be due to the previously discussed 
changes in actin organisation, a key regulator of RVI. 
 
The role of DEL1 in calcium homeostasis was investigated using REV5901 as 
pharmacological inducer of [Ca2+]i rise and there was no change in the 
magnitude of [Ca2+]i  rise, the contribution of intracellular stores in response to 
DEL1 knockdown. There was however, an increase and decrease in the NCX  
and SACC contribution, respectively, to REV5901-induced [Ca2+]i  rise to levels 
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observed in freshly isolated chondrocytes. Gd3+-sensitive SACC has been 
implicated in the loss of phenotype in rat chondrosarcoma cell line (Perkins et 
al., 2005) and shown to play a role in [Ca2+]i homeostasis of 2D cultured 
chondrocytes (Kerrigan and Hall, 2008). Our observations of a reduced SACC 
contribution upon DEL1 knockdown suggested that the loss of differentiated 
phenotype may be mediated, but not exclusively, by an alteration in activity of 
SACC, which may indeed be directly manipulated by co-localisation with 
integrins as previously reported (Shakibaei and Mobasheri, 2003).   
 
In conclusion, DEL1 has been shown to induce a decrease in col2:col1, increase 
the rate of attachment, increase cell volume, increase cell length, increase 
activity of SACC and induce slow RVI in response to hyperosmotic conditions. 
Taken together these data confirmed the role of DEL1 in initiating the loss of 
phenotype upon expansion by inducing a mesodifferentiated phenotype 
characterised by the upregulation of DEL1 (Table 5.3) and proposed a DEL1 
signalling pathway mediating the loss of phenotype (possibly via SOX9 and 
Twist; investigated in the following chapter). 
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Table 5.3: Summary of changes observed upon DEL1 knockdown and possible mode of 
action. 
Changes in key markers of differentiation were observed in response to DEL1 knockdown. It 
was concluded that DEL1 mediated the loss of the differentiated state of col2:col1 expression 
accompanied by the increase in cell volume to values previously recorded in 2D cultured 
chondrocyte chondrocytes. DEL1 was sufficient to induce an increase in SACC activity, a 
decrease in NCX regulation and the activation of slow RVI mechanisms. DEL1 was, furthermore, 
associated with an increased condensation of cortical actin possibly via the creation of focal 
contacts.  
 
 
 Effect of 
DEL1 
Type of 
Effect 
Possible Reason 
Col2:Col1 
expression 
YES Decrease DEL1 mediate signal via 
TWIST 
Cell length (c) YES Increase Increase in adhesion 
surface 
Actin organisation YES Decrease in 
StU 
Condensation of actin 
molecules at focal contacts 
RVI YES Activation Reorganisation of actin 
cytoskeleton 
Volume YES Increase Activation of RVI by actin 
organisation 
Rate of 
Attachment 
YES Increase Superiority of DEL1/Integrin 
attachment mechanisms 
Onset of 
attachment 
YES Decrease Time requirement for DEL1 
production 
Store activity NO - - 
SACC activity YES Increase Increase in activity and/or 
expression 
NCX YES Decrease Decrease in activity and/or 
expression 
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6 Experimental Chapter: The molecular signalling 
pathway of DEL1 in chondrocytes. 
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6.1 Chapter Introduction 
 
Integrin signalling pathway was investigated when it was first observed that 
integrin-ligand interaction induces integrin aggregation and the initiation of the 
signal (Schaller et al., 1994). Following integrin activation, FAK trans-
autophosphorylation occurs which in turn induces the activation of PI3K (Chen 
et al., 1996) and Rho (Hotchin & Hall, 1995) thereby activating Akt and Erk, 
respectively (Renshaw et al., 1996). Erk and Akt signals initiate a switch in 
expression battery and promote survival and cell proliferation. Furthermore, Rho 
activates actin polymerisation proteins including cofilin, via PIP2 and possibly 
[Ca2+]i regulation (Chong et al., 1994; Hartwig et al., 1995; Gilmore & Burridge, 
1996). 
 
The cellular signalling pathway of DEL1 binding was investigated by stable 
transfection of osteosarcoma cells with recombinant DEL1 sequence using a 
viral vector (Penta et al., 1999). It was concluded that DEL1 attachment was 
associated with clustering of integrins, recruitment of actin-binding proteins 
including Talin and Vinculin and the activation of FAK. In ovo, DEL1 possessed 
highly angiogenic properties which were inhibited upon using anti-αvβ3 
antibodies (Penta et al., 1999). Moreover, DEL1 has been shown to induce 
angiogenesis and a switch in gene expression through interaction with αvβ3 
heterodimers upon transfer to ischemic muscular tissue (Zhong et al., 2003; Ho 
et al., 2004). Finally, it has been confirmed that a close relative of DEL1, Edil1, 
promotes neovascularisation in vivo via αvβ3-dependent Akt phophorylation 
(Silvestre et al., 2005). 
 
SOX9 is a transcription factor that plays a role in chondrocyte differentiation by 
binding to the promoters and activating the transcription of chondrocyte-specific 
genes including type II collagen and aggrecan (de Crombrugghe et al., 2000; 
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Uusitalo et al., 2001), and our previous work has shown an association between 
DEL1 and SOX9 levels of expression (Section 5.2.1). Therefore, the effect of 
SOX9 on the transcription levels of DEL1 was studied using BMP2-induced rise 
in SOX9 levels in 2D cultured chondrocytes. 
 
BMP2 is a member of the TGF-β protein superfamily and is involved in the 
development of bone and cartilage. It is expressed in the perichondrium/ 
periosteum (Zou et al., 1997; Pathi et al., 1999) and signals back to initiate key 
cellular functions including proliferation (Venezian et al., 1998), hypertrophic 
differentiation (De Luca et al., 2001; Li et al., 2006) and extracellular matrix 
accumulation (Cheng et al., 2007). It was recently reported that BMP2 induced 
chondrocyte-specific genes (including SOX9, type II collagen and aggrecan) in 
synovium-derived progenitor cells (Park et al., 2005), an effect which could be 
inhibited by the expression of Twist (Reinhold et al., 2006). 
 
Twist is a member of basic helix loop helix (bHLH) transcription factors found to 
be expressed in mesoderm-derived adult tissue including cartilage, and it was 
recently observed to be overexpressed in 2D cultured chondrocytes (Stokes et 
al., 2002). Twist has the capacity to form complexes with various transcription 
factors thus performing various functions which include cell survival (Maestro et 
al., 1999; Dupont et al., 2001; Valsesia-Wittmann et al., 2004), cell death (Sosic 
et al., 2003; Ota et al., 2004), differentiation (Chen & Behringer, 1995; Spicer et 
al., 1996; Ishii et al., 2003; Bialek et al., 2004) and most recently chondrocyte 
maturation and dedifferentiation (Dong et al., 2007). 
 
It has been hypothesised that Twist inhibited chondrocyte-specific phenotype by 
direct interaction with the p65 subunit of NFκB transcription complex (Sosic et 
al., 2003) and/or p300, a close associate of SOX9 and enhancer of type II 
collagen production (Hamamori et al., 1999; Tsuda et al., 2003). Reinhold et al. 
reported that Twist expression was mediated by the canonical Wnt signalling 
pathway involving β-catenin and GSK3-mediated β-catenin ubiquitination 
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complex (Giles et al., 2003) as observed by the overexpression of Twist in the 
presence of Wnt3a or a pharmacological GSK3 inhibitor.  
 
In this chapter, Akt, a biological GSK3 inhibitor, was studied as a potential 
downstream element of DEL1, and key regulator of β-catenin levels 
(pharmacologically inhibited using 500µM R-Etodolac; Behari et al., 2007) and 
thus Twist expression. Furthermore, the effect of Twist knockdown using siRNA 
was also investigated as a key indicator of the role of Twist in chondrocyte 
phenotype manipulation.  
  
 
Aims of Experimental Chapter 
 
1 Determine the SOX9 regulatory effects on DEL1 expression using BMP2. 
 
2 Determine the activation of Akt in response to elevated DEL1 expression. 
 
3 Investigate the role of β-catenin in mediating DEL1-Twist signal. 
 
4 Investigate the expression level of Twist in response to 2D culture. 
 
5 Investigate the role of DEL1 on Twist expression. 
 
6 Establish Twist knockdown using the designed Twist siRNA. 
 
7 Study the effect of Twist knockdown on gene expression. 
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6.2 Results 
 
6.2.1 The role of DEL1 on Akt activation signalling 
 
6.2.1.1 Akt activity throughout 2D culture in bovine articular chondrocytes 
 
Being an indirect β-catenin activator and an integrin-mediated signalling 
downstream element, Akt activation was studied upon 2D culture using western 
blot and phosphorylation-sensitive antibodies. Freshly isolated and 2D cultured 
P1, P2 and P3 chondrocytes were collected, proteins extracted as previously 
described and subjected to SDS-PAGE. Membranes were probed with 
phosphorylation-sensitive anti-Akt antibodies and visualised using x-ray film 
before being stripped in stripping buffer for 30 minutes at 50°C and re-probed 
with anti-p-Akt antibodies to study Akt activity as the ratio of p-Akt:Akt. 
 
No significant changes in the levels of Akt production were observed upon 
culture (p>0.05) compared to freshly isolated chondrorocytes with 1.07±0.07, 
1.03±0.08 and 0.94±0.07 in P1, P2 and P3 chondrocytes respectively. 
Conversely, the levels of phosphorylated Akt detected transiently increased by 
1.35±0.23 during the first passage (p<0.05) and declined to baseline levels upon 
further culture reaching 0.97±0.05 and 0.93±0.07 in P2 and P3 chondrocytes, 
respectively. Therefore, the relative activity of Akt transiently increased by 
22.4±7.18% during the first passage prior to returning to levels observed in 
freshly isolated chondrocytes with 0.92±0.01 in P2 chondrocytes (Figure 6.1).  
 
These data indicated that the increase in DEL1 expression previously observed 
was simultaneous with changes observed in Akt activity in response to 2D 
culture, thereby suggesting a role for DEL1 on Akt activation. 
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Figure 6.1: Changes in Akt phosphorylation and activity upon 2D culture. 
Changes in Akt phosphorylation in response to 2D culture were investigated to establish 
baseline activity of Akt in chondrocytes. Freshly isolated and 2D cultured chondrocytes were 
isolated by trypsinisation and centrifugation prior to protein extraction in Akt lysis buffer and 
performing SDS-PAGE and western blot. Membranes were probed for Akt using phosphorylation 
sensitive antibodies. No change was observed in the protein content of Akt upon 2D culture, 
whereas there was an increase in Akt phosphorylation (and thus activity) in P1 chondrocytes by 
22.35±7.18%. Akt activity returned to baseline levels upon further culture with no significant 
difference observed. N=4, experiment repeated 3 times. Data shown as means ± s.e.m. T-test p-
values were p<0.05 (*). N/S, non significant. 
* * 
* * 
N/S * 
* 
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6.2.1.2 Akt activity in response to DEL1 knockdown 
 
To further investigate the effect of DEL1 on Akt activation, RNAi technology was 
used to diminish DEL1 expression and study the effect on Akt phosphorylation. 
Freshly isolated chondrocytes were seeded and transfected with 10nM anti-
DEL1 siRNA and 3µl/ml HiPerfect transfection reagent and chondrocytes 
cultured for up to 9 days under longterm knockdown conditions as previously 
described. Proteins were extracted from DEL1(-)/P1 and mock transfected P1 
chondrocytes as previously described and the proteins assayed by western blot 
for Akt and p-Akt proteins.  
 
No significant change was observed (p>0.05) in Akt protein expression in 
response to knockdown but there was a 47.39±1.87% reduction in p-Akt levels 
upon knockdown leading to an overall 37.94±3.58 % decrease in Akt activation 
in DEL1(-)/P1 chondrocytes compared to mock transfected P1 chondrocytes 
(Figure 6.2). These data confirmed that Akt activation was regulated by 
DEL1/integrin interaction and that the rise in Akt activity after 9 days in culture 
was induced by DEL1-dependent signalling pathway. 
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Figure 6.2: The effect of DEL1 knockdown on the phosphorylation and activity of Akt. 
To confirm the association between the upregulation of DEL1 and the activation of Akt, the 
phosphorylation of Akt in response to DEL1 knockdown was assayed by western blot. Briefly, 
freshly isolated chondrocytes were transfected in suspension with 1nM anti-DEL1 siRNA and 
9µl/ml HiPerfect transfection reagent and cultured for 9 days under long term knockdown 
conditions. There was no change in the protein level of Akt whereas there was a significant 
72.5% decrease of in the phosphorylation of Akt and thus Akt activity, suggesting that DEL1 
expression is necessary for Akt activation as observed in P1 chondrocytes. N=4, experiment 
repeated 6 times. Data shown as means ± s.e.m. T-test p-values were p<0.05 (*). N/S, non 
significant. 
 
 
 
 
 
 
* * 
N/S 
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6.2.2 The expression and role of Twist in 2D expansion of chondrocytes 
 
6.2.2.1 Changes in Twist expression upon 2D chondrocyte culture 
 
Being a potential downstream element of DEL1 and a key regulator of 
chondrocytic phenotype, Twist expression was assayed before and upon culture 
as a first indicator of its biological relevance. Freshly isolated and 2D cultured 
chondrocytes were collected and RNA extracted and subjected to RT-PCR to 
assay Twist expression. PCR products were separated using 2% agarose gel 
electrophoresis and band intensity assayed by ethidium bromide densitometery 
as previously described (see Materials and Methods).  
 
There was a significant increase (p<0.05) in the level of Twist relative 
expression from 1.08±0.08 to 3.00±0.54 after 9 days in culture and this elevation 
in Twist expression was maintained for the remainder of culture period studied 
with no further significant changes (p>0.05) with 3.33±0.54 and 3.32±0.53 in P2 
and P3 2D cultured chondrocytes, respectively. These data confirmed reported 
findings that suggest a role for Twist expression in the loss of differentiated 
chondrocytic phenotype upon 2D culture.  
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Figure 6.3: The level of Twist expression in freshly isolated and 2D cultured 
chondrocytes. 
Freshly isolated and 2D cultured chondrocytes were isolated and RNA extracted using RNeasy 
minikit, reverse transcribed and PCR performed using Twist primers. There was a ∼3-fold 
increase in Twist expression upon culture and these elevated levels of expression were 
maintained for the remainder of the culture period with no further significant differences 
observed. These data indicated a role for Twist in the loss of a chondrocytic differentiated 
phenotype. N=3, experiment repeated 3 times. Data shown as means ± s.e.m. T-test p-values 
were p<0.01 (**). N/S, non significant. 
 
** 
N/S 
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6.2.3 The dependency of Twist expression on DEL1 level in 2D culture of 
chondrocytes 
 
Data shown above indicated a change in Twist regulation occurring 
simultaneously with the transient rise in DEL1 expression. Therefore, the effect 
of DEL1 expression on Twist levels in 2D culture was further investigated by 
abolishing the former and studying changes in the latter. Anti-DEL1 siRNA was 
employed to inhibit the translation of DEL1 mRNA and consequent changes in 
Twist expression were recorded using RT-PCR. Briefly, freshly isolated 
chondrocytes were isolated transfected in suspension with 10nM anti-DEL1 
siRNA molecules complexed with 3µl/ml HiPerfect transfection reagent and 
incubated in culture media. Media was replaced after 6 days and chondrocytes 
repeat-transfected every 6 days with anti-DEL1 siRNA prior to RNA isolation. 
 
Upon 9 days in culture, P1 2D cultured chondrocytes exhibited 3.00±0.54-fold 
increase in Twist expression compared to freshly isolated chondrocytes as 
previously shown. This increase in Twist expression, however, was abolished in 
the absence of a transient increase in DEL1 expression upon knockdown with 
anti-DEL1 siRNA molecules with only 0.97±0.50 (p<0.05) which was not 
deemed significantly different from values obtained for freshly isolated 
chondrocytes (p<0.05). These data indicated a role for DEL1 in the regulation of 
Twist expression. 
 
 
 
186 
 
 
Figure 6.4: The effect of DEL1 knockdown on the expression of Twist in P1 chondrocytes. 
The effect of DEL1 upregulation in P1 chondrocytes on the expression of Twist was studied by 
DEL1 knockdown prior to culture, and observing Twist expression using RT-PCR. Following 9 
days in culture, mock-transfected P1 chondrocytes demonstrated a significant 3.00±0.54-fold 
increase in Twist expression which was abolished in the absence of DEL1. These data indicated 
a role for DEL1 in the upregulation of Twist expression in mesodifferentiated chondrocytes. N=4, 
experiment repeated 6 times. Data shown as means ± s.e.m. T-test p-values were p<0.01 (**). 
 
 
 
 
 
** ** 
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6.2.3.1 The role of the β-catenin-dependent DEL1/Akt signal on Twist 
expression 
 
To further study the signal between DEL1/integrin interaction and Twist 
expression, a pharmacological inhibitor of β-catenin, R-Etodolac, was used to 
confirm the necessity for β-catenin for the expression of Twist suggested by 
others (Reinhold et al., 2006). Freshly isolated chondrocytes were seeded in 
culture media with or without the presence of 500µM R-Etodolac and cultured as 
previously described. Upon confluence, RNA was extracted from P1 
chondrocytes using RNeasy minikit and subjected to RT-PCR to study the 
changes in Twist expression. 
 
As previously observed, there was an increase (p>0.05) in Twist expression by 
the end of the first passage to 3.00±0.54 which was significantly reduced 
(p<0.05) to 1.70±0.61% in the presence of R-Etodolac (p<0.05). Despite Twist 
expression levels not returning to baseline levels upon R-Etodolac treatment 
(p<0.05), these data indicated that the upregulation of Twist was significantly 
reduced by inhibition of intracellular β-catenin levels, which were in turn 
potentially regulated by Akt activity and DEL1 expression levels. 
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Figure 6.5: The effect of pharmacological inhibition of β-catenin on Twist expression. 
The necessity of β-catenin for DEL1-mediated upregulation of Twist via Akt was studied using a 
pharmacological inhibitor of β-catenin (R-Etodolac) in the culture technique. Freshly isolated 
chondrocytes were seeded in the presence of 500µM R-Etodolac and cultured for 9 days prior to 
RNA isolation using RNeasy minikit as previously described. In response to culture in R-
Etodolac, there was a significant decrease in Twist expression from 3.00±0.50 in control P1 
chondrocytes to 1.79±0.61 (relative to values obtained in freshly isolated chondrocytes). These 
data indicated that β-catenin was necessary for the expression of Twist in mesodifferentiated 
chondrocytes. N=4, experiment repeated 6 times. Data shown as means ± s.e.m. T-test p-values 
were p<0.05 (*) and p<0.01 (**). 
 
 
 
* ** 
** 
(500µM) 
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6.2.4 The feedback effect of Twist and SOX9 on DEL1 expression 
 
As Twist has been shown to inhibit BMP2-induced SOX9 activity and as we 
have shown that DEL1 induced the expression of Twist, it was now necessary to 
investigate the effect of Twist and SOX9 on the expression of DEL1. This was 
investigated using BMP2 (inducer of SOX9 expression) and anti-Twist siRNA to 
investigate a potential feedback autocrine signalling loop. For the following 
experiments, P3 chondrocytes were selected due to expression profile 
characterised by the reduced DEL1 and SOX9 expression and elevated Twist 
expression levels. 
 
6.2.4.1 The role of BMP2 dependent SOX9 expression on DEL1 levels  
 
Expression level of SOX9 is tightly regulated by BMP2 and therefore the effect 
of SOX9 on DEL1 expression was investigated by biochemical induction of 
SOX9 expression using BMP2 supplementation. Upon reaching confluence, P2 
chondrocytes were subcultured at optimum seeding density and incubated in 
culture media containing 500ng/ml BMP2 and cultured for 7 days as previously 
described (Minina et al., 2001). Upon reaching P3, chondrocytes were isolated 
by trypsinisation and gentle centrifugation and RNA isolated using RNeasy 
Minikit (Materials and Methods). RT-PCR was performed to study the 
expression levels of SOX9 and DEL1 in response to BMP2 treatment relative to 
the expression levels in freshly isolated chondrocytes. 
 
P3 chondrocytes expressed baseline levels of SOX9 expression (0.69±0.14–fold 
relative to freshly isolated chondrocytes) with no significant differences observed 
(p>0.05), whereas upon culture in 500ng/ml BMP2 for 7 days, there was an 
increase in SOX9 expression reaching 1.40±0.40% of baseline levels. The 
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BMP2-mediated SOX9 rise was not significantly different (p>0.05) from naturally 
occurring rise in SOX9 previously observed in P1 chondrocytes (Figure 6.6). 
 
It was observed that in the presence of SOX9 upregulation in response to BMP2 
treatment, there was an overexpression of DEL1 on RNA level relative to 
baseline expression in freshly isolated chondrocytes (p<0.05). In the presence 
of 500ng/ml BMP2 and thus higher levels of SOX9 expression, there was a ~3-
fold increase in DEL1 expression levels reaching 3.01±0.67 relative baseline 
levels, a rise deemed not significantly different (p>0.05) from the rise in DEL1 
expression observed in P1 chondrocytes (Figure 6.6). These data confirmed that 
BMP2 is a key regulator of SOX9 expression levels, which in turn appeared to 
be regulate the expression of DEL1. These data support the theory that SOX9 
and DEL1 upregulation in P1 chondrocytes is part of a regulatory pathway 
involved in chondrocyte differentiation. No further rise in Twist expression in 
BMP2-treated P3 chondrocytes was observed, thereby indicating no regulatory 
role for SOX9 on the expression of Twist in dedifferentiated chondrocytes 
(p>0.05). 
 
There was, however, no change in the expression of types I and II collagens and 
thus no change in col2:col1 expression in response to BMP2 treatment. Control 
P3 chondrocytes and BMP2-treated exhibited relative expression of 2.49±0.37 
and 1.43±0.51 of type I collagen and 0.98±0.34 and 0.78±0.52 of type II 
collagen, respectively. These data indicated that while BMP2 treatment induced 
a mesodifferentiated-like phenotype in dedifferentiated chondrocytes as 
characterised by SOX9, DEL1 and col2:col1 expression, it was not sufficient to 
recapture the differentiated phenotype in P3 chondrocytes following expansion 
(Figure 6.7). 
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Figure 6.6: The effect of BMP2 treatment on the expression of SOX9, Twist and DEL1. 
The effect of SOX9 level on the regulation of expression of DEL1 and Twist was investigated by 
biochemical induction of SOX9 expression using BMP2. Upon confluence, P2 chondrocytes 
were subcultured in the presence 500ng/ml BMP2 for 7 days and RNA subsequently isolated 
and RT-PCR performed. In response to BMP2 treatment, P3 chondrocytes exhibited a rise in 
SOX9 and DEL1 expression to 1.40±0.40 and 3.00±0.67, respectively, thereby inducing 
mesodifferentiated-like phenotype in P3 chondrocytes. No change, however, was observed in 
Twist expression. These data indicated that a BMP2-induced rise in SOX9 was sufficient to 
upregulate the expression of DEL1. N=4, experiment repeated 6 times. Data shown as means ± 
s.e.m. T-test p-values were p<0.05 (*) and p<0.01 (**). N/S, non significant. 
 
 
* 
** N/S 
 
 
192 
 
Figure 6.7: Changes in the expression of collagen molecules in response to BMP2 
treatment in P3 chondrocytes. 
The capacity of BMP2 treatment to recapture a differentiated phenotype as defined by the 
regulation of collagen expression was studied in P3 chondrocytes by culture in 500ng/ml BMP2 
followed by RNA isolation and RT-PCR. There was a slight yet insignificant decrease in the 
expression of types I and II collagens in response to BMP2 treatment and thus no significant 
change in col2:col1 expression. These data suggested that despite a rise in SOX9 expression 
following BMP2 treatment, there was no recapture of a differentiated phenotype. N=3, 
experiment repeated 3 times. Data shown as means ± s.e.m. T-test p-values were p>0.05 (N/S, 
non significant). 
 
 
N/S 
N/S 
N/S 
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6.2.4.2 Twist knockdown using RNAi  
 
 
To further assay the direct effect of Twist on chondrocytic phenotype, RNAi 
technology was employed to knockdown Twist expression and record changes 
in DEL1 expression. Anti-Twist siRNA were designed as previously described 
(Materials and Methods) and the efficacy of the knockdown of the selected 
sequences studied in P3 2D cultured chondrocytes where Twist overexpression 
was observed and deemed stable. 
 
Confluent P2 2D cultured chondrocytes were isolated by trypsin treatment and 
centrifugation prior to transfection in suspension using anti-Twist siRNA 
complexes freshly prepared with 1nM siRNA complexed with 3µl/ml HiPerfect 
transfection reagent (See Materials and Methods). Chondrocytes were seeded 
at standard seeding density, RNA isolated every 2 days in culture until reaching 
P3, and the levels of Twist expression studied by RT-PCR relative to GAPD and 
freshly isolated chondrocytes. 
 
Upon 2 days of transfection, there was a decrease in Twist expression to 
0.73±0.04-fold relative to control expression levels (p<0.05), indicating 
successful knockdown using the sequences designed. These values of 
expression were maintained for a further 2 days with no significant differences 
observed (p>0.05), whereas following 6 days of transfection, the levels of Twist 
expression increased reaching 2.50±0.13% of baseline P3 Twist expression 
(Figure 6.8). These data confirmed the transience of RNAi knockdown and were 
necessary to determine the frequency of repeat-transfection required to 
establish long-term Twist knockdown. 
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Figure 6.8: Twist expression upon knockdown using anti-Twist siRNA. 
The efficacy of the anti-Twist siRNA molecules designed was studied to determine their capacity 
to induce a knockdown in Twist expression. Briefly, P2 chondrocytes were transfected in 
suspension using 1nM siRNA complexed with 3µl/ml HiPerfect transfection reagent and seeded 
for culture. Following 2, 4, 6 and 9 days in culture, chondrocytes were isolated by trypsin 
treatment and centrifugation, RNA extracted and RT-PCR performed to study the expression of 
Twist upon transfection. Successful knockdown was obtained as early as 2 days with level of 
expression decreasing to 0.73±0.04 relative to P0, with no significant differences recorded for a 
further 2 days. 6 days post transfection, however, there was an increase in Twist expression to 
2.50±0.25, deemed not significantly different from baseline P3 expression levels. These data 
confirmed the efficacy and transience of knockdown using anti-Twist siRNA molecules designed. 
Repeat-transfection was therefore required every 4 days to maintain longterm Twist knockdown. 
N=3, experiment repeated 3 times. Data shown as means ± s.e.m. T-test p-values were p<0.05 
(*) and p<0.01 (**). N/S, non significant. 
** 
** 
N/S 
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6.2.4.3 The effect of Twist knockdown on chondrocyte phenotype as 
characterised by collagen expression 
 
The effect of Twist expression on chondrocyte phenotype regulation was 
investigated using anti-Twist siRNA. Briefly, P2 chondrocytes were tryspinised 
upon confluence and transfected in suspension with 1nM anti-Twist siRNA and 
3µl/ml HiPerfect transfection reagent and repeat transfected every 4 days to 
maintain long term Twist knockdown. Upon confluence, RNA extracted from 
control P3 and Twist-knockdown P3 chondrocytes and subjected to RT-PCR to 
assay the expression of key genes including types I and II collagen. The level of 
expression was calculated using gel densitometry and was expressed relative to 
the level of expression in freshly isolated chondrocytes.  
 
Twist knockdown did not have a significant effect on the regulation of types II 
and I collagen expression (Figure 6.9). There was a slight yet insignificant 
increase in the expression of type I collagen in response to Twist knockdown 
from 2.22±0.35 in P3 cultured chondrocytes to 3.26±0.34 in Twist knockdown P3 
chondrocytes (relative to freshly isolated chondrocytes; p>0.05). Similarly, 
collagen II expression increased from 1.50±0.09 in control mock-transfected P3 
chondrocytes to 1.82±0.12 upon Twist knockdown with no significant differences 
observed (p>0.05). 
 
There was therefore no significant change in the type II to type I collagen 
expression ratio upon Twist knockdown with a slight decrease from 0.71±0.16 in 
mock-transfected P3 chondrocytes to 0.56±0.02 in Twist knockdown P3 
chondrocytes relative to levels determined in freshly isolated chondrocytes 
(p>0.05). These details indicate that Twist knockdown is not sufficient to induce 
a restoration of chondrocyte differentiated phenotype. 
 
Interestingly, a ~2-fold increase in DEL1 expression was observed upon Twist 
knockdown with expression values of 1.88±0.37 relative to freshly isolated 
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chondrocytes (p<0.05; Figure 6.10). Furthermore, Twist knockdown had no 
significant effect on SOX9 expression with 0.69±0.14 of baseline expression 
observed in mock transfected and Twist knockdown P3 chondrocytes. These 
data showed that Twist knockdown induced DEL1 expression possibly via 
activation rather than upregulation of SOX9. 
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Figure 6.9: Changes in Expression of collagens in P3 chondrocytes in response to Twist 
knockdown using anti-Twist siRNA. 
The effect of Twist on the loss of differentiated phenotype was investigated by Twist knockdown 
in P3 chondrocytes. Briefly, P2 chondrocytes were transfected with 1nM siRNA and 3µl/ml 
HiPerfect transfection reagent, cultured as previously described and repeat transfected following 
4 days of seeding to ensure long-term knockdown. Upon confluence, RNA was isolated, reverse 
transcribed and PCR performed to study the expression of key collagen genes. No significant 
change in the expression of collagens was observed in response to Twist knockdown indicating 
that while Twist may play a role in loss of differentiated phenotype, Twist knockdown is not 
sufficient to cause a recapture of phenotype. N=3, experiment repeated 3 times. Data shown as 
means ± s.e.m. T test values were p>0.05 (N/S, non significant). 
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Figure 6.10: The effect of Twist knockdown on the expression of DEL1 and SOX9. 
Having determined the role of DEL1 on Twist expression, the effect of the latter on the regulation 
on SOX9 and DEL1 as a last step in a potential feedback autocrine loop was investigated using 
anti-Twist knockdown. P2 chondrocytes were transfected in suspension upon confluency using 
1nM anti-Twist siRNA and 3µl/ml HiPerfect and Twist knockdown maintained for the remainder 
of culture by repeat-transfection. 7 days post seeding, P3 chondrocytes were isolated and RNA 
extracted, reverse transcribed and subjected to PCR. Upon Twist knockdown there was an 
increase in DEL1 expression from 0.85±0.18 in control mock transfected P3 chondrocytes to 
1.88±0.37 in Twist(-) P3 chondrocytes. There was, however, no change in SOX9 expression 
indicating that Twist inhibited DEL1 expression by interfering with SOX9 activity rather than 
expression. N=3, experiment repeated 3 times. Data shown as means ± s.e.m. T-test p-values 
were p<0.05 (*) and p<0.01 (**). N/S, non significant. 
 
 
** 
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6.3 Chapter Discussion 
 
Having confirmed the role of DEL1 in chondrocyte phenotype regulation, it was 
necessary to investigate the proposed DEL1-integrin signalling pathway. Despite 
inducing the expression of chondrocyte-specific genes in mesenchymal and 
synovium-derived progenior cells (Park et al., 2005; Reinhold et al., 2005), BMP 
signalling plays a key role in mouse chondrocytes maturation (Li et al., 2006). 
Conversely, Twist has been shown to interfere with BMP2-induced gene and 
cause the downregulation of aggrecan and type II collagen, thereby promoting 
dedifferentiation (Reinhold et al., 2006).  
 
The biosignificance of the simultaneous increase in DEL1 and SOX9 expression 
in mesodifferentiated chondrocytes was investigated by biological stimulation of 
SOX9 expression in P3 chondrocytes by supplementation with 500ng/ml BMP-2 
(Minina et al., 2001) for 7 days in culture as previously described (Park et al., 
2005).  An increase in SOX9 expression was obtained and was accompanied 
with a 3-fold rise in DEL1 expression with both rises deemed similar to those 
observed naturally in P1 chondrocytes. These observations confirmed our 
hypothesis that DEL1 expression is mediated by SOX9 (Figure 6.6). Incubation 
with BMP2 was, nevertheless, not sufficient to recapture a differentiated 
phenotype but maintained a mesodifferentiated phenotype as defined by the 
expression of collagens (col2:col1 expression). 
 
Previous work has shown that members of Edil family of extracellular proteins 
act by the activation of Akt signalling protein (Silvestre et al., 2005) and our data 
confirmed a rise in Akt activity in P1 chondrocytes where DEL1 expression 
levels were elevated. To further investigate the effect of DEL1 on Akt activity, 
the latter was studied in response to DEL1 knockdown where it was shown that 
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knockdown reduced the activity of Akt by 46.12% (Figure 6.2). These data 
indicated the necessity of DEL1 for an overactivation of Akt in P1 chondrocytes. 
 
To investigate the potential signal initiated by DEL1, the expression levels of 
Twist, a potential downstream element of the DEL1 signal, were assayed in 
response to culture. A significant and sustained rise in Twist expression was 
observed as early as 9 days post culture (P1 chondrocytes). Upon DEL1 
knockdown, Twist expression was abolished (Figure 6.4) suggesting that the 
rise in Twist expression is mediated by DEL1-intgerin signalling pathway.  
 
It has been shown by others that Twist-induced dedifferentiation is tightly 
regulated by β-catenin levels (Reinhold et al., 2006), which are in turn indirectly 
positively influenced by Akt activity (Giles et al., 2003). Previous work has 
shown that the accumilation of β-catenin caused dedifferentiation in rabbit 
articular chondrocytes as characterised by a decrease in col2:col1 expression 
(Hwang et al., 2005). The role of β-catenin signal on Twist expression was 
therefore investigated using R-Etodolac, a pharmacological inhibitor of β-catenin 
at 500µM (Behari et al., 2007), to knock down the levels of β-catenin. Similarly 
to DEL1 knockdown, the reduction in β-catenin levels inhibited the expression of 
Twist at the end of P1 (Figure 6.5) confirming the dependency of Twist 
expression on β-catenin levels mediated by DEL1-induced Akt activation. 
 
To further study the role of Twist on chondrocyte phenotype, siRNA sequences 
designed to inhibit Twist expression were used and our data confirmed that the 
sequences selected induced Twist knockdown with 75.92% reduction in 
expression in P3 chondrocytes and possessed an effect lasting for up to 4 days 
post transfection. RNA isolated from Twist(-)/P3 chondrocytes did not show a 
recapture of phenotype as determined by the lack of change in the expression of 
SOX9 or col2:col1 despite an increase in type II collagen expression as reported 
elsewhere (Reinhold et al., 2006). Additionally, there was an increase in DEL1 
expression in response to Twist knockdown, thus indicating that Twist did not 
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inhibit the expression of SOX9 but inhibited SOX9 activity which included the 
transcription of type II collagen and DEL1. These data, however, showed that 
Twist knockdown (similarly to BMP2 treatment) was not sufficient to induce the 
recapture of the differentiated phenotype. 
 
In summary, we have investigated the proposed pathway involving DEL1-
induced dedifferentiation. These results concluded that DEL1 expression is 
mediated by SOX9 transcription and showed that DEL1 secretion induces an 
autocrine signal, most possibly upon interaction with αvβ3 as previously 
reported (Hidai et al., 1998). Upon DEL1 upregulation, an increase in Akt 
activation was observed possibly inducing a rise in the level of β-catenin, which 
was necessary for the expression of Twist as previously recorded (Reinhold et 
al., 2006). In endothelial cells, DEL1-mediated autocrine pathway (Penata et al., 
1999) and integrin-Akt-β-catenin signals (Joshi et al., 2007) have been 
previously observed in endothelial cells. We have confirmed that Twist inhibited 
SOX9 activity and thus created a negative feedback loop knocking down DEL1 
and type II collagen and initiating terminal dedifferentiation (Figure 6.11). 
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Figure 6.11: The proposed pathway of action of DEL1. 
SOX9 induced the expression of DEL1 (1) which subsequently bound to integrins (2) and in turn 
activating other key signalling proteins including Akt (3). Akt is indirectly involved in the 
regulation of intracellular levels of β-catenin (4), a key inducer of the expression of transcription 
factors including Twist (5). Twist was found to be responsible for the suppression of SOX9 
activity (6) and therefore downregulation of DEL1 expression and initiation of dedifferentiation. 
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7 Discussion, Conclusion and Future Work 
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7.1 Quantification of changes in phenotypic markers in 
response to 2D culture 
 
Expansion and in vitro tissue engineering are novel promising techniques for 
treatment of OA, are challenged by the ultimate loss of chondrocytic phenotype 
in response to chondrocyte monolayer culture. We have aimed to further our 
knowledge of the phenotypic changes occurring upon chondrocyte expansion, 
with quantification when possible, of key differentiation markers including cell 
shape and actin organisation, expression battery and mechanotransduction. 
 
Prior to studying the effects of 2D culture, it was necessary to establish a 
standard culture methodology to eliminate errors incurred by variation in length 
of time in culture. Several culture densities in the literature were studied and cell 
viability assayed (HD, MD and LD; Johansen et al., 2001; Hamilton et al., 2005a; 
Hamilton et al., 2005b Stokes et al., 2002 Waymouth, 1974). Despite obtaining 
higher levels of cell death in LD when compared to other culture densities, there 
was a steady increase in cell number upon LD 2D culture, and time points for 
subculture were determined at 9, 14 and 21 days post culture (termed P1, P2 
and P3, respectively). Therefore, LD culture density was selected for cell culture 
methodology performed (Table 3.2). 
 
Some of the first and most obvious changes in phenotype include a switch in cell 
morphology from ‘round’ to a ‘flat’ fibroblast-like shape. These changes were 
further confirmed by studying the dimensions and sphericity factors of individual 
chondrocytes at different culture intervals using CLSM. It was confirmed that a 
loss of sphericity occurred as early as the 9th day in culture (P1) and was due to 
an increase in cell length (c) and a reduction in cell depth (a). These changes 
were also accompanied with an increase in chondrocyte cell volume which was 
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additionally confirmed by mathematical calculation from values obtained for 
cellular dimensions (Table 3.3). 
 
Furthermore, changes in the actin cytoskeleton were observed in response to 
culture with a visually assessable increase in trans-cellular actin organisation in 
the form of actin filaments. We devised a new method for the analysis of the 
localisation and number of actin ‘striation units’ enabling us to quantify these 
changes. There was a marked increase in the percentage of filamentous actin 
seen as early as the first passage (Figure 3.8), and these changes were 
confirmed by the increase of trans-cellular actin filaments (Figure 3.7). Similarly 
to alterations in cell volume, sphericity and dimensions, no further reorganisation 
of the actin cytoskeleton was observed in response to further culture.  
 
On a molecular level, the loss of chondrocyte phenotype in response to 2D 
culture was confirmed by studying changes in expression of key genes and a 
switch from chondrocyte-specific type II collagen to type I (represented as 
col2:col1). Firstly, the expression of DEL1 in bovine articular chondrocytes was 
confirmed using RT-PCR and western blot and upon 9 days in culture, there was 
an increase in DEL1 expression, only previously observed in hydrogel-cultured 
foetal chondrocytes (Stokes et al., 2002). Moreover upon 9 days in culture, there 
was a rise in type II collagen, type I collagen, differentiation transcription factor 
SOX9, dedifferentiation transcription factor Twist and a decrease in col2:col1 
expression, thereby indicating the loss of differentiated phenotype (Figure 3.9, 
Figure 6.3). While changes in col2:col1 expression have been widely reported in 
response to 2D culture (Benya & Shaffer, 1982b; Stokes et al., 2001), an 
increase in type II collagen was not previously observed. Upon further culture, 
however, there was no change in col2:col1 ratio, type I collagen or Twist but a 
decline in the expression level of type II collagen, SOX9 and DEL1 was 
recorded.  
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The effect of cellular expansion on mechanotransduction was also used as a 
key marker of chondrocytic phenotype as previous work has shown that RVI and 
Gd3+-sensitive rise in [Ca2+]i  (in response to hypo-osmotic conditions) were 
solely exhibited by 2D cultured chondrocytes (Kerrigan & Hall, 2008). We were 
able to confirm that whereas freshly isolated chondrocytes did not exhibit RVI, 
P1 2D cultured chondrocytes recovered cell volume in a linear fashion with a t½ 
of 9.60 minutes post challenge. Conversely, P2 and P3 chondrocytes exhibited 
a logarithmic and thus ‘biphasic’ volume recovery pattern with robust RVI at t½ = 
3.45 minutes and slow RVI similar to that observed in P1 chondrocytes (Table 
4.1). Actin organisation has been shown to regulate the capacity of 
chondrocytes to exhibit RVI, whereby treatment with LB (an actin deploymeris-
ing toxin) induced bumentanide-sensitive RVI in freshly isolated chondrocytes 
(Kerrigan et al., 2006). Therefore, the activation of RVI mechanisms upon 
culture, possibly via actin reorganisation and thus NKCC activation, may 
contribute to the increase in cell volume discussed previously.  
 
To investigate changes in mechanotransduction responses upon expansion, the 
calcium responses of freshly isolated and 2D cultured chondrocytes were 
studied using REV5901 as a pharmacological stimulus of [Ca2+]i  rise. It was 
observed that freshly isolated chondrocytes were more sensitive to REV5901 
loading compared to 2D cultured chondrocytes (Figure 4.4) and the decrease in 
sensitivity was confirmed to be due to a reduction in intracellular calcium store 
release upon 2D culture. It was previously reported that mechanical pressure 
not only induced a rise in [Ca2+]i  (Guilak et al., 1999a), but also increased the 
activity of IP3R channels on intracellular stores in 2D cultured chondrocytes 
(Zhang et al., 2006), thus suggesting a reduction in store sensitivity upon 
culture. Moreover, research has indicated that a rise in REV5901 provided 
chondrocytes with protective mechanisms from the effects of pressure, possibly 
via [Ca2+]i  rise (Amin et al., 2008, Parker et al., in press). Taken together, these 
data suggest that an increase in store sensitivity plays a crucial role in 
differentiatied load-bearing chondrocyte which may be lost upon 2D culture.  
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As the contribution of transmembrane extracellular calcium influx in response to 
REV5901 was not altered upon expansion, the participation of membrane 
channels was assayed by incubation with channel inhibitors prior to REV5901 
loading. Upon 2D culture, there was a decrease in inhibition of [Ca2+]i  rise in the 
absence of extracellular sodium and an increase in inhibition in the presence of 
Gd3+ indicating a decrease in  NCX activity and an increase in SACC activity 
(Figure 4.5). Previous work has reported a decrease in NCX expression in 
chondrocytes taken from OA tissue (Trujillo et al., 1999) suggesting that the loss 
of apparent NCX contribution is possibly due to a similar down-regulation of 
NCX upon 2D culture. Conversely, previous work has shown that inhibition of 
SACC using Gd3+ inhibited hypo-osmotic challenge-induced [Ca2+]i  rise in 2D 
cultured but not freshly isolated chondrocytes (Kerrigan & Hall, 2008) and 
induced a loss of phenotype in rat chondrosarcoma cell line (Perkins et al., 
2005) confirming our results that SACC activity is phenotype-dependent and/or 
phenotype-regulatory. 
 
These data demonstrated the existence of a third phenotype, termed 
mesodifferentiated, previously unrecorded as defined by the RVI response in P1 
chondrocytes and the expression battery ( 
 
 
 
 
 
Table 7.1). 
 
 
7.2 The role of DEL1 in the regulation of chondrocyte 
phenotype 
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As it has been shown that the expression of DEL1 was associated with the 
upregulation of SOX9, the potential role of SOX9 on DEL1 expression was 
investigated by biochemical induction of SOX9 using BMP2 (Minina et al., 2001).  
There was an increase in SOX9 expression in response to BMP2 treatment and 
that was associated with a rise in DEL1 expression, thus confirming that SOX9 
is necessary for DEL1 expression. Moreover, there was an increase in type II 
collagen expression confirming that observed changes are in response to SOX9 
upregulation. 
 
To further our understanding of the cause and effect relationship of DEL1 in 
chondrocyte 2D culture, the expression level of DEL1 and col2:col1 was further 
investigated within the first week of culture. There was a ∼10-fold increase in 
DEL1 expression 2 days following 2D culture and the expression declined upon 
further culture, whereas the decline in col2:col1 expression was initiated 
following 4 days in culture (Figure 5.2). These data proposed a role for DEL1 in 
the regulation of chondrocyte phenotype which was further investigated using 
anti-DEL1 siRNA molecules to induce DEL1 knockdown in P1 chondrocytes. 
 
Upon DEL1 knockdown, there was no increase in type I collagen expression in 
response to 2D culture and thus no decline in col2:col1 ratio indicating the 
preservation of a differentiated phenotype. Furthermore, DEL1 knockdown and  
pharmacological inhibition of β-catenin induced the knockdown of Twist 
expression suggesting that the expression of Twist is mediated by an integrin 
signal involving DEL1 and relayed by β-catenin (Figure 6.2, Figure 6.5). It has 
been therefore confirmed that β-catenin levels regulated the expression of Twist 
in chondrocytes as previously investigated by others (Reinhold et al., 2006). 
 
The effect of DEL1 on mechanotransduction responses was investigated upon 
knockdown in P1 chondrocytes to confirm observations of phenotype 
preservation in response to DEL1 knockdown. It has been shown that DEL1-
knockdown P1 chondrocytes did not exhibit slow RVI as observed in control 
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mock transfected P1 chondrocytes and this was possibly due to changes in actin 
organisation in response to DEL1 knockdown. Furthermore, the effect of DEL1 
on calcium channel activation was seen in the decrease in SACC contribution in 
response to knockdown, rendering DEL1(-)/P1 similar to freshly isolated 
chondrocytes in the regulation of calcium homeostasis (Table 5.3).  
 
Due to the apparent effect of DEL1 on various phenotypic markers, the role of 
DEL1 in initiating an integrin-mediated signal was investigated with Twist as the 
final target. Being a downstream element of various integrin-ligand interactions 
including EDIL3 ligand (Silvestre et al., 2005), Akt activity was studied in culture 
and in response to DEL1 knockdown. It was observed that upregulation of DEL1 
expression in P1 mesodifferentiated chondrocytes was associated with an 
increase in Akt activity, which was abolished in response to DEL1 knockdown 
(Figure 6.1, Figure 6.2).  
 
Finally, Twist has been shown to inhibit BMP2-induced differentiation and thus 
SOX9 function (Reinhold et al., 2006) and these findings were confirmed using 
anti-Twist siRNA to inhibit the expression of Twist in P3 chondrocytes and assay 
the expression of key genes. While Twist knockdown did not induce a significant 
switch in col2:col1 expression, a sharp increase in the expression of DEL1 and 
type II collagen, two product genes of SOX9 transcription, was observed. No 
change, however, was observed in the level of SOX9 expression suggesting that 
Twist inhibited SOX9 activity rather than expression. These findings thus 
completed an autocrine feedback loop whereby DEL1-induced Akt activation, β-
catenin accumulation and consequently Twist expression which in turn inhibited 
SOX9 expression and finalised the dedifferentiation process (Figure 6.11).  
 
 
7.3 Summary and concluding remarks 
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In summary, we have reported the existence of a new (possibly homogenous) 
chondrocyte population upon 9 days in culture with a phenotype previously 
undefined ( 
 
 
 
 
 
Table 7.1). Mesodifferentiated chondrocytes are characterised by an elevation of 
SOX9 and DEL1 expression, and a decrease in col2:col1 expression, 
suggesting that dedifferentiation occurs in a multi-step process. Elevated levels 
of DEL1 expression have been shown to induce a switch in phenotype via Akt & 
β-catenin activation and Twist (an antagonist of SOX9) upregulation.  
 
DEL1 knockdown induced an inhibition of a group of mesodifferentiated 
mechanotransduction markers including slow RVI and elevated SACC activity 
without significant effect on culture properties. Therefore these data suggested 
that longterm DEL1 knockdown may be used in expansion to maintain 
chondrocytic differentiated phenotype. 
 
Chondrocyte expansion and matrix-induced autologous chondrocyte implant-
ation (MACI) are currently under research in an attempt to offer a ‘cure’ for 
osteoarthritis, but due to difficulties in clinical testing, there has been relatively 
slow progress in the innovation of commercial technologies. The technique 
involves 2D culture of mature chondrocytes or mesenchymal stem cells (MSC) 
from a patient prior to introduction into a 3D scaffold, and is currently limited in 
potential due to several hurdles. 
 
Firstly, neither 2D cultured adult chondrocytes nor MSCs exhibit suitable 
phenotypes. Whilst adult chondrocytes lose their differentiated phenotype upon 
culture, MSC’s have shown inclination to differentiation into fibrocartilage or scar 
tissue rather than hyaline cartilage for reasons yet to be elucidated. One of the 
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sets of markers used to screen and monitor cultures of 2D cultured 
chondrocytes is the SOX transcription factors (Polak et al., 2008). The use of 
serum-free media for the culture of chondrocytes has been suggested to limit 
dedifferentiation, and despite retention of elevated levels of SOX9 and a 
reduction in cellular hypertrophy, the expression of type I collagen was not 
halted (Ho et al., 2009). We have shown that a longterm DEL1 knockdown is 
sufficient to maintain the upregulation of SOX9, type II collagen and thus the 
differentiated state, whilst inhibiting collagen type I. Moreover, DEL1(-) 
chondrocytes have demonstrated a decrease in hypertrophy and can be 
cultured effectively in standardised economical serum-enriched systems. 
 
Due to the conservation of phenotype, DEL1(-) 2D cultured chondrocytes 
retained the expression of type II collagen, thus offering the advantage of the 
capacity to produce and maintain a potentially cartilage-like matrix  upon 
introduction into 3D scaffold. This eliminates the need for synthetic matrices 
required for cell entrapment and strength. Finally and unlike conventionally 
selected cultures, DEL1(-) chondrocytes have additionally differentiated-like 
mechanotransduction responses including the lack of RVI and SACC activity. 
 
Future work to support these observations includes transfection using a viral 
vector containing an inducible promotor for the transfer of siRNA gene prior to 
culture in the presence of an inducer. Adenoassociated virus is a relatively safe 
choice with no risk of infections or insertional mutations, and upon integration, 
offers a constitutive siRNA expression. Upon successful knockdown and 
sufficient expansion, chondrocytes would be introduced to 3D scaffold for further 
investigation of phenotype, mechanotransduction and matrix metabolism. 
 
Several steps would be taken to improve current methodologies including the 
use of more selective inhibitors (or possibly the use of RNAi) for the 
investigation of individual membrane channel contribution to both RVI and 
[Ca2+]i rise. Additionally, the filament tracer add-on in Imaris 6.3.1 allows for the 
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creation of filamentous structures and calculates the number of branch points, 
thereby providing more sophisticated data with improved accuracy for the 
estimation of actin reorganisation (Figure 7.1). 
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Table 7.1: Summary of the properties of differentiated, mesodifferentiated and 
dedifferentiated chondrocytes as defined using key markers of phenotype. 
 
Marker Differentiated Mesodifferentiated Dedifferentiated 
DEL1 Low High Low 
sox9 Intermediate High Low 
col I Low High High 
col II Intermediate High Low 
col2:col1 High Low Low 
Twist Low High High 
Volume Low High High 
a High Low Low 
c Low High High 
ϕ  High Low Low 
StU Low High High 
Intracellular 
store release High Low Low 
NCX High Low Low 
SACC Low High High 
attachment rate Low High Low 
Akt activity Low High Low 
RVI None Slow Biphasic 
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Figure 7.1: New Analysis tool for the study of filamentous actin organisation. 
Confocal images of a P3 2D cultured chondrocyte stained for actin with phalloidin-alexa 488 was 
chosen at random for representative purposes, deconvolved and reassembled in Imaris 6.31 
(PanelA; Bitplane). The filament tracer add-on was used with default settings to produce 
filamentous structures (Panel B; red) and an isosurface object was added for the same channel 
(green) for illustration. Imaris filament tracer can be used to record various parameters including 
the number of branch points, number of filaments and length of filaments, and can therefore be 
used for future actin analysis.  
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